Stockwinners Market Radar for October 29, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
DKL | Hot Stocks20:49 EDT Delek Logistics raises quarterly dividend to $1.10 per share from 1.09 - The dividend is payable on November 14, 2024, to unitholders of record on November 8, 2024.
|
ABSI | Hot Stocks20:15 EDT Cathie Wood's ARK Investment bought 447K shares of Absci today
|
ACHR | Hot Stocks20:14 EDT Cathie Wood's ARK Investment bought 830K shares of Archer Aviation today
|
KZR | Hot Stocks19:50 EDT Kezar Life Sciences trading halted, news pending
|
RDDT | Hot Stocks18:47 EDT Reddit CEO: We've been working hard at profitability - In an interview on CNBC's Mad Money, Steve Huffman said Reddit is growing revenue "substantially faster" than costs. Reddit is a place advertisers need to be, he noted. Currently, 50% of the company's users are in the U.S. and 50% are outside. Huffman expects the majority of both user and revenue growth to occur outside the U.S. going forward.
|
COIN V | Hot Stocks18:32 EDT Coinbase to integrate Visa Direct network to deliver real-time account funding - Visa (V) announced a partnership with Coinbase (COIN). This partnership adds convenience and new services for Coinbase customers across the U.S. and EU, including real-time, reliable, and secure money movement. By integrating with the Visa Direct network, Coinbase customers will be able to deposit funds into their Coinbase account in real-time using eligible Visa debit cards. Coinbase already has millions of users with a debit card connected to their account, and this new feature will help unlock real-time delivery of account funds for those using an eligible Visa debit card. This will allow customers to quickly add funds offering them more flexibility to take advantage of trading opportunities, which can be critical in a dynamic crypto environment. Visa Direct delivers quick and secure money movement and further helps to bridge the gap between traditional finance and blockchain technologies, helping to minimize waiting periods for fund availability.
|
BIIB | Hot Stocks18:01 EDT Biogen, Neomorph announces multi-target research collaboration - Biogen announced a research collaboration to discover and develop molecular glue degraders for priority targets in Alzheimer's, rare neurological, and immunological diseases. As part of the collaboration, the companies aim to utilize Neomorph's proprietary molecular glue discovery platform to accelerate the identification and validation of novel small molecule therapeutic molecular glue degraders. Small molecule protein degraders have been shown to effectively drug challenging targets with differentiated pharmacology from more traditional inhibitors. Pursuing innovative solutions aimed at modulating protein levels through targeted degradation holds promise for treating complex neurological, immunological and rare diseases. This collaboration will leverage Neomorph's research strengths in targeted protein degradation and Biogen's deep scientific expertise and drug development capabilities. "As part of our modality agnostic research strategy, Biogen is committed to investing in new approaches to unlock biological targets that have remained difficult to reach," said Jane Grogan, Ph.D., Head of Research at Biogen. "This collaboration with Neomorph reflects the approach we want to take to pair our internal drug development expertise with cutting-edge external innovation to create clinically meaningful therapies for patients." Under the terms of the agreement, Biogen and Neomorph will collaborate to identify, validate, and optimize small molecule molecular glue degraders for several high-priority targets and Biogen will advance clinical candidates for further development and potential commercialization. Neomorph will receive an upfront payment and is eligible to receive contingent milestone payments per target as the collaboration progresses through various stages. These include certain pre-clinical milestones payable in the near-term and certain clinical, regulatory, commercial and sales milestones that are anticipated to occur later this decade and beyond, for a total consideration of up to $1.45B. Biogen will reimburse Neomorph for certain research development costs. Neomorph is also eligible to receive potential future royalties in the mid-single digit to low double-digit range.
|
CZR | Hot Stocks18:00 EDT Caesars says received inquiries about asset sales, but nothing is active - Says "not optimistic" about entering Florida online gambling in the near term. Expects $400M per year in maintenance CapEx long term.
|
FSUN HMST | Hot Stocks17:41 EDT FirstSun, HomeStreet announce regulatory approvals for mergers not obtained - FirstSun (FSUN) ("FirstSun") and HomeStreet (HMST) announced that, based on discussions FirstSun and its subsidiary, Sunflower Bank, have had with the Federal Reserve and the Texas Department of Banking, that regulatory approvals necessary for the mergers with HomeStreet and its subsidiary, HomeStreet Bank to proceed have not been obtained and FirstSun and Sunflower have been asked to withdraw their merger applications. FirstSun and HomeStreet are discussing the pursuit of an alternative regulatory structure for the merger. The parties are also discussing terms on which they would terminate the merger agreement if no alternative structure is feasible. There can be no assurance that an alternative regulatory structure may ultimately be feasible.
|
FHN | Hot Stocks17:35 EDT First Horizon announces new $1B common stock repurchase program - First Horizon announced that its board of directors has authorized a new $1B common stock repurchase program to replace the company's prior repurchase program, effective as of the close of business on October 29. This new authorization will expire on January 31, 2026. The terminated program had approximately $174M of remaining authorization and was set to expire on January 31, 2025.
|
PDS | Hot Stocks17:32 EDT Precision Drilling expects long-term global energy demand to remain positive - The company said, "The long-term outlook for global energy demand remains positive with rising demand for all types of energy including oil and natural gas driven by economic growth, increasing demand from third-world regions, and emerging energy sources of power demand. Oil prices are constructive, and producers remain disciplined with their production plans while geopolitical issues continue to threaten supply. In Canada, the recent commissioning of the Trans Mountain pipeline expansion and the startup of LNG Canada projected in 2025 are expected to provide significant tidewater access for Canadian crude oil and natural gas, supporting additional Canadian drilling activity. In the U.S., the next wave of LNG projects is expected to add approximately 11 bcf/d of export capacity from 2025 to 2028, supporting additional U.S. natural gas drilling activity. Coal retirements and a build-out of AI data centers could provide further support for natural gas drilling. In Canada, we currently have 75 rigs operating and expect this activity level to continue until spring breakup, except for the traditional slowdown over Christmas. Our Canadian drilling activity continues to outpace 2023 due to increased heavy oil drilling activity and strong Montney activity driven by robust condensate demand and pricing. Since the startup of the Trans Mountain pipeline expansion in May, customer activity in heavy oil targeted areas has exceeded expectations, resulting in near full utilization of our Super Single fleet. Customers are benefiting from improved commodity pricing and a weak Canadian dollar. Our Super Triple fleet, the preferred rig for Montney drilling, is also nearly fully utilized and with the expected startup of LNG Canada in mid-2025, demand could exceed supply. In recent years, the Canadian market has witnessed stronger second quarter drilling activity due to the higher percentage of wells drilled on pads in both the Montney and in heavy oil developments. Once a pad-equipped drilling rig is mobilized to site, it can walk from well to well and avoid spring break up road restrictions. We expect this higher activity trend to continue in the Q2 of 2025. In the U.S., we currently have 35 rigs operating as drilling activity remains constrained by volatile commodity prices, customer consolidation and budget exhaustion. We view these headwinds as short-term in nature, which will continue to suppress activity for the remainder of the year and into 2025. However, looking further ahead, we expect that a new budget cycle, the next wave of Gulf Coast LNG export facilities, and new sources of domestic power demand should begin to stimulate drilling. Internationally, we expect to have eight rigs running for the remainder of 2024, representing an approximate 40% increase in activity compared to 2023. All eight rigs are contracted through 2025 as well. We continue to bid our remaining idle rigs within the region and remain optimistic about our ability to secure additional rig activations. As the premier well service provider in Canada, the outlook for this business remains positive. We expect the Trans Mountain pipeline expansion and LNG Canada to drive more service-related activity, while increased regulatory spending requirements are expected to result in more abandonment work. Customer demand should remain strong, and with continued labor constraints, we expect firm pricing into the foreseeable future. We believe cost inflation is largely behind us and will continue to look for opportunities to lower costs.
|
NGD | Hot Stocks17:24 EDT New Gold lowers FY24 gold production view to 300,000-310,000 ounces - CEO Patrick Godin commented, "On an asset basis, New Afton full-year gold production is expected to be at the top end of the guidance range and Rainy River gold production is expected to be lower than planned, mainly due to less high-grade tonnes on two open pit benches, and our decision to voluntarily suspend operations in July and gradually return to full production. Considering the performance to date, and after reviewing the open pit ore blocks planned at Rainy River in the Q4, together with the excellent performance at New Afton, we are confident in our updated consolidated production forecasts to the end of this year and our previously provided 2025 and 2026 outlook. Furthermore, through operational discipline and capital management, we continue to successfully manage costs to generate significant free cash flow and offset the financial impact of lower production at Rainy River. Following the free cash flow inflection point, achieved in the middle of this year, and with the completion of key growth project milestones, the Company is well positioned to continue delivering on our targets and leverage the current metal price environment". Gold production is expected to be in the range of 300,000-310,000 ounces, previously 310,000 to 350,000 ounces. New Afton gold production is expected to be at the top end of the guidance range of 60,000-70,000 ounces. Rainy River gold production is expected to be in the range of 230,000-240,000 ounces, previously 250,000 to 280,000 ounces. Copper production is expected to be at the mid-point of the guidance range of 50 to 60 million pounds. Cash costs are trending in-line with the mid-point of the guidance range of $725 to $825 per gold ounce sold, on a by-product basis, despite the slightly lower gold production outlook and lower capitalized waste stripping, as a result of lower mining and processing costs, achieved through operational discipline at both operations, and higher by-product revenues from higher copper prices. Overall, the unit mining cost per tonne is lower than plan due to operational efficiency improvements and cost reduction initiatives. All-in sustaining costs are expected to be at the low end of the guidance range of $1,240 to $1,340 per gold ounce sold, on a by-product basis, as a result of strong cash costs and lower sustaining capital spend. Rainy River's all-in sustaining costs are expected to be at the top end of its guidance range as lower mining and processing costs offset the lower expected production. All-in sustaining costs at New Afton are expected to be below the low end of its guidance range. Operating expenses per gold ounce (co-product) are now tracking to the high end or slightly above the top end of the guidance range of $965-$1,065 per gold ounce sold as a result of lower capitalized waste stripping and slightly lower gold production, which offset the impact of lower mining and processing costs. Operating expenses per copper pound are trending in-line with the mid-point of the guidance range of $1.90-$2.40 per copper pound sold. Sustaining capital is tracking approximately $20 million below the low end of the guidance range of $115M-$130M due to efficient capital management, savings related to execution of the Rainy River tailings dam raise, lower capitalized waste stripping and timing of capital spend at New Afton. Growth capital is tracking to the low end of the guidance range of $175M-$200M, due to efficient capital management and early commissioning of the materials handling system at New Afton.
|
CZR | Hot Stocks17:23 EDT Caesars 'remains optimistic' regarding operating trends - Expects "strong" Q4. Says "future very bright" for digital business. Sees FY25 CapEx $600M-$650M. Says debt reduction "remains the number one priority." Says discussions around non-core asset sales are "ongoing." Expects free cash flow to "increase dramatically" going forward. Comments taken from Q3 earnings conference call.
|
GOOG GOOGL | Hot Stocks17:22 EDT Alphabet sees Q4 capital expenditures similar to levels in Q3 - Says Maps surpassed 2B user milestone. Says Lens is one of the fastest growing queries on Search. Says very pleased with Google Cloud growth. Says NFL Sunday Ticket continues to receive positive feedback from advertisers, NFL and fans. Says pleased with progress made in reengineering cost structure. Says there will be a headwind to year-over-year growth in subscription platforms and devices revenue in Q4 due to pull forward of Made by Google launches into Q3 of this year. Says invested $13B of capital expenditures in Q3. Says 60% of investment in technical infrastructure went towards servers with 40% towards data center and network equipment. Says has been an exciting year with Waymo. Says has scaled paid rides. Says positive surprise how much consumers are loving the Waymo experience. Says pace to enter a new city is accelerating. Says YouTube Shorts watch time has particular strength. Says over 70B Youtube Shorts are watched every day. Says Gemini app has strong momentum on user growth. Comments and guidance taken from Q3 earnings conference call.
|
ECG... | Hot Stocks17:20 EDT Everus to replace Clearwater Paper in the S&P 600 at open on 11/1 - Everus Construction Group (ECG) will be added to the S&P SmallCap 600 effective prior to the opening of trading on Friday, November 1, replacing Clearwater Paper Corp. (CLW), which will be removed from the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 4. S&P SmallCap 600 constituent MDU Resources Group (MDU) is spinning off Everus Construction Group in a transaction expected to be completed on November 1. Following the spin-off, the parent company MDU Resources Group will remain in the S&P SmallCap 600 but will change its Global Industry Classification Standard, GICS, sector from Industrials to Utilities. Clearwater Paper is no longer representative of the small-cap market space.
|
RTX | Hot Stocks17:18 EDT RTX awarded $118.45M Navy contract modification - RTX was awarded a $118.45M firm-fixed-price modification to previously award contract for fiscal 2025 Navy procurements for Rolling Airframe Missile Block 2/2A/2B Guided Missile Round Pack, spare replacement components, and recertification. Work is expected to be completed by July 2028. This contract was not competitively procured in accordance with 10 U.S. Code 3204(a) (4), International Agreement. Naval Sea Systems Command is the contracting activity.
|
NOC | Hot Stocks17:14 EDT Northrop Grumman awarded $167.93M Navy contract modification - Northrop Grumman was awarded a $167.93M modification to a firm-fixed-price, indefinite-delivery/indefinite-quantity contract. This modification exercises option contract line items, or CLIN, 1001 and 2001 and increases the contract ceiling for the production of 50,000 FMU-139D/B Bomb Tactical Electronic Fuze systems, 25,000 for CLIN 1001, and 25,000 for CLIN 2001, in support of the Joint Direct Attack Mission family of weapons for the Navy, Air Force, and Foreign Military Sales customers. Work is expected to be completed in December 2029. No funds will be obligated at the time of award, funds will be obligated on individual orders as they are issued. This contract was not competed. Naval Air Systems Command is the contracting activity.
|
ESGR | Hot Stocks17:10 EDT Enstar Group announces Paul Brockman as CCO, Adrian Thornycroft as CAO - Enstar Group announced changes to its executive leadership team in connection with the upcoming retirement of Orla Gregory, president, at the end the year, and the expanding role of Enstar in the insurance industry. Paul Brockman has been appointed as chief commercial officer, or CCO, with immediate effect. Paul has been with Enstar since 2012, most recently in the role of group COO. Adrian Thornycroft will join as chief administrative officer, or CAO, in May 2025. Thornycroft will be based in Bermuda and will assume a number of responsibilities from Orla as well as take a leading role with respect to change strategy.
|
CZR | Hot Stocks17:09 EDT Caesars signs agreement to sell LINQ Promenade for $275M - Caesars Entertainment (CZR) announced an agreement to sell the LINQ Promenade to a joint venture to be formed between TPG Real Estate and the Investment Management Platform of Acadia Realty Trust (AKR) for $275M. This sale is subject to customary approvals and other closing conditions and is expected to close during the Q4. "The sale of the LINQ Promenade represents an accretive, non-core asset sale that will accelerate our debt reduction goals. I want to thank all the team members and the tenants of the LINQ Promenade for their partnership over the last 10 years and wish them continued success," said Tom Reeg, CEO of Caesars Entertainment. Latham & Watkins and Brownstein Hyatt Farber and Schreck, represented Caesars on the transaction. Kirkland & Ellis provided transaction counsel to TPG & Acadia.
|
USAC PXD | Hot Stocks17:06 EDT USA Compression names Christopher Paulse as new CFO - USA Compression (USAC) "announced that Christopher M. Paulsen will join the company on November 18, 2024 as its new Chief Financial Officer. Chris comes to USA Compression with over 20 years in the energy industry, most recently serving as the Senior Vice President of Business Development and Strategy at Pioneer Natural Resources (PXD)."
|
MASI | Hot Stocks17:06 EDT Masimo continues to evaluate strategic alternatives for consumer segment - As previously announced, Masimo continues to evaluate strategic alternatives for its consumer segment.
|
MASI | Hot Stocks17:05 EDT Masimo backs Q3 adjusted EPS view 81c-86c, consensus 84c - Backs Q3 revenue view $495M-$515M, consensus $502.67M.
|
CZR AKR | Hot Stocks17:04 EDT Caesars signs agreement to sell LINQ Promenade for $275MAcadia Realty Trust - Caesars Entertainment (CZR) announced an agreement to sell the LINQ Promenade to a joint venture to be formed between TPG Real Estate and the Investment Management Platform of Acadia Realty Trust (AKR) for $275M. This sale is subject to customary approvals and other closing conditions and is expected to close during the Q4. "The sale of the LINQ Promenade represents an accretive, non-core asset sale that will accelerate our debt reduction goals. I want to thank all the team members and the tenants of the LINQ Promenade for their partnership over the last 10 years and wish them continued success," said Tom Reeg, CEO of Caesars Entertainment. Latham & Watkins and Brownstein Hyatt Farber and Schreck, represented Caesars on the transaction. Kirkland & Ellis provided transaction counsel to TPG & Acadia.
|
MASI | Hot Stocks17:04 EDT Masimo board adopts resolutions to terminate CEO Kiani's employment - According to a regulatory filing, following a review by outside counsel, on October 24, 2024, the Board of Directors of Masimo adopted resolutions to terminate the employment of Masimo's Chief Executive Officer, Joe Kiani, effective October 24, 2024. As previously reported, the Board has appointed Michelle Brennan as Interim Chief Executive Officer.
|
OII | Hot Stocks17:02 EDT Oceaneering acquires Global Design Innovation - Oceaneering International "announced that it has acquired Global Design Innovation Ltd., a UK-based provider of digital and software services. This acquisition is a key step in Oceaneering's strategy to advance its digital capabilities and broaden the solutions available to its global clients. As the only provider certified by the United Kingdom Accreditation Service (UKAS) to perform remote visual inspection using point cloud data and photographic images, GDi brings advanced algorithms and data solutions that, when combined with Oceaneering's engineering expertise, will strengthen Oceaneering's ability to optimize asset management for clients in industries including oil and gas, utilities, and power generation. GDi's suite of solutions, including its Vision software, complements Oceaneering's portfolio by supporting enhanced safety, data quality and integrity, and cost efficiency for customers worldwide."
|
BAC | Hot Stocks17:01 EDT Bank of America falls 1% to $42.06 after commenting on possible sanctions
|
BAC | Hot Stocks17:01 EDT Bank of America says laundering sanctions may include public orders - Bank of America disclosed in its quarterly filing: "The Corporation has been engaged with several of its federal regulators in relation to certain aspects of the Corporation's Bank Secrecy Act/anti-money laundering and sanctions compliance programs, including transaction monitoring, training, governance, and customer due diligence. In cooperation with regulators, the Corporation has been, and plans to continue, implementing enhancements to these Programs. The Corporation is continuing discussions with its regulators about the Programs, and resolution of these discussions may include one or more public orders by the regulators. Based on these discussions, the Corporation does not expect these issues relating to the Programs will have a material adverse financial impact on the Corporation."
|
SLE | Hot Stocks16:54 EDT Super League Enterprise announces iR acquires 1.22M shares of common stock - Super League Enterprise announced that, as an initial step in the previously announced equity exchange transfer, Infinite Reality, or iR, has acquired 1,215,279 shares of Super League common stock. The exchange transfer will be finalized following the SLE annual general meeting with iR's ownership totaling 9.9% of Super League common shares outstanding.
|
ENVX | Hot Stocks16:51 EDT Enovix, smartphone OEM execute development pact for mass production in 2025 - Enovix announced that it executed a development agreement with a global smartphone OEM with top five market share in China. Under the terms of the agreement and subject to applicable milestones, the companies will develop a 100% active silicon anode battery customized for specific smartphone models targeted for launch in Q4 2025.
|
LFVN | Hot Stocks16:49 EDT LifeVantage announces results from MindBody GLP-1 System trial - LifeVantage announced results from a human clinical trial performed on the new MindBody GLP-1 System. Results from the trial included a 140% average increase in GLP-1 levels in the body leading to an average weight loss of nine pounds in eight weeks and up to 25 pounds in 12 weeks in participants. Production of GLP-1 in the body declines due to age, poor diet, stress, or other lifestyle factors. The decline can cause cravings, false hunger, and weight gain. The MindBody GLP-1 System uses ingredients to directly activate natural GLP-1 production in L-cells, supporting that activation indirectly by optimizing the gut microbiome to create short-chain fatty acids and fuel production. The 12-week human clinical trial began in early June and set out to investigate if, through these mechanisms of action, the MindBody GLP-1 System could holistically and sustainably increase GLP-1 hormone levels in overweight adults, without unwanted side effects. The study was conducted by independent researchers at Lighthouse Research. Sixty subjects ages 31-78 years with a BMI of 25 were randomized into three groups: a control group with no product use, a group using the MindBody GLP-1 System without diet and exercise guidelines, and a group using the MindBody GLP-1 System with diet and exercise guidelines. Subjects were evaluated every four weeks. Visits included anthropometric and biometric measurements, before and after photographs, food behavior questionnaires, and blood work for GLP-1 analysis. Twelve-week findings from the human trial include: 140% increase of GLP-1 on average; 92% of participants lost weight, with an average of 11 pounds; 92% saw a reduction in total body fat, with up to a 5.5% decrease; 71% experienced a reduction in visceral fat, with up to a 27% decrease; 100% of subjects who lost weight maintained or saw an increase in muscle %, with up to a 2.7% increase. No side effects were reported, including gastrointestinal issues. In addition to these physical results, participants reported notable changes in their relationship with food: 85% agreed their food cravings decreased; 95% agreed their sugar cravings decreased; 96% agreed their portion sizes at each meal decreased and 85% agreed they now eat for health, not emotional reasons; 82% felt more in control of their relationship with food. The clinical trial builds on in vitro research, which found that the MindBody GLP-1 System significantly increased GLP-1 production in L-cells by activating key genes. The in vitro study also revealed a 38% reduction in DPP-4 gene expression, allowing more GLP-1 to remain active within the body, and a 53% increase in GLP1R expression, which promotes the creation of GLP-1 cell receptors, further enhancing the body's ability to use GLP-1.
|
SPRO | Hot Stocks16:44 EDT Spero suspends development of SPR720, to reduce workforce by 39% - Spero Therapeutics announced that a planned interim analysis of the Phase 2a proof-of-concept study of SPR720 for the treatment of NTM-PD demonstrated that the program did not meet its primary endpoint. While the data showed antimicrobial activity associated with SPR720, the interim analysis did not show sufficient separation from placebo and highlighted potential dose limiting safety issues in subjects dosed at 1,000 mg orally once daily, including three cases of reversible grade 3 hepatotoxicity. In evaluating the totality of both the efficacy and safety data, the company has elected to suspend its current development program for SPR720 and will evaluate other potential paths forward as the remaining data are collected and analyzed. As a result of the suspension of the current SPR720 development program, Spero will undergo a restructuring and reduction in force of approximately 39%, which will extend cash runway and support operations into mid-2026, to further support the development of tebipenem HBr, SPR206, and potential strategic activities. Following the reduction in force and restructuring, Spero estimates that its existing cash and cash equivalents, together with earned and non-contingent development milestone payments from GSK, as well as other non-dilutive funding commitments, will be sufficient to fund its operating expenses and capital expenditures into mid-2026. During this period, the company remains focused on advancing tebipenem HBr in the ongoing global PIVOT-PO Phase 3 clinical trial and preparing for a Phase 2 clinical trial for SPR206 contingent on continued non-dilutive funding.
|
FLG | Hot Stocks16:42 EDT Flagstar Bank appoints Christopher Higgins as Chief Information Officer - Flagstar Bank, a subsidiary of Flagstar Financial, announced the appointment of two senior leaders to its technology and risk teams, effective immediately. Christopher Higgins, SEVP, is appointed as Chief Information Officer. Christopher brings nearly 40 years of executive leadership experience in banking to Flagstar. His expertise includes transformations, acquisitions, and developing technology and data solutions that enhance both customer and employee experiences. Most recently, Christopher served at U.S. Bank where he led 13 post-merger systems conversions, integrating 1.2M customers and 57 systems. Rich Martin, is appointed as Head of Credit Review. Rich brings nearly 30 years of executive leadership and credit review experience to Flagstar, with a strong foundation in credit risk management. His expertise includes leading large credit risk review teams with international mandates and reporting directly to board committees. He also has experience in Big Four consulting for global banks and has worked in commercial lending across corporate, middle market, and small business sectors.
|
ENSG CTRE | Hot Stocks16:42 EDT Ensign Group to add eight nursing operations in Tennessee, one in Alabama - Ensign Group (ENSG) announced today that it has agreed to add eight skilled nursing operations in the state of Tennessee and one in Alabama, subject to the completion of certain regulatory approvals and other closing conditions. Six of these operations will be jointly owned by CareTrust REIT (CTRE) and a large, private joint venture investor and will transition to Ensign affiliated operating companies subject to a new, long-term triple net master leases, and three will be purchased by Standard Bearer Healthcare REIT, Inc., Ensign's captive real estate subsidiary. All nine operations will be operated by Ensign affiliated operating companies. It is anticipated that the transaction will be effective in the next few months. Upon closing this transaction, Ensign's portfolio will consist of 332 healthcare operations, 30 of which also include senior living operations, across 15 states. Ensign will also own 125 real estate assets, 95 of which it operates.
|
NVRO | Hot Stocks16:40 EDT Nevro announces publication of new data from SCS stimulation study - Nevro announced the publication of new data in the Journal of Pain Research demonstrating significant, durable pain relief and long-term and clinically meaningful reductions in hemoglobin A1c, or HbA1c, and weight in study participants with painful diabetic neuropathy, or PDN, and Type 2 diabetes who received 10 kHz high-frequency spinal cord stimulation, or SCS, therapy. Globally, the number of people with diabetes has quadrupled in the last two decades, and PDN impacts up to 25% of all people with diabetes. PDN can have significant impacts on the quality of life for people living with this condition, with symptoms like numbness, tingling/paresthesia, loss of protective sensation, impaired balance, and reduced response to sensory stimuli.The analysis evaluated 144 patients with Type 2 diabetes and refractory PDN who received 10 kHz SCS therapy during the SENZA-PDN randomized controlled trial, or RCT, the largest RCT to evaluate SCS to treat PDN. Changes in pain intensity, HbA1c, weight, and sleep were evaluated over 24 months, with participants stratified according to preimplantation HbA1c. At 24 months, the following benefits were noted: Significant, durable pain relief; clinically meaningful, statistically significant mean reductions in HbA1c; Significant mean weight loss; and Significant, durable reductions in pain interference with sleep. The 24-month data from the SENZA-PDN RCT were originally published in Diabetes Research and Clinical Practice in 2023.
|
FSP | Hot Stocks16:37 EDT Franklin Street reports Q3 FFO 10c, one estimate 3c - Reports Q3 revenue $29.7M vs. $36.9M last year. The company states: "As the fourth quarter of 2024 begins, we continue to believe that the current price of our common stock does not accurately reflect the value of our underlying real estate assets. We will seek to increase shareholder value by continuing to (1) pursue the sale of select properties when we believe that short to intermediate term valuation potential has been reached and (2) strive to increase occupancy through leasing of vacant space. We intend to use proceeds from property dispositions primarily for debt reductions. During the third quarter of 2024, we leased a total of approximately 92,000 square feet of office space within our approximately 5.0 million square foot directly-owned property portfolio. During the third quarter of 2024, we completed the sale of our last property in the Commonwealth of Virginia on July 8, 2024. The property, located in Glen Allen and known as Innsbrook, sold for a gross selling price of $31 million. On July 10, 2024, we repaid approximately $25.3 million of our debt with a portion of the net proceeds of the Innsbrook disposition. On October 23, 2024, we completed the sale of our last property in Atlanta, Georgia. The property, known as Pershing Park Plaza, sold for a gross selling price of $34 million. On October 25, 2024, we repaid approximately $27.4 million of our debt with a portion of the net proceeds from the Pershing Park Plaza disposition. As of October 25, 2024, our total indebtedness was approximately $250.3 million, equivalent to approximately $52 per square foot on our remaining approximately 4.8 million square foot directly-owned property portfolio."
|
SNAP | Hot Stocks16:37 EDT Snap backs FY24 adjusted operating expense view $2.425B-$2.525B - The company said in prepared remarks ahead of its quarterly earnings call, "From a cost structure perspective, we are tracking well against our full year cost structure guidance. For Infrastructure, our guidance was for quarterly costs of $0.83 to $0.85 per DAU. We hit the mid-point of this range in Q3, and with growing ML and AI capacity utilization being partially offset by the benefit of recent pricing improvements, we anticipate being nearer the top end of this range in Q4. For all Other Cost of Revenue, our guidance range was 19% to 21% of revenue. We came in at the low end of this range in Q3, and anticipate being within the range again in Q4. For Adjusted Operating Expenses we provided full year guidance of $2.425 billion to $2.525 billion. In Q3 our annualized run rate was consistent with the low end of this range, and with modest sequential growth forecasted for Q4, we expect to be near the low end of the range for the full year. For SBC and related expenses, we guided for a range of $1.13 billion to $1.20 billion for the full year. In Q3, the annualized run rate of our SBC expense was below the low end of this range. We anticipate modest sequential growth in SBC expense in Q4 and therefore anticipate we will come in 4% to 5% below the low end of our guidance range for the full year. Given the revenue range above, and the progress we have made to optimize our cost structure, we estimate that Adjusted EBITDA will be between $210 million and $260 million in Q4. Given the strength of our balance sheet, our progress towards sustained free cash flow generation, and our desire to opportunistically manage our share count for the benefit of our long term shareholders, we have authorized a new share repurchase program in the amount of $500 million. As we move forward, we will remain focused on prioritizing our investments carefully to drive topline growth alongside improved financial performance."
|
SPRO | Hot Stocks16:35 EDT Spero Therapeutics trading resumes
|
CSTL | Hot Stocks16:33 EDT Castle Biosciences to present new TissueCypher data at ACG 2024 - Castle Biosciences announced new data demonstrating a significant reduction in healthcare management costs and an improvement in the quality of life for patients with Barrett's esophagus, or BE, whose management is guided by its TissueCypher test. The data was presented at the 2024 American College of Gastroenterology - ACG 2024 - Annual Scientific Meeting, being held Oct. 25-30, in Philadelphia. This study evaluated the cost-effectiveness of TissueCypher-guided management for patients with BE. The data demonstrated that care guided by the test can significantly reduce patient management costs due to de-escalated care for patients with low-risk test results and escalated care for patients with higher-risk test results. In addition to significant cost savings to the healthcare system, the study highlights how care guided by the TissueCypher test can improve patient quality of life and health outcomes, as well as contribute to a significant reduction in the incidence of HGD/EAC by 58.4% and EAC-related death by 59.6%.
|
CHWY | Hot Stocks16:31 EDT Keith Gill disposes of Chewy stake, reports holding no shares - Keith Gill, also known as "Roaring Kitty," disclosed a 0% stake in Chewy in a new 13G filing with the SEC. In July, the trader known for his YouTube and other social media appearances to discuss stocks, had disclosed a 6.6% stake in Chewy, which represented just over 9M shares.
|
CHWY | Hot Stocks16:30 EDT Chewy drops 2% after Keith Gill discloses stake is sold - The shares are down 2% to $26.25 in after-hours trading.
|
FE | Hot Stocks16:24 EDT FirstEnergy raises 2024 capital investment plan to $4.6B from $4.3B
|
DNB | Hot Stocks16:22 EDT Dun & Bradstreet, Databricks expand collaboration - Dun & Bradstreet has expanded its collaboration with Databricks, the Data and AI company, to deliver its comprehensive business data and analytics on hundreds of millions of businesses and other commercial entities around the globe through the Databricks Marketplace. This partnership utilizes the Databricks Data Intelligence Platform to enhance the accessibility and scalability of Dun & Bradstreet's in-depth datasets and analytical insights. As a result of this expansion, organizations will benefit from near real-time updates to business records, risk information and commercial opportunities, helping to optimize workflows and improving decision-making. From compliance challenges and credit decisioning, to ESG reporting and supply chain modelling, leaders will be better placed to identify areas for growth, manage risk and achieve a deeper understanding of customers and prospects. This broader collaboration will enable customers to leverage Dun & Bradstreet's global datasets using Databricks' Delta Sharing, providing seamless and secure access to company and financial insights. This integration improves time to value and offers a trusted foundation for both data delivery and AI capabilities.
|
CTRE... | Hot Stocks16:21 EDT CareTrust REIT to acquire portfolio of nursing facilities for about $500M - CareTrust REIT, Inc. (CTRE) announced that, together with a joint venture partner, it has entered into a binding agreement to acquire a portfolio of skilled nursing facilities for a purchase price of approximately $500 million. The portfolio consists of 31 skilled nursing facilities and a total of 3,290 licensed beds, with 30 of the facilities located in Tennessee and 1 in Alabama. The acquisition is subject to customary closing conditions, and there can be no assurance that the transaction will close in the anticipated timeframe, or at all. The Company anticipates that the transaction will close in the fourth quarter of 2024. It is anticipated that most of the facilities will be operated by existing CareTrust tenant relationships, including affiliates of The Ensign Group (ENSG), PACS Group, Inc. (PACS), and Links Healthcare Group. PACS has agreed to operate 12 of the facilities, Ensign affiliates 9 of the facilities, and Links 7 of the facilities. Three facilities will be master leased to a regional operator that is a new tenant relationship for CareTrust. Three of Ensign's 9 facilities will be acquired by Ensign's real estate subsidiary with the remaining 6 to be included in a new master lease. The acquisition will be completed through a joint venture arrangement entered into between CareTrust and a large third-party healthcare real estate owner. In connection with the joint venture's acquisition of the portfolio, CareTrust expects to provide a combined common equity and preferred equity investment amount totaling approximately $442 million at an initial contractual yield on its combined preferred and common equity investments in the joint venture of approximately 9.0%.
|
GVP | Hot Stocks16:20 EDT GSE Systems shareholders approve merger with Pelican Energy Partners - GSE Solutions announced that its stockholders overwhelmingly approved its merger with an affiliate of Pelican Energy Partners. Pursuant to the terms of the merger agreement, dated August 8, and amended October 20, Pelican will acquire all of the outstanding common stock of GSE for $4.60 per share.
|
IMKTA | Hot Stocks16:19 EDT Ingles Markets provides update on impact from Hurricane Helene - Ingles Markets "announced improvements since Hurricane Helene impacted the operation of both the company's stores and its distribution center. Of our 198 stores, 194 stores are currently open. Four of our stores sustained damage due to flooding and winds and are temporarily closed. We expect all four to reopen over the next three to nine months. Our distribution center is fully operational and has returned to normal operations. We have currently estimated that the financial impact of inventory and property loss will be between $35 and $55 million, for which we expect between $10 to $15 million of insurance reimbursement, and such impact will be included in our results of operations for our fiscal quarter and year ended September 28, 2024."
|
ASB | Hot Stocks16:19 EDT Associated Banc-Corp raises quarterly dividend to 23c from 22c per share - The Board of Directors of Associated Banc-Corp declared a regular quarterly cash dividend of 23c per common share, payable on December 16 to shareholders of record at the close of business on December 2.
|
PRO | Hot Stocks16:18 EDT Pros Holdings CEO Reiner to retire - Pros Holdings announced that its President and Chief Executive Officer, Andres Reiner, intends to retire from the Company. Mr. Reiner will remain in his role through the completion of the search for his successor and serve as an advisor for a 12-month period thereafter to ensure a seamless succession. The Company's Board of Directors is executing its succession plan and searching for the next CEO with the assistance of a nationally recognized executive search firm. "I'm incredibly proud of where PROS is as a business and the strong leadership team we have in place. Our strategy, platform, and people are well positioned to continue to set the standard for innovation in our market and drive sustainable long-term growth," said President and CEO Andres Reiner. "We are committed to finding the best candidate to continue on our mission of helping people and companies outperform, and I look forward to supporting my successor through a successful transition."
|
CELH PEP | Hot Stocks16:18 EDT Celsius Holdings names Israel Kontorovsky to board - Celsius Holdings "announced the appointment of Israel Kontorovsky to the company's board of directors. Kontorovsky also will serve on the board's Audit and Enterprise Risk Committee and was nominated by PepsiCo, Inc. to serve as its designee pursuant to an agreement with Celsius. Kontorovsky replaces former board member and PepsiCo designee, Jim Lee, who departed the board in September 2024 in connection with his resignation from PepsiCo. Kontorovsky brings to Celsius more than 30 years of consumer packaged goods experience and has a proven track record of driving growth domestically and internationally. He currently serves as the Chief Financial Officer of PepsiCo LatAm, and, since joining PepsiCo in 2000, he has held various leadership roles including Senior Vice President, Commercial Finance at PepsiCo Foods North America and Chief Financial Officer of Quaker Foods North America."
|
RDDT | Hot Stocks16:18 EDT Reddit jumps 17% to $96.00 after Q3 beat, Q4 outlook
|
MOD | Hot Stocks16:17 EDT Modine Manufacturing says 'holding our current guidance ranges' - "Our outlook for the data center business continues to improve, driven by strong organic growth and the strategic actions taken over the past year, including the acquisition of Scott Springfield," added Brinker. "We are gaining share with both colocation and hyperscale customers and continue to expand our product offering and our manufacturing capacity to meet market demand. In the Performance Technologies segment, we remain focused on further advancing our 80/20 initiatives and improving our business mix, as we anticipate ongoing weakness in our vehicular markets. We are holding our current guidance ranges, as we work towards delivering another record year of revenue and earnings."
|
NRDS | Hot Stocks16:15 EDT NerdWallet says board approves new $25M share repurchase authorization - NerdWallet said: "Following our utilization of the share repurchase authorization announced on September 9, 2024, we announced on October 29, 2024 that our Board of Directors approved a new share repurchase authorization under which we may repurchase up to $25 million of our Class A common stock. Under the October 2024 Repurchase Plan, shares of Class A common stock may be repurchased from time to time in the open market, through privately negotiated transactions or otherwise, in accordance with applicable securities laws and other restrictions."
|
CMG | Hot Stocks16:15 EDT Chipotle opened 86 new company-operated restaurants in Q3 - Opened 86 new company-operated restaurants with 73 locations including a Chipotlane, and one international licensed restaurant.
|
NRDS | Hot Stocks16:14 EDT NerdWallet reports resignation of Lauren StClair as CFO, effective March 7, 2025 - The company announced the resignation of Lauren StClair, CFO effective March 7, 2025, to pursue other opportunities. StClair will stay on through March 7, 2025 to ensure an orderly transition. The company will open a search for a new CFO immediately and will provide updates as appropriate.
|
BXC | Hot Stocks16:12 EDT BlueLinx says average daily sales volumes improved slightly in Q4-to-date vs. Q3 - BlueLinx said: "Through the first four weeks of the fourth quarter of 2024, specialty product gross margin was in the range of 18% to 19% and structural product gross margin was in the range of 9% to 10%. Average daily sales volumes improved slightly versus the third quarter of 2024."
|
SNAP | Hot Stocks16:12 EDT Snap board authorizes up to $500M stock repurchase program - Snap announced its board of directors has authorized a stock repurchase program of up to $500M of its Class A common stock. Repurchases of the Class A common stock may be made from time to time, either through open market transactions (including through Rule 10b5-1 trading plans) or through privately negotiated transactions in accordance with applicable securities laws. The timing and actual number of shares repurchased will depend on a variety of factors, including stock price, trading volume, market and economic conditions, and other general business considerations. Repurchases under the program have been authorized for 12 months but the program may be initiated, modified, suspended, or terminated at any time during such period.
|
CMG | Hot Stocks16:11 EDT Chipotle backs FY24 comparable restaurant sales growth mid to high single digits - For 2024, management is anticipating the following: Full year comparable restaurant sales growth in the mid to high-single digit range; 285 to 315 new company-operated restaurant openings with over 80% having a Chipotlane; An estimated underlying effective full year tax rate between 24% and 26% before discrete items. For 2025, management is anticipating the following: 315 to 345 new company-operated restaurant openings with over 80% having a Chipotlane.
|
WERN | Hot Stocks16:10 EDT Werner sees FY24 CapEx $240M-$260M
|
GOOGL GOOG | Hot Stocks16:09 EDT Alphabet Class A shares up 3% after Q3 report - Class A shares of Alphabet are up $5.47, or 3%, to $175.15 in after-hours trading.
|
THRY | Hot Stocks16:08 EDT Thryv Holdings announces strategic acquisition of Keap for $80M - Thryv Holdings "announced that the Company has signed a definitive agreement to acquire Infusion Software, Inc, or "Keap", a prominent player in customer relationship management and marketing automation for SMBs. Total transaction value of $80 million, paid in cash, subject to customary adjustments. The transaction is expected to close in the fourth quarter of 2024, subject to satisfaction or waiver of closing conditions. Keap generated approximately $85 million of revenue during the trailing twelve months through June 30, 2024."
|
V | Hot Stocks16:08 EDT Visa had 'robust' Q4 to finish 'very strong' fiscal year, says CEO - CEO Ryan McInerney said: "Visa had a robust fourth quarter to finish a very strong fiscal year. I am proud of what our team accomplished, delivering on our financial expectations and enabling our clients with innovative solutions. In the fourth quarter, net revenue and GAAP EPS grew by 12% and 17%, respectively, driven by relatively stable growth in payments volume, cross border volume and processed transactions plus strong momentum across new flows and value added services. We see tremendous opportunity ahead to grow our business, deliver for our clients and collectively shape the future of commerce."
|
GOOGL GOOG | Hot Stocks16:08 EDT Alphabet announces cash dividend of 20c per share - Alphabet said dividend payments to stockholders of Class A, Class B, and Class C shares were $1.2B, $173M, and $1.1B, respectively, totaling $2.5B for the three months ended September 30. On October 29, Alphabet announced a cash dividend of 20c per share that will be paid on December 16, to stockholders of record as of December 9, on each of the company's Class A, Class B, and Class C shares.
|
V | Hot Stocks16:07 EDT Visa reports Q4 payments volume up 8% - Reports Q4 transactions processed 61.5B.
|
GOOGL GOOG | Hot Stocks16:07 EDT Alphabet CEO says momentum across company 'extraordinary' - Sundar Pichai, CEO, said: "The momentum across the company is extraordinary. Our commitment to innovation, as well as our long-term focus and investment in AI, are paying off with consumers and partners benefiting from our AI tools. In Search, our new AI features are expanding what people can search for and how they search for it. In Cloud, our AI solutions are helping drive deeper product adoption with existing customers, attract new customers and win larger deals. And YouTube's total ads and subscription revenues surpassed $50 billion over the past four quarters for the first time. We generated strong revenue growth in the quarter, and our ongoing efforts to improve efficiency helped deliver improved margins. I'm looking forward to driving more advances for consumers, customers and creators globally."
|
PHYT | Hot Stocks16:06 EDT Pyrophyte Acquisition Corp trading halted, news pending
|
GOOGL GOOG | Hot Stocks16:06 EDT Alphabet reports Q3 Google Cloud revenue $11.35B vs. $8.41B last year
|
GOOGL GOOG | Hot Stocks16:06 EDT Alphabet reports Q3 Google Cloud revenue $11.35B vs. $8.41B last year
|
EXE | Hot Stocks16:06 EDT Expand Energy provides update on new capital return framework - The company said, "Expand Energy plans to pay its quarterly base dividend of $0.575 per share on December 4, 2024 to shareholders of record at the close of business on November 14, 2024. The company announced today its enhanced capital return framework which is designed to more effectively return cash to shareholders and reduce net debt. The plan is expected to go into effect January 1, 2025, and prioritizes the base dividend of $2.30 per share and $500 million of annual net debt reduction. Once both have been funded, it is anticipated that 75% of remaining free cash flow be distributed as market conditions warrant, between share repurchases and additional dividend payments. The remaining free cash flow would be maintained on the balance sheet."
|
FSLR | Hot Stocks16:06 EDT First Solar down 5% at $189 after Q3 earnings miss, guidance cut
|
GOOGL GOOG | Hot Stocks16:05 EDT Alphabet reports Q3 Google advertising revenue $65.85B vs. $59.65B last year - Reports Q3 Google Search & other revenue $49.39B vs. $44.03B last year. Reports Q3 YouTube ads revenue $8.92B vs. $7.95B last year.
|
EXE | Hot Stocks16:05 EDT Expand Energy raises synergy outlook, outlines 2025 operating plan - The company said, "Expand Energy increased its expected annual synergy outlook by $100 million to $500 million. The company expects to achieve approximately $225 million in synergies in 2025 and to achieve the full $500 million in annual synergies by year end 2027. In 2025, at current market conditions, the company expects to run 10 to 12 rigs and invest approximately $2.7 billion yielding an estimated daily production of approximately 7 bcfe per day. Expand Energy will provide complete guidance in early 2025."
|
CZR | Hot Stocks16:02 EDT Caesars reports Q3 adjusted EBITDA $1.00B vs. $1.04B last year
|
SPRO | Hot Stocks16:00 EDT Spero Therapeutics trading halted, news pending
|
UNF | Hot Stocks15:56 EDT UniFirst raises quarterly dividends on common, Class B common stock - The Board of Directors of UniFirst declared increased quarterly cash dividends of 35c per share on the company's common stock and 28c on the company's Class B common stock. Both dividends are payable on January 3, 2025 to shareholders of record on December 6, 2024.
|
TVGN | Hot Stocks15:34 EDT Tevogen regains compliance with Nasdaq - Tevogen announced that it received written notice from the Listing Qualifications Staff of Nasdaq stating that the company has regained compliance with the minimum bid price requirement, as set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq.
|
RTX | Hot Stocks15:27 EDT U.S. State Department approves sale of RTX's AMRAAM missiles to Denmark - The U.S. State Department has made a determination approving a possible Foreign Military Sale to the Government of Denmark of AIM-120D-3 Advanced Medium Range Air-to-Air Missiles and related elements of logistics and program support for an estimated cost of $744M. The Defense Security Cooperation Agency delivered the required certification notifying Congress of this possible sale Tuesday. The Government of Denmark has requested to buy up to 203 AIM-120D-3 Advanced Medium Range Air-to-Air Missiles; and up to nine AIM-120D-3 AMRAAM guidance sections to include precise position provided by either Selective Availability Anti-Spoofing Module or M-Code. The following non-MDE items will also be included: spare AMRAAM control sections; missile containers and support equipment; munitions support and support equipment; spare parts, consumables and accessories, and repair and return support; weapons software and support equipment; classified software delivery and support; classified publications and technical documentation; transportation support; studies and surveys; U.S. Government and contractor engineering, technical and logistics support services; and other related elements of logistics and program support. The estimated total cost is $744M. The principal contractor will be RTX Corporation, located in Tucson, AZ. The purchaser typically requests offsets. Any offset agreement will be defined in negotiations between the purchaser and the contractor. Reference Link
|
NVS | Hot Stocks15:25 EDT Novartis says Scemblix FDA approved in newly diagnosed CML - Novartis announced that Scemblix was granted accelerated approval by the U.S. Food and Drug Administration for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase. "The accelerated approval is based on major molecular response rate at week 48 from the ASC4FIRST Phase III trial that compared once daily Scemblix to all other investigator-selected standard of care tyrosine kinase inhibitors. In the study, Scemblix demonstrated superior MMR rates in both primary endpoints at week 48 vs. IS SoC TKIs and imatinib alone1-3. Continued approval for the newly diagnosed indication may be contingent upon verification and description of clinical benefit from confirmatory evidence. The expanded indication in Ph+ CML-CP increases the population eligible for Scemblix by approximately four times, including newly diagnosed and previously treated adults. Newly diagnosed patients will now have access to a treatment that has shown superior efficacy vs. all standard of care therapies and a favorable safety and tolerability profile," the company stated.
|
FE PAYX | Hot Stocks15:05 EDT FirstEnergy names Karen McClendon CHRO - FirstEnergy (FE) announced that Karen McClendon has been named senior VP and chief human resources officer, or CHRO, effective November 11. McClendon will spearhead efforts to integrate and advance the company's human capital strategy. She will oversee human resources functions, including talent management, benefits and compensation, labor and employee relations. McClendon will report to Brian Tierney, FirstEnergy president and CEO. McClendon most recently served as the CHRO at Paychex (PAYX).
|
ABBV | Hot Stocks14:59 EDT AbbVie small cell lung cancer treatment granted FDA orphan designation - AbbVie was granted FDA orphan designation for an antibody drug conjugate comprising monoclonal antibody anti-SEZ6 IgG1 antibody conjugated to a Top1 inhibitor as a treatment of small cell lung cancer, according to a post to the FDA website. Reference Link
|
ALTR SIEGY | Hot Stocks14:00 EDT Altair jumps 8% to $110.30 after Bloomberg says Siemens near buyout
|
SONY | Hot Stocks13:53 EDT Sony shuts down video game studios Neon Koi and Firewalk - Sony Interactive Entertainment's Studio Business Group CEO Hermen Hulst said in an email to employees that the PlayStation maker has shut down Neon Koi and "Concord" developer Firewalk Studios. "We consistently evaluate our games portfolio and status of our projects to ensure we are meeting near and long-term business priorities," Hulst said. "As part of our ongoing efforts to strengthen SIE's Studio Business, we have had to make a difficult decision relating to two of our studios - Neon Koi and Firewalk Studios. Expanding beyond PlayStation devices and crafting engaging online experiences alongside our single-player games are key focal areas for us as we evolve our revenue streams. We need to be strategic, though, in bringing our games to new platforms and recognize when our games fall short of meeting player expectations. While mobile remains a priority growth area for the Studio Business, we are in the very early stage of our mobile efforts. To achieve success in this area we need to concentrate on titles that are in-line with PlayStation Studios' pedigree and have the potential to reach more players globally. With this re-focused approach, Neon Koi will close, and its mobile action game will not be moving forward. I want to express my gratitude to everyone at Neon Koi for their hard work and endless passion to innovate. Regarding Firewalk, as announced in early September, certain aspects of Concord were exceptional, but others did not land with enough players, and as a result we took the game offline. We have spent considerable time these past few months exploring all our options. After much thought, we have determined the best path forward is to permanently sunset the game and close the studio.I want to thank all of Firewalk for their craftsmanship, creative spirit and dedication. The PvP first person shooter genre is a competitive space that's continuously evolving, and unfortunately, we did not hit our targets with this title. We will take the lessons learned from Concord and continue to advance our live service capabilities to deliver future growth in this area." Reference Link
|
TBNK HOPE | Hot Stocks13:53 EDT Blue Hill says Territorial arguments based on 'false premise' - Blue Hill Advisors issued an letter to shareholders of Territorial Bancorp (TBNK) saying in part, "Territorial's Board of Directors has flooded you with materials urging you to support the Company's proposed sale to Hope Bancorp (HOPE) and dismiss our proposal. Most of their arguments are based on a false premise: that they cannot engage with us for fear of losing the Hope deal. This is simply not true. Under the Hope merger agreement, Territorial is entitled to explore a competing offer that is 'reasonably likely to lead to a Superior Proposal.' We believe we have always cleared that bar. And since sending more information about our offer in an addendum to the Board last week, we have no doubt...Seven investors, including Blue Hill Advisors, have made a $12.50 per share cash offer for up to 100% of Territorial shares - that's a 25% premium to the current value of the Hope consideration. Our proposal also allows up to 49% of existing holders to stay on as shareholders if they choose to participate in Territorial's considerable upside. Territorial has bizarrely attacked the proposal both for being too liquid (citing taxes on imaginary gains under the cash option) and too illiquid (for shareholders who choose not to tender and instead participate with us in the potential upside). The point is that our proposal lets you, the shareholder, decide-isn't whatever you choose going to be superior."
|
MSFT | Hot Stocks13:39 EDT LinkedIn launches AI agent Hiring Assistant - Microsoft's LinkedIn launched its first AI agent, Hiring Assistant, designed to take on a recruiter's most repetitive tasks so they can spend more time on their most impactful work - like advising hiring managers, connecting with candidates and creating exceptional candidate experiences. Hiring Assistant is available Tuesday in charter to a select group of LinkedIn customers, including AMD, Canva, Siemens and Zurich Insurance. "We're also rolling out a new coaching feature in LinkedIn Learning that helps learners practice human skills through interactive scenarios using text or voice," the company said. "Learners can practice delivering performance reviews, having conversations on work-life balance, and giving feedback. They will receive personalized feedback on strengths and areas of improvement in a safe, virtual environment, helping them feel more confident navigating similar conversations in the future." Reference Link
|
CVI | Hot Stocks13:36 EDT CVR Energy says exploring potential increase in liquidity, non-core asset sales - CVR Energy executives stated on the company's Q3 earnings call: "Overall refining markets remain challenging. While the Board's decision to suspend the dividend was difficult, we believe the key to surviving these downturns and refineries is maintaining adequate liquidity and protecting the balance sheet. While we focus on areas we control - safe, reliable operations while reducing costs and capital spend - we are currently exploring the potential increase in our liquidity through possible access to capital markets... We are confident in our ability to navigate this challenging environment and be well prepared post turnaround for any improvements in refining margins... This creates an opportunity for us to focus on positioning our business for the long term so we are best equipped to take advantage of favorable market conditions when they return, as I believe they will... This includes internal cost cutting initiatives and reduced hiring. Focus also includes focusing our capital spend on projects that are in flight and those critical to safe, reliable operations. And finally, we are exploring access to capital markets, which could include non-core asset net sales. Suspending the dividend is also part of this, but our Board will continue to look at it each and every quarter. But we think this shows as we can make the tough decisions necessary to support the Company's future and our goal of increasing value to our stockholders to focusing on executing our upcoming turnaround safely on time and on budget... Our track record for exceptional project execution speaks for itself. Although we've had some hiccups this year, we are great operators and have demonstrated our ability to successfully execute turnarounds in the past... We will not ignore accretive opportunities before us and liquidity measures we announced yesterday should help with this for, as always, continue to focus its focus on safe, reliable operations in an environmentally responsible manner. This should result lower operating costs, better capture rates and ultimately superior financial performance for our shareholders and stakeholders. In summary, despite the weakness in the current refining market, we see continue to believe the US fleet is the most advantage in the world. Given the high complexity access to low-cost crude oil and natural gas, our refineries are very competitive among this fleet. We have tremendous confidence in the future, and we see the actions we announced in our intended path forward as best positioning CVR to take advantage of it."
|
SPTN | Hot Stocks13:02 EDT SpartanNash acquiring Markham Enterprises - SpartanNash announced that it has entered into an Asset Purchase Agreement with Markham Enterprises, Markham Oil and its affiliates, a three-store chain of convenience stores and fuel distributor in mid-Michigan. Following the closing of this transaction in early December, SpartanNash will continue employment of Markham Enterprises' 42 team members. The transaction is expected to close in December, subject to customary closing conditions. Terms of the deal were not disclosed. "Markham Enterprises fits well in our current retail portfolio, as we look to expand our fuel center and convenience store footprint. We are in the process of refreshing many of our existing fuel centers, so this acquisition is another exciting milestone in our investment in this part of our business - and in our strategic growth plans overall. We will continue to leverage insights from our fuel centers and convenience stores to continuously innovate our products and operations across our wholesale business, unlocking new customer potential," said SpartanNash Executive Vice President and Chief Strategy and Information Officer Masiar Tayebi.
|
HOTH | Hot Stocks12:46 EDT Hoth Therapeutics: Treatment 'successfully' stabilized tumor growth in study - Hoth Therapeutics announced early data from a preclinical study of its latest cancer treatment. The preliminary results demonstrate that the treatment successfully stabilizes tumor growth with remarkable consistency across subjects, showing potential as an effective therapeutic option in oncology. This study was performed and took place under a sponsored scientific research agreement with NC State University. The study measured tumor volumes in treated and untreated subjects over the course of the experiment. Key observations from the initial data include: Tumor volumes in treated subjects remained remarkably stable over the course of the study, suggesting that the treatment may significantly inhibit tumor growth. Tumor sizes were highly consistent across all treated animals, as demonstrated by the minimal error bars on the graph. This uniform response highlights the treatment's potential reproducibility and reliability. In contrast, untreated subjects showed greater variability and an increase in tumor volume, underscoring the potential efficacy of the treatment in slowing or halting tumor growth. As Hoth Therapeutics advances this research, the company will continue analyzing additional tissue data to further validate these results. The company is committed to moving forward with the development of this promising treatment and exploring its full potential for patients in need of effective cancer therapies.
|
NWN | Hot Stocks12:42 EDT Northwest Natural Gas: OPUC resolves remaining open items in rate case - In a regulatory filing, Northwest Natural Gas notes that the company's Northwest Natural Gas Company subsidiary filed a request for a general rate case with the Public Utility Commission of Oregon. The filing requested a $154.9 annual revenue requirement increase, which included $34M related to an updated depreciation study. Prior to the Second Stipulation, NW Natural, the OPUC staff, CUB and AWEC reached a partial settlement on the cost of long-term debt of 4.712%. The Second Stipulation provides for a total revenue requirement increase of $95M over revenues from existing rates, which includes $9.6M related to an updated depreciation study, subject to completion of capital projects identified as being placed in service prior to the rate effective date. On October 25, 2024, the OPUC issued an order approving the Stipulations and resolving the remaining open items in the Rate Case. Along with resolving several non-revenue items, the OPUC affirmed its decision in NW Natural's prior general rate case docket to phase out NW Natural's line extension allowance by November 1, 2027. Additionally, the OPUC ordered a downward adjustment to rate base of $13.7M of undepreciated line extension costs, which we expect to result in a non-cash, pre-tax charge of approximately $13.7M, or approximately $10.1M after-tax, in the fourth quarter of 2024. The final order and adjustments for completed capital projects resulted in a revenue requirement increase of $93.3M over existing rates. Average rate base after final adjustments for completed capital projects was $2.09B or an increase of $334M since the last rate case. NW Natural expects new rates to take effect November 1, 2024.
|
NFLX... | Hot Stocks12:35 EDT Netflix, Universal Filmed Entertainment expand U.S. licensing deal - Netflix (NFLX) and NBCUniversal's (CMCSA) Universal Filmed Entertainment Group have reached an agreement to renew the existing licensing deal for animated films including those from Illumination and DreamWorks Animation and, beginning with the 2027 slate, will add U.S. rights to live-action films from both Universal Pictures and Focus Features. As part of the new agreement, Netflix will continue to have exclusive rights to UFEG animated films and, starting in 2027, will add live-action films no later than eight months following theatrical release. After the initial premiere on Peacock, Netflix will have a 10-month window during which these films are available only on Netflix before they return to Peacock. Netflix will also license rights to Universal's full animation and live-action film slate for additional windows in subsequent years as well as rights to select titles from Universal's film library. "We have always valued our partnership with NBCUniversal, and we are excited to expand it to bring even more entertainment to our U.S. members starting in 2027," said Bela Bajaria, Chief Content Officer, Netflix. "Illumination and DWA animated films have always been incredibly popular on Netflix, and we are looking forward to adding Universal Pictures and Focus Features live-action films in the years to come. By combining these licensed titles with our Netflix original programming, we can offer our members an exceptional entertainment package with an even greater selection of films to enjoy." Reference Link
|
MSCI | Hot Stocks12:26 EDT MSCI expects to be toward higher end of expense guidance range for FY24 - The company said that if markets remain at current levels or higher, it expects to be toward the higher end of its expense guidance range for FY24.
|
LLY | Hot Stocks12:19 EDT Eli Lilly says Donanemab redudced ARIA-E in early Alzheimer's patients - Eli Lilly announced "positive results" from the TRAILBLAZER-ALZ 6 Phase 3b study, showing a reduction in amyloid-related imaging abnormalities with edema/effusion at the 24-week primary endpoint for people receiving a slightly modified titration of donanemab in adults with early symptomatic Alzheimer's disease. The primary endpoint of the study was the proportion of participants with any occurrence of ARIA-E by week 24, and the results showed the incidence of ARIA-E was 14% in patients receiving the modified titration compared with 24% for those receiving the standard dosing regimen, a 41% lower relative risk. The largest ARIA-E reduction with the modified titration was seen in apolipoprotein E homozygotes, carriers of a known genetic risk factor for developing Alzheimer's disease. In these patients, 19% had ARIA-E on the modified titration as compared to 57% on the standard dosing regimen, resulting in a 67% lower relative risk. Lilly is discussing the results of this study with global regulators, with the intent to submit for a potential label update for Kisunla.
|
DQ | Hot Stocks12:04 EDT Daqo New Energy falls -23.0% - Daqo New Energy is down -23.0%, or -$6.71 to $22.43.
|
CVI | Hot Stocks12:03 EDT CVR Energy falls -24.9% - CVR Energy is down -24.9%, or -$5.93 to $17.89.
|
JBI | Hot Stocks12:03 EDT Janus falls -27.4% - Janus is down -27.4%, or -$2.83 to $7.48.
|
SSTK | Hot Stocks12:02 EDT Shutterstock rises 14.5% - Shutterstock is up 14.5%, or $4.29 to $33.82.
|
NARI | Hot Stocks12:02 EDT Inari Medical reports PEERLESS study met primary composite endpoint - Inari Medical announced "positive" results from the prospective PEERLESS Randomized Controlled Trial comparing FlowTriever to catheter-directed thrombolytics, or CDT. The results were presented by Dr. Wissam Jaber, Professor of Medicine at Emory University School of Medicine and Co-Global Principal Investigator, during the Late-Breaking Clinical Trial Session at the 2024 Transcatheter Cardiovascular Therapeutics, or TCT, Annual Scientific Symposium in Washington, D.C. In recognition of the clinical relevance of the study, results were also simultaneously published in Circulation, the premier peer-reviewed journal of the American Heart Association. PEERLESS met its primary composite endpoint of win ratio 5.01, driven by patients experiencing significantly fewer clinical deteriorations or therapy escalations, fewer ICU admissions, and shorter ICU lengths of stay with FlowTriever versus CDT. Patients also had faster recovery of clinical symptoms and hemodynamics, shorter hospital length of stay, and fewer 30-day readmissions. "These results are crucial to guiding optimal PE treatment decisions, providing strong evidence that FlowTriever may reduce clinical deterioration and the need for reintervention through more effective early thrombus resolution," said Dr. Jaber. "As the only randomized trial evaluating mechanical thrombectomy in PE, PEERLESS allows us to now confidently say that treatment with FlowTriever is safe, effective, and superior to CDT."
|
LAC | Hot Stocks12:00 EDT Lithium Americas rises 16.3% - Lithium Americas is up 16.3%, or 68c to $4.82.
|
VFC | Hot Stocks12:00 EDT VF Corp. rises 25.8% - VF Corp. is up 25.8%, or $4.39 to $21.42.
|
NVO | Hot Stocks11:52 EDT FDA posts summary of Novo Nordisk site inspections made earlier this year - The FDA has posted a summary of Novo Nordisk site inspections made over several dates in March of this year at the company's Drug Substance Manufacturing Site in Kalundborg Sjalland 4400 DK. Reference Link
|
NTDOY | Hot Stocks11:50 EDT Nintendo says 'Xenoblade Chronicles X' coming to Switch March 30, 2025 - Nintendo announced that "Xenoblade Chronicles X: Definitive Edition," an enhanced port of the Wii U game of the same name, will be coming to Nintendo Switch on March 30, 2025. The original version of the game released exclusively for Wii U in 2015. Reference Link
|
MPLX | Hot Stocks11:36 EDT MPLX increases quarterly dividend 12.5% to 95.65c per share - The board of directors of the general partner of MPLX LP has declared a quarterly cash distribution of 95.65c per common unit for the third quarter of 2024, or $3.826 on an annualized basis. This represents a 12.5% increase, or 10.65c increase per common unit, over the second quarter 2024 distribution. The distribution will be paid on Nov. 15, 2024, to common unitholders of record as of Nov. 8, 2024.
|
MSCI | Hot Stocks11:31 EDT MSCI sees elevated cancellation activity, longer sales cycles continuing in NT - Comments taken from Q3 earnings conference call.
|
JBLU | Hot Stocks11:29 EDT JetBlue sees negative capacity in Q1 due to engine issues
|
BBW KO | Hot Stocks11:04 EDT Build-A-Bear appoints Kim Utlaut as chief brand officer - Build-A-Bear Workshop (BBW) is announcing the appointment of Kim Utlaut as Senior Vice President and Chief Brand Officer. Utlaut most recently served as a General Manager for Franchise Leadership at The Coca-Cola Company (KO). In her new role, Kim's responsibilities include leading the continued evolution of Build-A-Bear's brand and communications strategy, with an increased focus on strengthening and elevating the valued relationship the company shares with its diverse consumer base across multiple revenue streams and product offerings worldwide.
|
AAPL | Hot Stocks11:02 EDT Apple unveils Mac mini built for Apple Intelligence - Apple unveiled the all-new Mac mini powered by the M4 and new M4 Pro chips, and redesigned around Apple silicon to pack an incredible amount of performance into an even smaller form of just 5 by 5 inches. With M4, Mac mini delivers up to 1.8x faster CPU performance and 2.2x faster GPU performance over the M1 model. With M4 Pro, it takes the advanced technologies in M4 and scales them up to tackle even more demanding workloads. For more convenient connectivity, it features front and back ports, and for the first time includes Thunderbolt 5 for faster data transfer speeds on the M4 Pro model. The new Mac mini is also built for Apple Intelligence, the personal intelligence system that transforms how users work, communicate, and express themselves while protecting their privacy. And marking an important environmental milestone, Mac mini is Apple's first carbon neutral Mac with an over 80 percent reduction in greenhouse gas emissions across its materials, manufacturing, transportation, and customer use. Starting at just $599 with 16GB of memory, the new Mac mini is available to pre-order today, with availability beginning November 8.
|
AJG | Hot Stocks11:02 EDT Arthur J. Gallagher acquires Washington-based Adept Benefits - Arthur J. Gallagher announced the acquisition of Snoqualmie, Washington-based Adept Benefits. Terms of the transaction were not disclosed. Adept Benefits is a health and benefits consulting firm serving clients in the greater Seattle area. "Adept Benefits has a strong record of growth and will expand our benefits consulting capabilities in the Pacific Northwest," said J. Patrick Gallagher, CEO.
|
UPXI | Hot Stocks10:52 EDT Upexi trading resumes
|
UPXI | Hot Stocks10:47 EDT Upexi trading halted, volatility trading pause
|
JBLU | Hot Stocks10:41 EDT JetBlue expects depressed travel during week of U.S. elections
|
JBLU SAVE | Hot Stocks10:35 EDT JetBlue not interested in revisiting Spirit deal, focusing on Jet Forward
|
SYY | Hot Stocks10:32 EDT Sysco says 'on target' to deliver positive operating leverage - Says returned 'meaningful' cash back to shareholders. Says focused on executing on 'things we can control', including continued improvements to core business. Says 'well-positioned' to fully leverage size and scale advantages. Says remains on target to return $2B to shareholders this fiscal year. Says optimizing portfolio by announcing planned divestment of JV in Mexico. Says supply chain remains fully staffed. Says building on productivity gains. Says health of balance sheet remains 'source of competitive advantage'. Says debt is well laddered with no maturities over $1B until FY27. Says net sales growth guidance includes contributions from inflation, low single-digit volume growth and M&A. Says expects stronger rate of adjusted EPS growth in 2H25. Says remains on track to return 'essentially all free cash flow' to shareholders. Sees FY25 tax rate at 25%.
|
PGHL | Hot Stocks10:28 EDT Primega Group Holdings Ltd trading resumes
|
JBLU | Hot Stocks10:24 EDT JetBlue says won't guide 2025 metrics until January call
|
PGHL | Hot Stocks10:18 EDT Primega Group Holdings Ltd trading halted, volatility trading pause
|
SYY | Hot Stocks10:17 EDT Sysco says traffic trends improved throughout the quarter - Says food away from home continues to gain share. Says seeing 'strong performance' across the board in non-commercial sectors. Says 'on track' for full-year guidance. Says pleased with international business segment. Says national sales business 'performing at a very high-level'. Says confident Sygma will continue to deliver 'strong results' over remainder of the year. Says growing local business, however the company knows it can take share and drive higher volume profitably. Says 'confident' in actions to support local case growth. Says will continue to look for high-quality assets that complement business offerings. Comments taken from Q1 earnings conference call.
|
JBLU | Hot Stocks10:17 EDT JetBlue: LT capacity planning challenged by aircraft on ground
|
JBLU | Hot Stocks10:16 EDT JetBlue sees 2025 capacity roughly flat y/y
|
JBLU | Hot Stocks10:12 EDT JetBlue 'confident' in underlying supply, demand backdrop into 2025
|
JBLU | Hot Stocks10:11 EDT JetBlue CEO sees 'significant work' ahead on path to FY operating profitability
|
JBLU RTX | Hot Stocks10:11 EDT JetBlue CEO says in talks with Pratt & Whitney regarding aircraft on ground
|
JBLU | Hot Stocks10:09 EDT JetBlue targeting $800M-$900M in incremental EBIT from 2025-2027
|
ALE | Hot Stocks10:08 EDT Allete unit sells Whitetail wind project in Wisconsin to Invenergy - Allete Clean Energy, a wholly owned subsidiary of Allete, announced the company has sold the Whitetail wind project in southwestern Wisconsin to Invenergy, with the intent that it be constructed and subsequently sold to WEC Energy Group utilities We Energies and Wisconsin Public Service as well as Madison Gas and Electric Co. "Allete Clean Energy acquired the Whitetail wind project in 2021 and developed it for sale to help companies advance their carbon-reduction goals. The approximately 70-megawatt Whitetail project will consist of up to 21 turbines on about 5,938 acres in Clifton and Wingville townships in Grant County. It will produce enough energy to power tens of thousands of homes," the company said in a statement.
|
JBLU | Hot Stocks10:08 EDT JetBlue sees y/y positive unit revenue in Q4 - Sees relatively improved macro backdrop to continue driving positive unit revenues in Q4. Comments taken from Q3 earnings conference call.
|
CLVT | Hot Stocks10:07 EDT Silverchair to acquire ScholarOne from Clarivate; terms not disclosed - Silverchair announced signing a definitive agreement with Clarivate Plc to acquire ScholarOne Manuscripts and ScholarOne Conferences. The acquisition is expected to close within the fourth quarter of 2024 subject to the satisfaction of customary closing conditions.
|
SSTK | Hot Stocks10:00 EDT Shutterstock rises 11.3% - Shutterstock is up 11.3%, or $3.35 to $32.88.
|
PSQH | Hot Stocks10:00 EDT PSQ Holdings rises 12.2% - PSQ Holdings is up 12.2%, or 35c to $3.21.
|
VFC | Hot Stocks10:00 EDT VF Corp. rises 25.0% - VF Corp. is up 25.0%, or $4.26 to $21.29.
|
DQ | Hot Stocks10:00 EDT Daqo New Energy falls -21.0% - Daqo New Energy is down -21.0%, or -$6.13 to $23.01.
|
CVI | Hot Stocks10:00 EDT CVR Energy falls -25.1% - CVR Energy is down -25.1%, or -$5.97 to $17.84.
|
JBI | Hot Stocks10:00 EDT Janus falls -26.9% - Janus is down -26.9%, or -$2.77 to $7.54.
|
JBLU | Hot Stocks09:48 EDT JetBlue: On track to deliver positive RASM throughout 2H - Says sequential decline of fuel price expected into Q4. Comments taken from Q3 earnings conference call presentation slides.
|
HAYW | Hot Stocks09:48 EDT Hayward rises 9.8% - Hayward is up 9.8%, or $1.45 to $16.25.
|
CWH | Hot Stocks09:48 EDT Camping World rises 11.9% - Camping World is up 11.9%, or $2.55 to $23.96.
|
VFC | Hot Stocks09:47 EDT VF Corp. rises 18.3% - VF Corp. is up 18.3%, or $3.11 to $20.14.
|
DQ | Hot Stocks09:47 EDT Daqo New Energy falls -17.1% - Daqo New Energy is down -17.1%, or -$5.00 to $24.14.
|
CVI | Hot Stocks09:47 EDT CVR Energy falls -19.4% - CVR Energy is down -19.4%, or -$4.61 to $19.21.
|
JBI | Hot Stocks09:47 EDT Janus falls -33.0% - Janus is down -33.0%, or -$3.40 to $6.91.
|
DLPN | Hot Stocks09:43 EDT Dolphin partners with Loti AI for likeness protection technology - Dolphin has partnered with Loti AI to protect its brands, partners and celebrity clients against fake accounts, false endorsements, explicit deepfakes and unlicensed distribution of content. Through the partnership, Dolphin will provide its roster of hundreds of brands, celebrities, content creators and talent with access to Loti's proprietary tools in order to better protect their intellectual property or likeness from being unlawfully used or infringed upon online.
|
DJT | Hot Stocks09:42 EDT Trump Media halts for volatility after rallying 14% to $54.09
|
DJT | Hot Stocks09:41 EDT Trump Media trading resumes
|
KNSA | Hot Stocks09:38 EDT Kiniksa Pharmaceuticals trading resumes
|
LUCY | Hot Stocks09:37 EDT Innovative Eyewear Inc trading resumes
|
DJT | Hot Stocks09:36 EDT Trump Media trading halted, volatility trading pause
|
PLMJ | Hot Stocks09:35 EDT Plum Acquisition Corp. III, Tactical Resources file F-4 Registration Statement - Tactical Resources has filed a Form F-4 Registration Statement with the U.S. Securities and Exchange Commission regarding Tactical Resources' recently announced proposed business combination with Plum Acquisition Corp. III to form a new publicly traded entity. The closing of the Business Combination is subject to approval by the shareholders of each of Tactical Resources and Plum, the declaration of the Registration Statement as effective by the SEC and other customary requirements. The Company's flagship asset, the Peak Project, contains the rights to acquire rare earth elements-enriched tailings and stockpiled materials extracted from the Sierra Blanca Quarry. The Peak Project is a REE-focused project strategically located southeast of El Paso, Texas. This convenient location in a mining-friendly jurisdiction offers extensive infrastructure, including easy highway, power, water, and rail line access. Tactical Resources believes that the Peak Project will enable it to become a significant REEs producer in the United States. The Peak Project is one of only a few rare earth hard rock direct-leach-extractable projects in the world, with initial quarry operating permits already in place. The Company also has an exclusive option to purchase SBQ's mining lease and associated infrastructure for the Peak Project.
|
KNSA | Hot Stocks09:33 EDT Kiniksa Pharmaceuticals trading halted, volatility trading pause
|
CION ARES | Hot Stocks09:33 EDT Cion Ares Diversified Credit Fund announces over $6B in total AUM - CION Ares Management, a joint venture between affiliates of CION Investments and Ares Management announced, that CION Ares Diversified Credit Fund recently surpassed $6 billion in total assets under management. CION co-CEO Michael Reisner noted, "We introduced a diversified credit strategy in an interval fund structure in 2017 because we believed that individual investors, through their financial advisors, should have access to the benefits that the private markets can bring in achieving long-term investment goals. We were ahead of the curve in finding the right structure to offer alternatives to individuals, and the Fund's growth is a testament to the commitment we've made to the space, and the partnerships we've built. CADC can offer the opportunity for income, stability and lower portfolio volatility through diversification away from public markets, and we believe financial advisors are increasingly seeking these assets as a differentiator in their clients' portfolios."
|
BYD... | Hot Stocks09:32 EDT Nevada reports September statewide gaming win up 3.34% to $1.31B - The Nevada Gaming Control Board reports September Las Vegas Strip gaming win down 1.83% versus last year to $727.66M. Publicly traded companies in the gambling space include Boyd Gaming (BYD), Caesars (CZR), Churchill Downs (CHDN), DraftKings (DKNG), Flutter Entertainment (FLUT), Gan Limited (GAN), Genius Sports (GENI), Las Vegas Sands (LVS), MGM Resorts (MGM), Penn Entertainment (PENN), Rush Street Interactive (RSI), Sportradar (SRAD) and Wynn Resorts (WYNN).
|
LUCY | Hot Stocks09:32 EDT Innovative Eyewear Inc trading halted, volatility trading pause
|
MCD | Hot Stocks09:31 EDT McDonald's says gaining share with lower end consumers - Says visits for $5 meals have increased. Will be "thoughtful" about incremental pricing actions.
|
RMBL | Hot Stocks09:29 EDT RumbleON's RideNow partners with Octane to launch RideNow Finance - RumbleOn company RideNow, a powersports retailer in North America, and Octane Lending, a fintech company specializing in major recreational purchases, announced a partnership to launch branded finance in RideNow's 56 retail stores under the RideNow Finance brand. Effective immediately, RideNow Powersports customers can purchase over 18,000 new and pre-owned vehicles from a large selection of manufacturers using RideNow Finance. The new private label partnership allows RideNow Powersports dealerships to leverage Octane's digital tools and financing experience under its own name. At the same time, RideNow Finance customers will benefit from credit coverage.
|
NESR | Hot Stocks09:27 EDT National Energy Services acquires minority stake in SALTTECH - National Energy Services Reunited announced that it has acquired a minority stake in SALTTECH. Funded through cash, the acquisition follows the successful deployment of Dyvar on several key pilot projects in the MENA region, including the recently announced Circular Water project deployed successfully with NESR's largest customer. The Dyvar represents a core component of NESR's growing portfolio of fit-for-purpose water solutions within its NEDA segment, and the acquisition deepens the collaboration between NESR & Salttech in pursuing the sustainable scale-up of this novel, Circular Water concept in Saudi Arabia and other key countries. NESR will also have the sole option to acquire additional stake and become the majority owner of Salttech in subsequent years.
|
OMH | Hot Stocks09:25 EDT Ohmyhome reports Q3 brokerage GTV grew 51% year-over-year - The agent brokerage business has achieved impressive growth, with GTV reaching USD 84 million in Q3 2024. This marks a 48.7% increase compared to USD 56.5 million in Q3 2023. This strong performance is a testament to our expanding client base and the growing demand for our brokerage services. The renovation segment has seen significant momentum, with contracts signed totaling SGD 1.93 million for the three months ended September 30, 2024. This is a substantial increase compared to the SGD 1.3 million for six months ended June 30, 2024, reflecting the robust growth of this segment and increasing customer interest in our renovation solutions. Our property management arm continues to expand, with the number of units under management growing to 9,283 units, up from 7,560 units as of June 30, 2024. Most of the newly appointed projects will contribute to revenue growth from October 2024 onwards. This growth in units managed underscores our strengthened presence in the market and the increasing value of our property management services. Ohmyhome remains committed to achieving profitability and optimizing cash flow. The Company is pleased to report that losses narrowed significantly in Q3 2024 due to enhanced operational efficiencies and revenue growth across key business segments. Rhonda Wong, CEO, remarked, "We are thrilled to report stronger business performance in the third quarter of 2024. Our ongoing efforts toward profitability, combined with sustained revenue growth, cost management, and improved cash flow, place us in a strong position to achieve breakeven and profitability in the near future."
|
MCD | Hot Stocks09:25 EDT McDonald's says 'on pace' with development goals in U.S.
|
NCNC | Hot Stocks09:22 EDT noco-noco, DG Capital sign MOU for decarbonization solutions - noco-noco and DG Capital Group have signed a Memorandum of Understanding to jointly develop innovative decarbonization solutions for corporations and communities aiming to reduce carbon emissions and achieve green transition goals. This collaboration unites noco-noco's revolutionary battery technology, designed to extend battery lifespan and enhance durability, with DGCG's advanced Digital Grid-Forming Inverter System, which is integral to supporting renewable energy infrastructures. Together, they will aim to offer sustainable, resilient energy solutions by combining high-efficiency, highly reliable technologies to support the energy transition both in Japan and globally. The MOU formalizes a partnership between noco-noco and DGCG, focused on overcoming energy transition challenges such as stable energy supply, effective energy storage, and long-term carbon neutrality. By integrating DGCG's DGR System with noco-noco's high-performance battery technology, the companies will develop energy solutions independent of conventional infrastructures to enable reliable renewable energy utilization. Under the terms of the MOU, the companies plan to collaborate in the following areas: DGCG will incorporate noco-noco's battery technology, known for its extended lifespan and high-temperature resilience, into its DGR System to create an enhanced grid-forming solution. This advanced solution will be jointly developed, and will leverage the strengths of both technologies to achieve higher performance standards. Leveraging their combined networks, DGCG and noco-noco will seek to expand market opportunities for their enhanced DGR System. Target markets include remote islands, weak-grid regions, industrial complexes, and semiconductor plants, both within Japan and abroad. The two companies plan to establish a joint venture to pursue business partnerships and develop microgrids or grid-scale energy storage solutions, with earnings generated through these ventures to be shared between both parties. 2024: Formulation of the technology development roadmap and business plan. 2025-2026: Execution of technology and business development, and preparation for establishing the joint venture. From 2026: Utilizing DGCG and noco-noco's market networks to expand sales and deployment of the enhanced DGR System in target regions.
|
MODVF | Hot Stocks09:21 EDT Melcor REIT announces filing of information circular for special meeting - Melcor Real Estate Investment Trust announced the filing of its management information circular and related documents for the special meeting of the holders of units and special voting units of the REIT to consider a special resolution approving the previously-announced plan of arrangement under the Business Corporations Act involving the REIT, Melcor REIT GP and Melcor Developments. The Meeting will be held at the Windsor Room, Third Floor, Manulife Place, 10180 101st Street, Edmonton, Alberta,T5J 3V5 on November 26, 2024 at 9:30 a.m. The REIT has also commenced the process of mailing the Circular and related documents to Unitholders. Under the terms of the Arrangement, Voting Unitholders will receive cash consideration of $4.95 per Unit representing a premium of 46.0% to the REIT's closing Unit price of $3.39 on September 12, 2024, the last trading day prior to the announcement of the Arrangement, and a 61.3% premium to the 30-day volume weighted average Unit price ending September 12, 2024. Additionally, on or about the closing of the Arrangement, the REIT will cause the redemption of, and the Purchaser will pay out in cash, all principal amount of the $46.0 million of the REIT's 5.10% convertible unsecured subordinated debentures having a maturity date of December 31, 2024, with the REIT paying any accrued but unpaid interest on the Debentures. The special resolution approving the Arrangement must be approved by: not less than 66 2/3% of the votes cast by Voting Unitholders, voting as a single class, present in person or represented by proxy and entitled to vote at the Meeting; and a simple majority of the votes cast by Voting Unitholders present in person or represented by proxy and entitled to vote at the Meeting, excluding for this purpose votes attached to 100% of the SVUs and Units held by Unitholders who are excluded pursuant to Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions.
|
FBLG | Hot Stocks09:18 EDT FibroBiologics announces updates for novel artificial thymus organoid technology - FibroBiologics announced new findings from its artificial thymus organoid program. Recent results from the artificial thymus organoid program showed that fibroblasts and thymus-derived cell organoids can persist and function for over 50 days post-transplantation, with vascularization and the generation of a diverse array of mature T cells in animal models. The artificial thymus organoid has shown an ability to support distinct vascularization, critical for sustained functionality in vivo, while producing fully mature T cells expressing T cell receptors. Fully mature T cells differentiate into various types of cells, including CD4, CD8, T-regulatory, and gamma delta T cells, and contribute to a well-rounded immune response. The artificial thymus organoid also produces T cells with diverse TCR-beta chains that enable the recognition of a broad spectrum of antigens."This data further supports our unique approach to using fibroblast-based organoids as potential therapeutics. Our findings to date underscore the potential of our artificial thymus organoid to restore and enhance immune function," said Hamid Khoja, Ph.D., Chief Scientific Officer. "The diverse TCR-beta repertoire, in combination with extended organoid functionality and vascularization, may provide an effective immune support platform for patients facing immune dysregulation, such as those with age-related immune decline or who have undergone chemotherapy. We are excited by this prospect and will continue our work to advance this technology toward clinical application."
|
GMFI | Hot Stocks09:17 EDT Aetherium Acquisition receives letter terminating business combination agreement - Aetherium Acquisition received written notice from Capital A Berhad stating that it has elected to unilaterally terminate the business combination agreement dated February 28, entered into between Capital A Berhad, the company and other parties named therein. The company was not made aware of Capital A Berhad's decision prior to it receiving notice. The termination was made with reference to Section 9.1(h) of the Business Combination Agreement and relating to Aetherium previously receiving a written determination by Nasdaq to delist Aetherium's securities for failure to meet a continued listing standard. Capital A's management understood the basis for Aetherium's continued non-compliance, which resulted from Capital A's delays in timely completing Form F-4 to submit to the SEC. Prior to Nasdaq's delisting decision, Capital A had fully supported Aetherium through its Nasdaq extension requests and had completed its Form F-4 several months ago. Since then, Aetherium has been waiting for Capital A to submit Form F-4 to the SEC to complete the business combination. Aetherium's Board considers this unilateral termination of the BCA while simultaneously submitting a Regularization Plan to Bursa Malaysia, which initially included but now excludes this business combination merger is not acting in good faith as is bilaterally stipulated in the BCA. Prior to receiving the notice of termination, Aetherium regularly received reassurances that Capital A would move forward toward completing this business combination. Aetherium intends to engage with Capital A's management to determine whether Bursa Malaysia was preventing this transaction, as applying for a listing on Nasdaq is a separate process, and no approvals are required until the SEC process is complete.
|
JAMF | Hot Stocks09:16 EDT Jamf Ventures invests in LifeSaver Mobile - Jamf announced it has invested in LifeSaver Mobile, a leader in Distracted Driving Solutions, through its Jamf Ventures Investment Fund. Announced in October 2022, Jamf Ventures strives to grow the Jamf and Apple ecosystem faster and more comprehensively than Jamf could do alone. The Fund facilitates Jamf partnerships with early-stage founders, entrepreneurs and innovators across the globe that focus on increasing security to further enhance the transformational power of Apple. In March of 2022, Jamf announced the LifeSaver Mobile integration, meant to maximize driver safety easily and without gizmos and gadgets that added more hardware to the vehicle. The LifeSaver Mobile solution consists of a mobile application deployed to employees' phones, with each app managed by a cloud-based fleet portal used by the company's managers to administer the LifeSaver program. With Jamf, admins can streamline that deployment and prevent employees from deleting the app off of their devices, thus improving employee compliance. Further, LifeSaver gets an added layer of device restriction through real-time locking of iOS devices behind the wheel. The Jamf + LifeSaver Mobile integration prevents screen access, while still allowing phone calls and access to navigation, maximizing driver productivity.
|
MCD | Hot Stocks09:15 EDT McDonald's says 'strong start' to Q4 in U.S. - Says significant events "behind us." Planning on getting quarter pounders back on menus. Says will do what is needed to get momentum back in the business. Says overall industry environment "remains challenging." Says lower end consumers under "acute pressure."
|
MITI | Hot Stocks09:15 EDT Mitesco provides shareholder update on restructuring, expands advisory board - Mitesco has finalized over $8 million in the restructuring of its debt and senior equity, with a goal to extinguish virtually all obligations by December 31, 2024. It also announced it has added two additional professionals to its recently formed Advisory Board. Lastly, its Vero Technology Ventures arm has begun evaluation of both existing cloud computing solutions providers, and its own A.I.-based application aimed at sales automation. "We are working aggressively to eliminate all of our legacy liabilities before year-end to reduce our costs and position the company for meaningful expansion in 2025," said Mitesco CEO Mack Leath. "Already, holders of over $8 million in debt and senior securities have converted into common stock at $4 per share, and we expect a majority of the remaining liabilities to follow over the next few weeks. For our accredited institutional investors, we are creating a new Series A Amortizing Preferred stock which bears no interest and provides for redemption with cash or restricted common stock, or conversion, over the next 36 months. These same investors have provided the funding during FY2024 for our rebuilding process, and their continued support will help to strengthen our business plans going forward. Our data center business is making progress establishing itself in the market, and with our two newly appointed directors we expect to accelerate gains in key accounts, and in the data center operations as well. Our Vero Technology Ventures arm is actively reviewing potential early-stage cloud computing solution vendors and is developing its own artificial intelligence based application set. The new 'Robo' application utilizes A.I. to promote more efficient sales and marketing within certain markets, and with highly targeted market research." The latest appointments to the Advisory Board are executives whose careers have focused on data center business development and data center systems software, as noted here: Gabriel Crawford has over 20 years' experience in data center development from site selection, design/ build/ engineering services, and, most recently, hyperscale and AI co-location leasing. Most recently, Mr. Crawford was at Dallas-based Center Square DC, which specializes in delivering a comprehensive suite of colocation and data center services with more than 50 data centers owned and operated. Jim Clifton is a senior sales and marketing executive focused on systems software, data analytics and innovative implementation to improve productivity across corporations and workforces worldwide. Most recently, Mr. Clifton drove sales at Alteryx.
|
LCID | Hot Stocks09:14 EDT Lucid Group opening orders for Lucid Gravity EV November 7 - Lucid Group announced customer orders for the Lucid Gravity will open on November 7 at 9:00 am Pacific Time. Orders will initially be taken for the Grand Touring trim. The Lucid Gravity Grand Touring is scheduled to begin production in late 2024 and the Lucid Gravity Touring is planned for late 2025. On November 7, orders will open for customers in the U.S., with current Lucid owners given priority for taking delivery of their Lucid Gravity.
|
KDLY CI | Hot Stocks09:12 EDT KindlyMD enters partnership with Cigna Healthcare - KindlyMD is now contracted with Cigna Healthcare, after receiving additional credentialing. Cigna's innovative approach to behavioral health focuses on integrating mental health services with primary care and ensuring that individuals receive comprehensive support tailored to their unique needs. The inclusion of Cigna Healthcare marks another significant milestone for the Company, which has recently emerged as one of the first alternative medical treatment providers in the state to achieve this prestigious status, alongside contracts with Select Health, Medicare, and Medicaid. Following this achievement, KindlyMD also announced its contract with Blue Cross Blue Shield and United Healthcare, further solidifying its position in the healthcare landscape.
|
SGD | Hot Stocks09:12 EDT Safe and Green Development updates construction on Sugar Phase I project, Texas - Safe and Green Development announced the start of construction on its Sugar Phase I project in South Texas. Following the recent completion of all required site work and receipt of necessary elevation certificates and permits, SG Devco has officially broken ground on this first phase, which will consist of 5 single-family homes. Framing is expected to be completed later this week as construction progresses.
|
CTSH AMZN | Hot Stocks09:10 EDT Cognizant partnering with Amazon Web Services for smart industrial applications - Cognizant (CTSH) has signed a strategic collaboration agreement with Amazon (AMZN) Web Services, or AWS, with plans to deliver advanced technology solutions and cloud computing services, focused on enhancing smart manufacturing capabilities for global enterprises across industries. This latest expansion of Cognizant's collaboration with AWS is designed to meet the growing market demand for Internet of Things, data, artificial intelligence and cloud adoption in Industry 4.0 applications, such as digital twins, simulations, manufacturing execution systems, edge computing, and operational technology cybersecurity solutions, which Cognizant plans to demonstrate in its manufacturing innovation centers in the U.S. and India. Cognizant will work with clients to advise, implement, deploy and manage smart manufacturing solutions, which include performing OT system integration, network modernization using an industrial data platform and autonomous plant operations tools built on AWS.
|
HIG | Hot Stocks09:09 EDT Hartford Financial and Coalition announce UK Cyber partnership - The Hartford and Coalition have announced a strategic, long-term capacity partnership in response to growing customer and broker demand for Coalition's unique Active Cyber Insurance approach in the U.K. market. "We continue to capitalize on the strengths of The Hartford and our London operations, securing new opportunities to meaningfully grow our International business and footprint," said Carl Bach, Head of The Hartford's International Business. "Drawing on our deep expertise underwriting cyber in the U.S. market, we recognize the innovative model of active insurance that Coalition possesses, designed to help businesses identify and mitigate cyber risk before it becomes a disruption. We look forward to partnering with Coalition to serve more customers and brokers in the U.K. for years to come." As part of the agreement, The Hartford is assuming a quota share of Coalition's U.K. cyber program, in addition to the insurance provider's existing capacity partner relationships. "We are thrilled to have The Hartford join our panel of capacity partners and support our efforts to continue providing outstanding cyber coverage to our policyholders," commented Shawn Ram, Coalition's Head of Insurance. "Coalition continues to see robust interest in our innovative and profitable Active Insurance model in the U.K., which has disrupted the standard approach to cyber insurance and offered businesses a way to manage their risk as it evolves."
|
TTEK | Hot Stocks09:07 EDT USAID selects Tetra Tech for $5B governance/stabilization contract deal - Tetra Tech announced that the U.S. Agency for International Development, USAID, has selected the Company for a $5 B, multiple-award indefinite delivery, indefinite quantity, IDIQ, contract to support global democracy initiatives. Under the 10-year contract, Tetra Tech will support USAID's Office of Transition Initiatives to address complex governance and resiliency challenges in developing countries around the world. Our technical experts will leverage evidence-based approaches to strengthen local engagement, revitalize critical infrastructure, and enhance the access and resiliency of essential public services such as clean water supplies. n"For more than four decades Tetra Tech has supported USAID to strengthen local governance systems for communities in developing countries," said Dan Batrack, Tetra Tech Chairman and CEO. "We are pleased to continue supporting USAID in their mission to foster strong democracies around the world."
|
GDRX | Hot Stocks09:07 EDT GoodRx announces exclusive cash price for Qsymia - GoodRx announced that Qsymia is available for a low cash price in more than 70,000 retail pharmacy locations nationwide exclusively via GoodRx. This initiative not only propels GoodRx's momentum in weight loss solutions, but also broadens its portfolio in offering significant savings on brand-name medications, making obesity treatment more accessible and affordable for millions.
|
UBER | Hot Stocks09:06 EDT Uber Eats now accepting SNAP EBT payments nationwide with several companies - Uber Eats announced the arrival of a new initiative through which Uber Eats is accepting SNAP - Supplemental Nutrition Assistance Program - EBT - Electronic Benefits Transfer - payments, starting with the regional grocery banners Albertsons, Safeway, Jewel-Osco and Vons as well as Walgreens locations nationwide and Duane Reade stores exclusively in New York. Eligible customers can now use their SNAP EBT benefits to order groceries from participating locations through the Uber Eats app, with payments powered by Forage, a payments company. In the months ahead, Uber teams will work to add even more retailers who will accept SNAP EBT payments on Uber Eats orders. Customers will be able to browse through a wide range of SNAP-eligible groceries available for delivery from their local Albertsons, Safeway, Jewel-Osco, Vons and Walgreens stores.
|
PACB | Hot Stocks09:06 EDT PacBio announces SPRQ chemistry for Revio sequencing systems - PacBio announced SPRQ, an improved sequencing chemistry for its Revio long-read sequencing system. The new chemistry will reduce Revio DNA input requirements by 4x to 500ng per sample, which enables more sample types such as saliva extracted with PacBio's new Nanobind protocol and tumor samples to be sequenced with HiFi sequencing technology. It will also increase the Revio system's output, which together with improved analysis methods, enables customers to reduce their sequencing cost per genome by up to 50 percent.
|
GLXZ CCL | Hot Stocks09:06 EDT Galaxy Gaming's Galaxy Operating System now live on over 50 Carnival ships - Galaxy Gaming (GLXZ) announced that the Galaxy Operating System is now live on over 50 ships worldwide with Carnival Corporation (CCL). Since the installation, tables powered by GOS have awarded over $5 million in jackpot payouts to players. GOS is the jackpot progressive system for all Carnival Corporation ships, including Carnival Cruise Line, Holland America Line, and Princess Cruise.
|
SNAP | Hot Stocks09:05 EDT Snap partners with Zefr - Zefr announced the launch of its new Brand Safety and Suitability Measurement solution for Snapchat. This new offering, developed in partnership with Snap, provides advertisers with increased transparency and control over their campaigns by leveraging Zefr's patented AI and machine learning technology. This marks the latest expansion of Zefr's industry-leading measurement capabilities, now extending to one of the most dynamic and popular social platforms.
|
ACN | Hot Stocks09:05 EDT Accenture awarded $1.6B Air Force task order - Accenture Federal Services has been awarded a task order of up to $1.6B to efficiently scale and enhance the U.S. Air Force's multi-cloud Cloud One environment. This task order is the first of three follow-ons to the Air Force's original Cloud One contract and serves as the agency's one-stop multi-cloud, multi-vendor ecosystem for cutting-edge cloud services. Under the terms of the task order, Accenture Federal Services will perform as a managed service provider for cloud account services, delivering enterprise-scale software support foundational to the Cloud One modernization objective.
|
IBEX | Hot Stocks09:05 EDT Ibex announces the launch of ibex Wave iX AI Virtual Agent - ibex announced the launch of ibex Wave iX AI Virtual Agent, a sophisticated AI solution designed for seamless and scalable automated customer and brand interactions. ibex Wave iX AI Virtual Agent provides AI-driven voice and text conversations that are customized to align with a brand's persona and specific business needs. It offers human-like, infinitely scalable, and hyper-personalized customer experiences while integrating seamlessly with existing agent support systems to facilitate swift escalation and efficient resolution of more complex customer issues.
|
NRXS | Hot Stocks09:04 EDT Neuraxis announces Capital Blue Cross Medical Policy Coverage for PENFS - NeurAxis announced medical policy coverage for Percutaneous Electrical Nerve Field Stimulation, PENFS, for Capital Blue Cross Medical Members, effective October 1, 2024. Capital Blue Cross serves a 21-county region in Central Pennsylvania and the Lehigh Valley. "We are excited regarding our coverage with Capital Blue Cross, further solidifying our patient reach in the Central Pennsylvania region," said Brian Carrico, President and Chief Executive Officer of NeurAxis. "The strong body of published research has resulted in the increased acceptance of our PENFS technology, including expanding payer coverage, as well as the recent establishment of a new CPT Category I code, effective January 1, 2026, by the American Medical Association." Mr. Carrico concluded.
|
NKTR | Hot Stocks09:04 EDT Nektar's rezpegaldesleukin Phase 1 study featured in peer-reviewed publication - Nektar announced the publication of peer-reviewed data from two Phase 1b studies in Nature Communications highlighting the efficacy, safety, and tolerability of rezpegaldesleukin in patients with atopic dermatitis - AD - and psoriasis, or PsO. Results from the Phase 1b studies showed that rezpegaldesleukin safely and dose-dependently increased Tregs and rapidly improved measurable exploratory disease outcomes that are largely durable for at least 36 weeks after ceasing treatment. Rezpegaldesleukin is safe and well-tolerated and demonstrates consistent pharmacokinetics in participants receiving subcutaneous doses of 10 to 12 undefined/kg or 24 undefined/kg once every 2 weeks for 12 weeks, meeting the primary and secondary objectives of each study. AD patients receiving high dose rezpegaldesleukin demonstrate an 83% improvement in EASI score after 12 weeks of treatment EASI improvement of greater than or equal to 75%and vIGA-AD responses are maintained for 36 weeks after treatment discontinuation in 71% and 80% of week 12 responders, respectively. The clinical improvements are accompanied by sustained increases in CD25bright Tregs. Results validate the role of IL-2-induced Treg proliferation and activation in the AD treatment paradigm, and support the advancement of rezpegaldesleukin in the Phase 2b study in AD.
|
SHPH | Hot Stocks09:03 EDT Shuttle Pharmaceuticals doses first patients in Phase 2 trial of Ropidoxuridine - Shuttle Pharmaceuticals announced that the first three patients in its Phase 2 Clinical Trial of Ropidoxuridine for the treatment of patients with glioblastoma have been successfully dosed. "The initiation of patient dosing in our Phase 2 trial of Ropidoxuridine for the treatment of patients with glioblastoma is a significant milestone for both Shuttle Pharma and the thousands of patients with brain tumors who currently lack effective therapies," commented Shuttle Pharma's Chairman and CEO, Anatoly Dritschilo, M.D. "The results of this trial will be important as Shuttle Pharma looks to leverage radiation sensitizers to increase cancer cure rates, prolong patient survival and improve quality of life for patients suffering from glioblastoma."
|
AMZN | Hot Stocks09:03 EDT Blue Duck Capital voices concerns about Amazon.com's 'lackluster performance' - Blue Duck Capital, a long/short equity investment manager focused on thematic opportunities within Technology, Media, Telecom, Consumer, and Industrial sectors and long-term shareholder of Amazon common stock, issued an open letter to the Amazon Board of Directors voicing concerns about the lackluster performance of the company's stock. In the letter, Blue Duck outlines a number of initiatives it believes management can undertake to remedy the underperformance, including: Initiate a formal and significant capital return program to match the Company's market cap, free cash flow and capital reserves. Improve on inefficient business execution across AWS and retail businesses. Provide more transparency around substantial projected A.I. Investment. Leverage Whole Foods' leading market position to better capitalize on growing national health food movement. Refocus Amazon Studios, Wondery and all related media verticals to realign capital spend with viewership to avoid further talent and content missteps. Reference Link
|
AIP | Hot Stocks09:02 EDT Arteris selected by TIER IV for intelligent vehicles - Arteris announced TIER IV has licensed FlexNoC 5 interconnect IP and Magillem Connectivity SoC integration automation software for its next generation of intelligent vehicle electronics. These products support the development of high-performance, reliable automotive SoC products that are essential to realizing fully autonomous driving in the future. "We are pleased to bring our advanced network-on-chip IP and connectivity software to TIER IV's open-source platform for autonomous driving," said K. Charles Janac, president and CEO of Arteris. "Our industry-proven NoC IP and SoC integration automation software offer flexibility and configurability, enabling our customers to confidently develop leading-edge SoCs for any end product, including intelligent vehicles."
|
POCI | Hot Stocks09:01 EDT Precision Optics announces its customer has received FDA 510k clearance - Precision Optics announced that its customer, a surgical robotics company focused on transformative solutions in urology, recently announced FDA 510(k) clearance of its next-generation AI-powered platform for treatment of Benign Prostate Hyperplasia. Precision Optics designed and currently manufactures the single-use endoscope imaging assembly used within the new system.
|
SLB BP | Hot Stocks08:59 EDT SLB joint venture awarded contract by BP for a subsea boosting system - SLB (SLB) announced the award of a contract by BP (BP) to its OneSubsea joint venture for a subsea boosting system in the greenfield development of the Kaskida project in the deepwater U.S. Gulf of Mexico. This award marks the latest milestone in the long-standing relationship between SLB OneSubsea and bp and is the first engineering, procurement and construction contract for a subsea boosting system between the two companies. The project scope includes a supplier-led, high-pressure subsea pump solution complete with an integrated power and controls umbilical, as well as associated topside equipment.
|
LPLA | Hot Stocks08:57 EDT LPL Financial: Goodwin Petrilli join broker-dealer, RIA, custodial platforms - LPL Financial announced that financial advisors Randy Petrilli, Matt Goodwin, Travis Whitaker and Jeff McWhorter of Goodwin Petrilli Financial have joined LPL Financial's broker-dealer, RIA and custodial platforms. The advisors reported having approximately $205 million in advisory, brokerage and retirement plan assets. They join LPL from Cambridge Investment Research. Based in Fort Collins, Co., the firm was founded in 1992 by Harry Goodwin, Matt's father, who retired last year after serving clients for more than three decades. The ensemble practice offers a comprehensive range of financial planning and investment management services to individuals, families and businesses throughout Northern Colorado.
|
ECDA | Hot Stocks08:57 EDT ECD Automotive Design opens collaboration opportunities for luxury brands - ECD Auto Design announced an expanded opportunity for high-end luxury brands to collaborate with us. As leaders in bespoke automotive design, ECD Auto Design is extending unique partnership opportunities to premium brands, offering joint marketing campaigns and exclusive product placements featuring our iconic, one-of-one vehicles. The company said, "Our highly sought-after vehicles represent the pinnacle of design, craftsmanship, and exclusivity, providing a stunning canvas for luxury brands looking to reach an affluent, discerning audience. In this new collaboration effort, ECD is offering unparalleled co-marketing opportunities, including: Joint Product Placement: Luxury brands can showcase their products alongside our custom vehicles in lifestyle photoshoots, videos, and exclusive events. Whether it's high-end fashion, bespoke accessories, or premium travel gear, ECD's stunning builds will elevate your brand's presence among a curated luxury audience. Exclusive Use of ECD Vehicles: Our one-of-one vehicles are available for complimentary use by select partners for brand campaigns, VIP events, or experiential marketing activations. Imagine your product being featured inside a meticulously crafted, custom classic Defender or Mustang in a campaign that resonates with the ultra-affluent. These exclusive opportunities allow for creative storytelling and brand synergy. Luxury Event Collaborations: ECD will work with partners to co-host luxury events, where both the vehicle and the partnering brand are the centerpieces. From private unveilings to high-end experiences, these joint ventures are designed to provide a unique, immersive experience for the target clientele of both ECD and our partners"
|
GDS | Hot Stocks08:55 EDT GDS Holdings announces $1B equity raise by international affiliate - GDS Holdings announced that its international affiliate, DigitalLand Holdings, which acts as the holding company for GDSH's data center assets and operations outside of mainland China, has entered into definitive agreements for certain institutional private equity investors to subscribe for $1B of Series B convertible preferred shares newly issued by GDSI. GDS International was established in 2022 with its corporate headquarters in Singapore. Its portfolio currently comprises approximately 480 MW of data center capacity in service and under construction and an additional 590 MW held for future development across strategic locations in Hong Kong, Singapore, Malaysia, Indonesia, and Japan. The $1B Series B investment is mostly comprised of new US investors, led by Coatue Management with substantial participation by The Baupost Group. Together with GDSI's existing equity, the Series B raise will be sufficient to capitalize the development of up to 1 GW of total data center capacity. GDSH has determined not to exercise its pre-emption rights for the Series B equity raise. Post closing and on an as-converted basis, GDSH will own approximately 37.6% of the equity interest of GDSI in the form of ordinary shares. The value of GDSH's equity interest in GDSI implied by the Series B subscription price is approximately $1.3B, equivalent to approximately $6.75 per American Depositary Share of GDSH. Post closing, GDSH will no longer consolidate GDSI for accounting purposes and GDSH will no longer have the right to appoint a majority of directors to the Board of GDSI.
|
RZLV | Hot Stocks08:53 EDT Rezolve AI congratulates Sierra on recent $4.5B valuation - Rezolve AI congratulates Sierra on its recent $4.5 billion valuation achieved through fundraising led by Greenoaks Capital, with participation from ICONIQ and Thrive Capital. This milestone signals robust investor confidence in AI-driven customer engagement, a vision Rezolve AI has advanced with its proprietary brainpowa large language model and suite of commerce-focused AI solutions. "We applaud Sierra's groundbreaking fundraising, which not only validates the rapid growth of conversational AI but also reinforces the importance of empathy-driven technology, something we at Rezolve AI have been building for years," said Daniel M. Wagner, Founder, Chairman, and CEO of Rezolve AI. "Our partnership with Microsoft underscores our leadership in this space, expanding the reach of our Brain Suite to offer retailers around the globe access to AI solutions specifically designed for compassionate, intelligent customer interactions."
|
CHKP | Hot Stocks08:52 EDT Check Point sees FY results 'well within range' previously provided
|
NEOV | Hot Stocks08:51 EDT NeoVolta, Barrio Electrico execute installation of battery storage systems - NeoVolta in partnership with Barrio Electrico executed the first installation of the NeoVolta NV24 battery storage systems in Puerto Rico. This milestone marks Barrio Electrico's 100th installation and fourth installation under the U.S. Department of Energy's Puerto Rico Energy Resilience Fund, underscoring the impactful collaboration aimed at providing reliable and sustainable energy solutions to Puerto Rican families. NeoVolta's CEO and team were on-site to ensure a smooth installation, demonstrating the company's commitment to advancing clean energy and supporting communities in need. The DOE and local community members also showed their support for the Barrio Electrico initiative, highlighting the importance of this collaborative effort. As part of its expansion strategy, NeoVolta is scaling its operations across the United States and Puerto Rico, with the next shipment of NeoVolta NV24 battery storage systems in route. The company remains committed to meeting the unique solar storage needs of these communities and driving progress in renewable energy.
|
MCD | Hot Stocks08:51 EDT McDonald's says E.coli situation will not have material impact to FY24 results
|
MCD | Hot Stocks08:49 EDT McDonald's plans to introduce value platform revamp in 1Q25
|
MCD | Hot Stocks08:49 EDT McDonald's says 'beginning to see progress' in International markets
|
CAUD | Hot Stocks08:48 EDT Collective Audience launches AI-powered AudienceServices Group - Collective Audience has launched its new AudienceServices Group comprised of a 20-member global professional marketing team based in the U.S., Canada and Europe. The AudienceServices team will leverage a new AI technology, called Copycraft AI, that the company gained from its recent acquisition of DSL Digital, a global provider of Marketing-as-a-Service. Copycraft AI generates high performing ad creative using a brand's unique voice and content. It enables the development of ad campaigns based on a creative agency's brand briefs, and then automatically creates ad creatives that are optimized based on campaign performance metric objectives. The powerful technology delivers results that consistently outperforms today's industry benchmarks.
|
PYPL | Hot Stocks08:47 EDT PayPal expects Braintree to continue to weigh on topline through 2025
|
MCD | Hot Stocks08:47 EDT McDonald's says most major markets growing share - Says "very confident" in growth strategy. Says McCrispy to be in 70+ markets by year-end. Says accelerating roll-out of Big Arch burger. Says $5 meal deal attracting customers, especially at the low end. Extending $5 meal deal into December.
|
AMZN | Hot Stocks08:46 EDT Amazon to shut down Kindle Vella in February 2025 - Amazon plans to shut down its Kindle Vella serialized story platform in February 2025, the company announced. Amazon said: "This was a difficult decision. We are grateful for all of the authors and readers who participated in Kindle Vella and, while we remain committed to experimenting and testing new ideas to deliver unique and delightful experiences for both readers and authors, Kindle Vella hasn't caught on as we'd hoped. All the stories and episodes you have read or unlocked with tokens will remain available in your library in the free Kindle app on iOS and Android after the program closes." Reference Link
|
IBG | Hot Stocks08:46 EDT Innovation Beverage receives largest shipment of bitters to date in the U.S. - Innovation Beverage Group has received its largest shipment of Australian Bitters Company and BITTERTALES brands to serve its expanding distribution network. Recently, IBG announced that its Australian Bitters Company brand is now available nationwide through Sysco and is the first bitters to be sold by the global leader in foodservice distribution. IBG's bitters brands are produced at its U.S. FDA and GMP certified facility in Australia and shipped worldwide.
|
ATNF | Hot Stocks08:45 EDT 180 Life Sciences appoints Jay Goodman to board of directors - 180 Life Sciences announced the appointment of Jay Goodman to its Board of Directors, effective immediately. Currently, Goodman serves as Sales Director for Asia Pacific and Japan at Docker, Inc., a position he has held since January 2024. Goodman was appointed as an independent member of the Board of Directors and as a member of the Company's Audit Committee, as well as positions on other committees.
|
CDR | Hot Stocks08:44 EDT Cedar Realty Trust announces final results of tender offer - Cedar Realty Trust announced the final results of its modified "Dutch auction" tender offer to repurchase up to an aggregate amount paid of $9 million of shares of its outstanding 6.50% Series C Cumulative Redeemable Preferred Stock at a price per share not less than $13.25 and not greater than $15.50, which expired at 5:00 P.M., New York City Time on October 24, 2024. Based on the final count by Computershare, the depositary for the tender offer, an aggregate of 688,670 Series C Shares were properly tendered and not properly withdrawn at or below the final purchase price of $14.00 per share. The Company accepted for purchase all Series C Shares that were properly tendered and not properly withdrawn at or below the final purchase price, which includes 45,813 Series C Shares that the Company has elected to purchase pursuant to its ability to purchase up to an additional 2% of its outstanding Series C Shares. The Company will promptly pay for the shares accepted for purchase and return to tendering shareholders any shares tendered and not purchased. The aggregate purchase price for the Series C Shares purchased in the tender offer is approximately $9.6 million, excluding fees and expenses relating to the tender offer. The shares purchased represent approximately 14% of the Company's issued and outstanding Series C Shares as of October 28, 2024.
|
VCIG | Hot Stocks08:43 EDT VCI Global wins its first AI contract worth $16M - VCI Global announces that its subsidiary, V Gallant Sdn, has been awarded a $16M contract to develop an advanced AI digital human-enabled live streaming platform for a Malaysian e-commerce player. "This contract represents a tremendous boost for our AI division," said Dato' Victor Hoo, Group Executive Chairman and Chief Executive Officer of VCI Global. "As competition in the AI space intensifies, we are well-positioned to secure additional projects within the e-commerce industry, particularly as we approach 2025. Our commitment to innovation aligns with the growing demand for sophisticated digital marketing tools in one of the largest digital markets globally."
|
REBN | Hot Stocks08:43 EDT Reborn Coffee to launch nationwide distribution of Cold Brew line - Reborn Coffee announced the upcoming nationwide distribution of its Cold Brew line, building on the momentum from its recent Miami Passion event with Hagerty Garage + Social during the Austin F1 Race. This launch features Miami Passion, a limited-edition Cold Brew blend, which combines Reborn's signature coffee with tropical Passion Fruit, capturing the vibrant spirit of Miami. Reborn's U.S. distribution strategy will target key markets where demand for premium Cold Brew is high, focusing on both retail locations and e-commerce platforms to ensure easy access for on-the-go consumers. In addition to Miami Passion, Reborn's RTD lineup will include two other popular Cold Brew fruit infused, each crafted to meet the tastes of health-conscious coffee drinkers who prefer low-acid, naturally caffeinated options.
|
CMLS | Hot Stocks08:42 EDT Cumulus Media, TuneIn expand content partnership agreement - Cumulus Media and TuneIn announced that they have renewed and expanded their existing content partnership. Under the terms of the deal, TuneIn will continue to make Cumulus Media's high-quality local sports, news, talk and entertainment programming available to its 75 million monthly global listeners. The extended agreement also includes a new, non-exclusive sales and supply partnership to optimize digital audio advertising monetization for Cumulus' diverse radio stations.
|
PODC LVO | Hot Stocks08:41 EDT PodcastOne acquires exclusive sales, distribution rights to 'Pop Apologists' - PodcastOne has acquired the exclusive sales and distribution rights to Pop Apologists, an Apple Chart topping pop culture podcast hosted by acclaimed influencers and cultural commentators, Lauren and Chanler. Since its debut in 2020, Pop Apologists has garnered a loyal following for its witty commentary and in-depth discussions on pop culture, celebrity news, and trending topics. With millions of downloads to date, the podcast began when the then recent college graduates took their regular phone chats to the podcast airwaves to unapologetically share their interest in celebrities and reality TV. Fast forward four years later, sisters Lauren and Chanler record their twice-weekly podcasts together in New York, and guests have included Heather Gay, Arielle Lorre, Mary Bonnet, Amanda Hirsch, Kate Casey, Ryan Bailey and Madi Murphy.
|
BLIN | Hot Stocks08:41 EDT Bridgeline Digital's HawkSearch selected by distributor of tools, supplies - Bridgeline Digital announced that a leading distributor of fasteners, tools, maintenance, shop, and industrial supplies has selected HawkSearch to enhance their on-site search capabilities. The distributor will leverage HawkSearch to optimize their customer experience and product discovery on the Optimizely platform. The solution will address common challenges and use cases for complex part number searches as well as dimensional products with data discrepancies in unit of measure. They will also utilize HawkSearch's merchandising features including Instant Engage, boost and bury rules, machine learning multipliers, product recommendations, campaigns, as well as entitlements and Visitor Targets for their multiple branch locations.
|
LSB | Hot Stocks08:40 EDT LakeShore Biopharma regains ompliance with Nasdaq minimum bid price requirement - LakeShore Biopharma has received a written notice from the Nasdaq Listing Qualifications Department informing the company that it has regained compliance with the minimum bid price requirement. According to the compliance notice, the company regained compliance with the Minimum Bid Price Requirement because the closing bid price of the company's ordinary shares have been $1.00 per share or greater for 11 consecutive business days, from October 4 to October 18, and the matter is now closed.
|
CLBT | Hot Stocks08:40 EDT Cellebrite announces Tim Tebow as keynote for C2C User Summit 2025 - Cellebrite announced that Tim Tebow will keynote the Company's inaugural Case-to-Closure User Summit, which will be held from March 31 to April 3, 2025, at the Hilton National Mall in Washington, D.C. The inaugural C2C User Summit further cements Cellebrite's position as the true end-to-end digital investigative solutions leader by bringing the brightest digital forensics minds together to discuss best practices and to obtain hands-on instruction. Tim Tebow is a two-time national football champion, Heisman Trophy winner, first-round NFL draft pick and a former professional baseball player who is also known for his extensive advocacy work to protect children through his namesake foundation. At the C2C User Summit, Tim Tebow will address his foundation's global fight against human trafficking. His participation complements Cellebrite's Operation Find Them All initiative, a landmark commitment to accelerating investigations of online crimes against children.
|
AMPG | Hot Stocks08:39 EDT AmpliTech Group releases latest 5G Network In a Box product line - AmpliTech Group announced the release of its latest 5G Network In A Box mobile product line. The company had previously released a 'fixed site' 5G NIB which is a custom bundled, private 5G solution that comes preconfigured, assembled and set up for usage. Our new mobile 5G NIB product line is designed as a ready-to-use single portable device, that contains all software and hardware components required to deploy a pop-up 5G network on the go, for identified commercial end-users, government personnel such as first responders and the military. These products are strategically designed to address the ever-growing needs of having 5G signal service on demand wherever is needed.
|
CETY | Hot Stocks08:39 EDT Clean Energy Technologies signs MOU with Exergy International - Clean Energy Technologies has signed a Memorandum of Understanding, MOU, with Exergy International. This strategic partnership aims to drive growth in the field of heat recovery solutions by promoting, selling, and supporting Exergy's ORC systems across the Americas and potentially other global regions. The collaboration will expand Exergy's and CETY's Waste Heat to Power solutions throughout the Americas, enabling CETY to offer small to large-scale ORC systems for industries such as cement, steel, glass, oil & gas, utilities and for power generation from geothermal resources and biomass.
|
CLIR | Hot Stocks08:38 EDT ClearSign receives flare order for energy company in California - ClearSign has received an engineering order for a flare from an energy company for use in California. This order is for the initial engineering for a flare retrofit to be installed at a production facility. The final product is expected to be fabricated and shipped in Q2 2025 to be installed at the customer's site in the San Joaquin Valley of California.
|
BLDE | Hot Stocks08:38 EDT Blade Air Mobility opens shareholder Q&A platform ahead of Q3 results - Blade Air Mobility announced the opening of the shareholder Q&A platform to be used for its upcoming conference call to discuss the financial results for the third quarter ended September 30, 2024. Blade will conduct the call at 8:00am ET on Tuesday, November 12, 2024. Starting today, any shareholder will be able to submit and upvote questions to management of the Company. To submit questions ahead of the conference call, please visit the Say platform here. Shareholders using brokers that are integrated with Say can also participate directly through their investing app or broker's website.
|
DVAX | Hot Stocks08:37 EDT Dynavax adopts limited-duration stockholder rights plan - Dynavax's board has adopted a limited-duration stockholder rights plan, effective immediately. The board adopted the Rights Plan in response to the recent rapid accumulations of stock by Deep Track Capital, which recently disclosed in a Schedule 13D/A filing its ownership of 13.6% of the company's outstanding common stock. The Rights Plan is intended to protect the investment of Dynavax stockholders during a period in which it believes shares of the company do not reflect the inherent value of the business or its long-term growth potential. In connection with the adoption of the Rights Plan, the board declared a dividend of one preferred share purchase right for each outstanding share of Dynavax's common stock as of the close of business on November 8. Under the Rights Plan, the Rights generally would become exercisable only if a person or group acquires beneficial ownership of 15% or more of Dynavax common shares. Once the Rights become exercisable, each Right will entitle its holder to purchase, for $52.00, additional shares of Dynavax common stock having a market value of twice such exercise price. Any stockholders with beneficial ownership of Dynavax's outstanding common stock above the applicable threshold as of the time of this announcement are grandfathered at their current ownership levels but are not permitted to increase their ownership without triggering the Rights Plan. In addition, the Rights Plan has customary flip-over and exchange features. Dynavax intends to submit the Rights Plan to a vote of its stockholders at its 2025 Annual Meeting.
|
MCD | Hot Stocks08:37 EDT McDonald's says recent E.coli cases 'deeply concerning' - Says "committed" to making things right. Says "swiftly removed" slivered onions from supply chain. Says "confident" in returning quarter pounders to menus. Says serving customers safely is "top priority." Says E.coli situation "appears to be been contained." Says "challenging backdrop" for QSR sector. Says performance in 2024 has "fallen short of expectations." Says company's value leadership gap has shrunk. Comments taken from Q3 earnings conference call.
|
CHRO | Hot Stocks08:37 EDT Chromocell unveils injectable depot program for treating surgical pain - Chromocell Therapeutics announced the unveiling of its injectable depot program utilizing peripheral nerve blocks for the treatment of post-operative pain. The depot program is based on the Company's novel NaV1.7 molecule for treating chronic pain and eye pain. "We are leveraging our existing know-how and intellectual property to target different pain indications and methods of delivery in an efficient and synergistic manner. We are taking advantage of the extensive pre-clinical and Phase I studies performed with CC8464 demonstrating strong efficacy in a wide variety of preclinical models and no dose limiting tolerability concerns in four Phase I trials," said Frank Knuettel, Chief Executive Officer.
|
CRML | Hot Stocks08:36 EDT Critical Metals evolves development strategy for Tanbreez project - Critical Metals provided a project update for the Tanbreez Greenland Rare Earth Mine, one of the world's largest rare earth assets located in Southern Greenland. "The team continues to make remarkable strides at our rare earth project in Southern Greenland," said Tony Sage, CEO and Executive Chairman of Critical Metals Corp. "We have identified two new high-grade areas that were not previously recorded or factored into the development strategy, significantly enhancing the upside potential of this foundational asset. In addition, through our collaboration with the Greenland Government, we have secured a cost-effective power supply, enabling us to optimize our development strategy and create a more favorable project roadmap."
|
SKYQ | Hot Stocks08:35 EDT Sky Quarry appoints Delwo as CFO, Apache as VP of Finance - Sky Quarry announced two key appointments. Darryl Delwo, CPA, a seasoned finance and accounting executive, was previously named Chief Financial Officer, CFO, effective August 20, 2024, and Cyla Apache has recently been promoted to Vice President, VP, of Finance. These appointments reflect Sky Quarry's focus on strengthening its finance leadership as it advances its growth strategy as a publicly listed company on Nasdaq.
|
MNK | Hot Stocks08:34 EDT Mallinckrodt presents data on Terlivaz in hepatorenal syndrome - Mallinckrodt announced a poster presentation on Terlivaz - terlipressin - for injection in patients with hepatorenal syndrome, or HRS, with rapid reduction in kidney function at the annual meeting of the American College of Gastroenterology in Philadelphia from October 25-30. Terlivaz is the first and only FDA-approved product indicated to improve kidney function in adults with HRS with rapid reduction in kidney function, an acute and life-threatening condition requiring hospitalization. The analysis showed real-world socio-demographics, hospital and clinical characteristics, treatment patterns, and clinical outcomes from a retrospective cohort of 125 patients hospitalized with HRS-AKI and treated with Terlivaz for two days or more. Terlivaz was used as the first-line treatment in one-fifth of cases, 20.8%. Among patients with available SCr data, HRS reversal, defined as the return of pre-treatment serum creatinine to less than or equal to1.5 mg/dL, was 47.6%. The limitations of this study include, but are not limited to, small sample sizes, variables in methodology and possible errors and omissions within the data sets.
|
HTCR | Hot Stocks08:34 EDT HeartCore Enterprises to appeal Nasdaq delisting notice - HeartCore Enterprises announced that on October 22, 2024, the Company received written notice from the Nasdaq Listing Qualification Department indicating that it was not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market. Pursuant to the October 2024 Nasdaq Notice, unless the Company requests an appeal of the determination to delist the Company's common stock before a Nasdaq Hearings Panel by October 29, 2024, trading of the Company's common stock will be suspended at the opening of business on October 31, 2024, and a Form 25-NSE will be filed with the SEC which will remove the Company's securities from listing and registration on Nasdaq.
|
MAMA | Hot Stocks08:33 EDT Mama's Creations appoints Chris Darling as Chief Commercial Officer - Mama's Creations announced the appointment of senior CPG sales and retail executive Chris Darling to the role of Chief Commercial Officer. Prior to joining Mama's Creations, he served on the Boar's Head executive leadership team leading national sales.
|
ALLO | Hot Stocks08:32 EDT Allogene Therapeutics receives FDA RMAT designation for ALLO-316 - Allogene Therapeutics announced that the U.S. Food and Drug Administration, FDA, granted Regenerative Medicine Advanced Therapy, RMAT, designation to ALLO-316 for the treatment of adult patients with CD70 positive advanced or metastatic renal cell carcinoma, RCC. The RMAT designation was based on clinical data from the TRAVERSE trial indicating the potential of ALLO-316 to address the unmet need for patients with difficult-to-treat RCC who have failed multiple standard RCC therapies, including an immune checkpoint inhibitor and a VEGF-targeting therapy. The ongoing development of ALLO-316 continues to advance the scientific understanding and applicability of the Dagger(R) technology as the next-generation allogeneic platform to maximize the potential of a single infusion of "off-the-shelf" CAR T product in solid tumors.
|
DSP SCOR | Hot Stocks08:29 EDT Viant licenses Comscore data for training ViantAI - Viant Technology (DSP) announced an expanded integration with Comscore (SCOR), which will enable the use of its trusted audience data to train ViantAI, the world's first fully autonomous media buying platform. This integration will allow ViantAI to leverage Comscore's site ranking and audience reach data, alongside Viant's foundation of data, in the creation of media plans, offering advertisers and agencies the assurance of insights from a respected measurement and analytics partner. By utilizing data-driven insights, ViantAI enables users to create and optimize media plans with greater precision and effectiveness in a matter of seconds. ..This expanded collaboration with Comscore underscores Viant's commitment to equipping its clients with AI technology that provides reliable, actionable information to drive more effective media strategies, helping advertisers to navigate the complex and time-consuming media planning and execution processes.
|
GDDFF | Hot Stocks08:27 EDT Goodfood Market partners with Michelin-recommended restaurant L'Abattoir - Goodfood Market has teamed up with Michelin-recommended restaurant L'Abattoir, expanding their line of restaurant partnerships. Goodfood delivers farm-fresh ingredients and chef-curated recipes directly to customers' doorsteps. Its latest partnership with L'Abattoir will bring elevated French inspired cuisine from one of Canada's best 100 restaurants to subscribers nationwide. Continuing to demonstrate the brands mission of providing accessible, restaurant quality dining experiences that help Canadians explore new cuisines and enhance their cooking skills at home. Goodfood and L'Abattoir will offer two delicious meal-kits developed in collaboration by L'Abattoir's Executive Chef and this year's Vancouver Magazine's Chef of The Year, Lee Cooper, and Goodfood Head Chef Jordana Rebner
|
CRWD | Hot Stocks08:26 EDT Crowdstrike announces new ISO 27001 Certification for products from past year - CrowdStrike announced it has received new ISO/IEC 27001:2022 certification for products made generally available in the past year, CrowdStrike Falcon Next-Gen SIEM, CrowdStrike Charlotte AI and CrowdStrike Falcon for IT, extending the list of certified modules and services on the CrowdStrike Falcon cybersecurity platform. This certification demonstrates CrowdStrike's ongoing dedication to protecting the security and privacy of customer and organizational data by meeting the most rigorous international standards..."Our latest ISO 27001 certification is a testament to our ongoing commitment to upholding the highest information security management standards," said Justin Acquaro, chief information officer, CrowdStrike. "As CrowdStrike continues to advance the industry's leading AI-native cybersecurity platform to stop evolving threats, customers can trust that we follow stringent practices and protocols to keep organizational information safe."...The ISO 27001 certification was awarded after an extensive audit process conducted by an independent, accredited certification body. It includes comprehensive assessments of CrowdStrike's policies, procedures and controls related to data management and security.
|
NKGN | Hot Stocks08:26 EDT NKGen Biotech announces presentation of two posters in AD - NKGen Biotech announced the presentation of two posters, on its first-in-kind, autologous, non-genetically modified NK cell product, troculeucel, in Alzheimer's Disease, AD. The posters entitled, "Use of Non-genetically Modified Natural Killer Cells, SNK01, With Enhanced Activity in Subjects with Active Alzheimer's Disease. Further Biomarker Analysis and Implications for Use in Prevention" and "Treatment of Moderate Alzheimer's Disease Subjects with Expanded Non-genetically Modified Natural Killer Cells with Enhanced Activity - Report of the Phase 1 results of the Phase 1/2a Study" were presented at the 17th Clinical Trials on Alzheimer's Disease Annual Meeting, CTAD, on October 29, 2024.
|
SHIP | Hot Stocks08:24 EDT Seanergy Marine issues statement on Court's dismissal of Economou's litigation - Seanergy Maritime issued the following statement regarding the decision by the High Court of the Republic of the Marshall Islands dismissing the litigation brought by Economou through his entity Sphinx Investment Corp., and with it Sphinx's motion for a temporary restraining order which sought to delay the Company's 2024 Annual Meeting of Shareholders. The Company issued the following statement: The Seanergy Board of Directors is pleased that the Court has dismissed the litigation that Economou brought against Seanergy and its Board members. We are moving forward with our regularly scheduled 2024 Annual Meeting. The Company and our shareholders are benefitting from the strategic actions that the Board and management team are taking, and they are poised to continue to do so through the cycle and beyond. Our Board strongly recommends that shareholders vote on the WHITE proxy card "FOR" Seanergy's nominees and "AGAINST" Economou's proposals.
|
TIVC | Hot Stocks08:24 EDT Tivic Health announces 1st subject enrolled in optimization study for ncVNS - Tivic Health Systems announced that the first study subject has been enrolled in the optimization study for Tivic Health's patent pending, non-invasive vagus nerve stimulation device. The study, being run by The Feinstein Institute of Bioelectronic Medicine, will identify device parameters, including frequency and duration of treatment, that optimally influence autonomic nervous system ANS function. The results will be used to inform clinical indication priority and commercial development. Enrollment is expected to be complete by early December. "The effectiveness of Tivic's non-invasive cervical vagus stimulation or ncVNS, which influences autonomic function, has already been established, demonstrating large ANS responses impacting cardiovascular and central nervous system activity," stated Tivic Health Chief Scientific Officer Blake Gurfein. "The data from this study will advance our technology toward potential FDA approval for non-invasive treatment of large market indications, where current treatments are invasive, inadequate, or both."
|
IMMP | Hot Stocks08:23 EDT Immutep reports Q1 cash receipts from custmers $20,000 - The company said, "During the quarter, Immutep continued to advance its clinical trial programs for efti and preclinical program for IMP761 to create value for shareholders. The Company is well funded with a strong cash and cash equivalent balance as at 30 September 2024 of approximately A$120.3 million. In addition to this cash balance, Immutep has an A$52.0 million bank term deposit, which has been recognised as a short-term investment due to the maturity date of 5-12 months. This aggregate position of A$172.3 million as at 30 September 2024 gives Immutep an expected cash reach to the end of CY2026."
|
SNEX | Hot Stocks08:23 EDT StoneX Group announces election trading partnership between FOREX.com, Kalshi - FOREX.com announce a new partnership with Kalshi, the CFTC-regulated exchange for trading on the outcome of future events. This partnership enables traders to trade FX markets with the leading forex broker in the US while expressing a view on the US Presidential Election through Kalshi's unique event-based platform. This partnership also incorporates a $20 bonus for FOREX.com clients accessing the Kalshi platform to trade the US Presidential Election, subject to certain conditions.
|
AONC | Hot Stocks08:22 EDT American Oncology, Vantage Health partner to enhance access to AI care platform - American Oncology Network has partnered with Vantage Health Technologies to enhance access to and delivery of exceptional cancer care. Vantage's AI-enabled platform provides real-time health data for actionable insights and next-best-actions that can promote better patient experiences and outcomes, reduce provider burnout, and lower the cost of care. The platform also helps AON further enhance its Value-Based Care model in community oncology.
|
PYPL | Hot Stocks08:22 EDT PayPal sees lower Braintree volume, revenue growth in Q4
|
PYPL | Hot Stocks08:21 EDT PayPal assuming relatively consistent macro, consumer spending environment - PayPal is assuming a relatively consistent macro and consumer spending environment for the remainder of the year.
|
IMNM | Hot Stocks08:21 EDT Immunome presents preclinical data for IM-1021, ADC payload HC74 - Immunome recently presented preclinical data for IM-1021 and the associated proprietary ADC payload HC74. The results were presented in a poster entitled "Preclinical evaluation of IM-1021, a ROR1-targeted antibody-drug conjugate with a novel topoisomerase I linker payload" at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona on October 24. The poster included preclinical results for IM-1021 in both liquid and solid tumors while also highlighting the enhanced ADME properties of HC74: IM-1021 showed superior efficacy compared to zilovertamab vedotin in both the Jeko-1 mantle cell lymphoma model and the MDA-MB-468 triple negative breast cancer model. In the MDA-MB-468 study, 5 out of 8 animals achieved complete responses after three 5 mg/kg doses. HC74 demonstrated superior potency compared to deruxtecan in a panel of 89 cancer cell lines. HC74 showed faster hepatocyte clearance, higher permeability, and lower efflux than deruxtecan. When evaluated in doxorubicin-resistant and vincristine-resistant cell lines, HC74 showed no reduction in potency compared to the parental NCI-H69 cell line. Immunome expects to submit an IND for the IM-1021 program to the FDA in the first quarter of 2025.
|
SHFS | Hot Stocks08:21 EDT Safe Harbor Financial originates $1.07M secured credit facility for operator - SHF Holdings has originated a $1.07 million secured credit facility for a Missouri-based cannabis operator, the first tranche of a $5 million commitment to refinance existing senior debt. The loan further solidifies Safe Harbor's position as a key partner for cannabis operators seeking competitive financial solutions in the rapidly evolving cannabis financial sector. The facility is secured by a portfolio that includes four retail dispensaries and a manufacturing facility in Missouri. The refinancing reduces the operator's borrowing costs and will enable them to optimize their operations within the state's growing cannabis market.
|
GRFS | Hot Stocks08:20 EDT Grifols receives FDA approval to treat surgical bleeding with FS solution - Grifols announced that its plasma-protein based fibrin sealant, FS, for controlling surgical bleeding has received approval from the United States Food and Drug Administration, FDA, for pediatric patients. The U.S. indication for children and adolescents extends the availability of FS, which is already approved for this patient segment in Europe, in addition to adults. During surgery Grifols FS promotes hemostasis and tissue sealing, resulting in reduced blood loss and potentially fewer complications.
|
VSTE | Hot Stocks08:19 EDT Vast, GGS Energy partner to bring CSP-powered green methanol, SAF to U.S. - Vast Renewables announced it has signed a development services agreement with GGS Energy, a leading energy transition development company with deep project development experience, to pursue a commercial-scale synthetic fuels project in the Southwest United States. Project Bravo, Vast's first deployment in the U.S., will see Vast's CSP v3.0 technology used to generate carbon free heat and electricity to power a co-located refinery that will produce green methanol and/or electrically powered sustainable aviation fuel. The project is expected to be located in the Southwest United States
|
CRVO | Hot Stocks08:18 EDT CervoMed to present at International Lewy Body Dementia Conference - CervoMed will deliver an oral presentation providing detailed safety and efficacy results from its completed RewinD-LB Phase 2b clinical trial of neflamapimod in dementia with Lewy bodies at the eighth International Lewy Body Dementia Conference taking place on January 29-31, 2025 in Amsterdam, the Netherlands. "As we await topline results from the RewinD-LB Phase 2b trial in DLB, we are extremely encouraged by the scientific community's interest in the data and pleased to have an opportunity to present them at the leading scientific conference dedicated to Lewy Body Dementia," said John Alam, CEO. "There are currently no approved therapies for DLB, and the dementia clinical research community has a strong interest in the ongoing RewinD-LB Phase 2b study and its potential beneficial impact to patients and families. Topline results for RewinD-LB are expected to be disclosed in December 2024 and we are also presenting data on RewinD-LB baseline patient characteristics at the upcoming Clinical Trials on Alzheimer's Disease Conference. Based on our preliminary analyses, we are confident that we have optimized RewinD-LB trial design to detect a statistically significant and clinically meaningful difference between neflamapimod and placebo."
|
BIIB BMY | Hot Stocks08:18 EDT Biogen appoints Quirk as Chief Medical Officer - Biogen (BIIB) has appointed Daniel Quirk, M.D., M.P.H., M.B.A. as Chief Medical Officer and Head of Medical Affairs, effective October 28, 2024. Dr. Quirk will report to Priya Singhal, M.D., M.P.H., Head of Development at Biogen. Prior to joining the Biogen team, Dr. Quirk was Senior Vice President of Worldwide Medical Affairs for Immunology and Neuroscience at Bristol-Myers Squibb (BMY).
|
HRB | Hot Stocks08:17 EDT H&R Block opens 2024 application period for Emerald Advance Loan - H&R Block announced the opening of the 2024 application period for the H&R Block Emerald Advance Loan. Applications will be accepted November 1 through December 31, 2024. The Emerald Advance Loan originated by Pathward provides qualifying individuals up to $1,300 the same day they apply. The Emerald Advance Loan could provide a little extra breathing room to help with holiday shopping, bills, or unexpected expenses.
|
NXRT | Hot Stocks08:16 EDT NexPoint Residential raises quarterly dividend 10.3% to 51c per share - NexPoint Residential Trust announced that its board of directors unanimously approved a dividend of 51c per share of NXRT common stock, payable on December 31 to stockholders of record on December 13. This represents an 10.3% increase over the previous quarter's dividend per share and an increase of 147.6% since inception in 2015.
|
PYCR | Hot Stocks08:16 EDT Paycor HCM launches Integration Platform to transform connevtivity - Paycor HCM announced the launch of its Integration Platform, offering flexible solutions to make connecting data and systems easier, especially for organizations who don't have in-house IT or developer support. The platform enables customers to integrate their third-party HR software and business applications more efficiently, as well as drive better data accuracy and real-time availability.
|
PBI | Hot Stocks08:16 EDT Pitney Bowes appoints Lance Rosenzweig permanent CEO, Milena Alberti-Perez chair - Pitney Bowes announced the appointment of Lance Rosenzweig as the company's permanent CEO, effective immediately. The company's board carried out a CEO search process that was supported by an executive recruiting firm and included both internal and external candidates. In addition, Pitney Bowes announced the following changes and enhancements to its board: the election of Milena Alberti-Perez as non-executive chair. Alberti-Perez previously held CFO roles, has served on the board since May 2023.
|
SYY | Hot Stocks08:16 EDT Sysco says 'on track' to return approximately $2B back to shareholders in 2025 - "Additionally, we remain on track to return approximately $2 billion back to shareholders for the fiscal year," said Kenny Cheung, CFO.
|
TKLF | Hot Stocks08:15 EDT Yoshitsu announces opening of new 'Reiwatakiya' store in Fashion Show Las Vegas - Yoshitsu announced the upcoming opening of a new store under its "Reiwatakiya" brand at Fashion Show Las Vegas. The Store is set to open in November 2024 at Fashion Show, a premier shopping, dining, and entertainment destination on the Las Vegas Strip. This move is expected to further strengthen the Company's presence in the U.S. market and enhance global brand recognition.
|
GSK | Hot Stocks08:15 EDT GSK to acquire CMG1A46 from Chimagen Biosciences - GSK plc and Chimagen Biosciences, a privately held biotechnology company, announced an agreement for GSK to acquire CMG1A46, a clinical-stage dual CD19 and CD20-targeted T cell-engager, from Chimagen for $300M upfront. GSK plans to develop and commercialize CMG1A46 with a focus on B cell-driven autoimmune diseases, such as systemic lupus erythematosus, or SLE, and lupus nephritis, or LN, with potential to expand into related autoimmune diseases. CMG1A46 is currently in phase I clinical trials in leukemia and lymphoma in both the U.S. and China. GSK aims to begin a Phase 1 trial in lupus in 2025. "For over a decade, GSK has been a pioneer in the treatment of lupus. This agreement underscores the importance of novel therapeutic approaches to address the heterogeneity of lupus manifestations and the continued burden, particularly in patients who suffer from severe disease and are refractory to current standard of care," the company stated. Tony Wood, Chief Scientific Officer, GSK, said: "Through our work in systemic lupus erythematosus and lupus nephritis, we increasingly understand the underlying drivers of B cell-driven diseases. As a novel therapeutic option directed at deep B cell depletion, CMG1A46 offers exciting potential which we are pleased to take forward to address unmet need in lupus and related autoimmune conditions." Under the terms of this agreement, GSK will pay $300M upfront to acquire full global rights to CMG1A46. In addition, Chimagen will be eligible to receive success-based development and commercial milestone payments for CMG1A46 totalling $550M. This agreement is subject to customary conditions, including applicable regulatory agency clearances under the Hart-Scott-Rodino Act in the U.S.
|
ULCC | Hot Stocks08:14 EDT Frontier Group narrows FY24 adjusted CASM view to down 1% from down 1%-3%
|
NBY | Hot Stocks08:13 EDT NovaBay board determines Refresh Acquisitions offer is superior to PRN pact - NovaBay announced that the company's board of directors has determined that an unsolicited and non-binding offer from Refresh Acquisitions BidCo for an affiliate of Refresh to acquire the company's Avenova brand and related assets is a "Superior Proposal" to the company's asset purchase agreement with PRN Physician Recommended Nutriceuticals, or PRN. Refresh's unsolicited offer provides for terms that are substantially similar to the contemplated transaction with PRN, except that the company would receive a purchase price of up to $11.5M, subject to a downside net working capital adjustment. Refresh's unsolicited offer also includes Refresh providing a secured term loan to the company in the principal amount of $2M, which is expected to be repaid upon closing and deducted from the purchase price. The company has notified PRN of the board of directors' determination and that the company intends to terminate its asset purchase agreement with PRN unless the company receives a revised proposal from PRN by 11:59 p.m. Pacific time on November 4, such that the company's board of directors determines that Refresh's unsolicited offer is no longer a superior proposal, in accordance with the process provided in the asset purchase agreement with PRN. The company's asset purchase agreement with PRN, in accordance with such agreement, remains in full force and effect, and the company's board of directors has not withdrawn or modified its recommendation regarding stockholders approving the pending transaction with PRN. The company's transaction with PRN remains subject to certain closing conditions, including receiving stockholder approval. Consistent with its fiduciary duties, the company's board of directors conducted an evaluation of the Refresh unsolicited offer with assistance from independent financial and legal advisors, before making its determination.
|
PYPL | Hot Stocks08:12 EDT PayPal CEO believes Venmo will ultimately have multiple monetization levers
|
MASI | Hot Stocks08:12 EDT VUMC teams with Masimo to bring Radius VSM to patients in the ED - Masimo announced that Vanderbilt University Medical Center VUMC , a renowned healthcare facility in Nashville, Tennessee, is piloting the use of the Masimo Radius VSM patient-worn vital signs monitor with Masimo Patient SafetyNet supplemental remote monitoring in the Emergency Department ED and nontraditional care spaces. Launched as part of a successful pilot program aimed at tackling the ongoing crisis of emergency room congestion, Radius VSM has been used on hallway beds, in the emergency medical service offload area, and on patients in the waiting room who are typically only monitored periodically - thus providing continuous, wireless monitoring for those who may otherwise be left vulnerable to unexpected deterioration...Bilal Muhsin, Chief Operating Officer of Masimo, said, "We are excited to partner with Vanderbilt University Medical Center to bring Radius VSM to vulnerable patients in the emergency department, where continuous monitoring is not the norm. A core tenet of our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications-and one of the ways we achieve that is through continued innovation. With Radius VSM, clinicians have the power of cutting-edge technology in a modular, scalable design that's both easy to use and comfortable for the patient. The applications are virtually limitless, and I cannot wait to see how the use of this technology is expanded to enhance patient safety not only in the emergency department, but across the continuum of care."
|
ULCC | Hot Stocks08:12 EDT Frontier Group sees Q4 capacity down 2%-3% vs. last year - Sees Q4 average fuel price per gallon $2.40-$2.50. Adjusted total operating expenses excluding fuel are expected to be $725M-$745M, which includes an estimate of approximately $10M of cost inefficiencies from hurricane-related impacts and temporary excess crew-related costs due to capacity reductions. Adjusted pre-tax margin is expected to be 0%-2%, including storm-related impacts.
|
EOLS | Hot Stocks08:10 EDT Evolus rewards patient loyalty program surpasses 1M enrolled consumers - Evolus announced it recently surpassed one million enrolled consumers and completed the two-millionth Jeuveau redemption in its Evolus Rewards patient loyalty program. "The achievement of these milestones underscores the success of our strategy to democratize beauty and make aesthetics accessible to a new generation of consumers," said David Moatazedi, President and Chief Executive Officer. "Our easy-to-use, SMS-based loyalty program offers consumers an instant $40 savings on every Jeuveau treatment, while providing practices with the only co-branded solution to encourage repeat visits. We're proud of the rapid adoption of this innovative program, which has grown to over 1 million consumers and achieved more than 2 million redemptions. "We are excited to expand our loyalty offering with the upcoming launch of Club Evolus, the industry's first subscription-based consumer membership program from a neurotoxin manufacturer, debuting on November 4th. Powered by the same proprietary digital platform that enhances the practice experience, Club Evolus will offer consumers even more value and convenience."
|
WKSP | Hot Stocks08:09 EDT Worksport announces significatn milestone in its B2B sales growth - Worksport announce a significant milestone in its business-to-business, B2B, sales growth, and the newly initiated pre-order campaign for its highly anticipated AL4 Premium Tonneau Cover. In the last four months, Worksport has impressively achieved over 200% growth in Dealer Account sales of its Worksport-branded products, with key dealers in most major areas across the USA and Canada. This exponential growth is attributed to the surging interest in high-quality, aggressively priced tonneau covers that meet the demands of today's market. Strategic Dealer Expansion with High Conversion Rates: Worksport has shipped hundreds of displays to key dealer accounts across the United States; These display units have generated an outstanding 31% conversion rate; strong dealer interest signals a substantial opportunity for continued sales growth
|
ZVSA | Hot Stocks08:09 EDT ZyVersa highlights review article on inflammasome-induced inflammation - ZyVersa Therapeutics highlights data from a review article published in the peer-reviewed journal, Life. The article summarizes data from 345 publications on the role of inflammasome-induced inflammation in obesity and its comorbidities, and it reinforces the need for therapeutic options to better address the inflammation. "Strong evidence that obesity treatment needs to go beyond weight loss and address the damaging inflammation leading to life-altering comorbidities is driving ZyVersa and other biopharma companies to invest in development of drugs to be used along with incretin therapy to treat inflammation," said Stephen C. Glover, ZyVersa's Co-founder, Chairman, CEO and President. "Studies documenting the key role of inflammasomes in triggering obesity-associated inflammation led ZyVersa to focus on this area for development of Inflammasome ASC Inhibitor IC 100. We are excited about the potential of IC 100 to effectively control the inflammation of obesity. Unlike the NLRP3 inhibitors in development, IC 100 targets ASC to inhibit multiple inflammasomes, including NLRP3 and AIM2, which are associated with obesity. More importantly, IC 100 uniquely disrupts the function of ASC specks to attenuate chronic, systemic inflammation leading to obesity comorbidities. We look forward to progressing IC 100's obesity development program into phase 1 around mid-2025." In the review article titled, The Interplay between Obesity and Inflammation, the authors concluded: Development of adipose tissue inflammation triggers subsequent cardiovascular events and therefore represents a major reason for the treatment of obesity. The interplay between obesity and inflammation is complex, involving a variety of cellular and humoral factors, and due to the complexity and particular features of the adipose tissue, the inflammation within may persist for long periods of time. Macrophages are the main cellular component driving adipose tissue chronic inflammation. Modulation of macrophages and their release of proinflammatory cytokines, such as NLRP3-driven IL-Ibeta and IL-18, can be a key factor in medical intervention in obese patients. Understanding the pathophysiological changes in adipose tissue and the interplay with chronic inflammation can assist in the design of future studies and reveal opportunities for the development of more efficient therapies for obesity.
|
IPGP | Hot Stocks08:08 EDT IPG Photonics announces agreement to acquire CleanLASER - IPG Photonics announced that it has signed a definitive agreement to acquire Clean-Lasersysteme, cleanLASER, a leader in laser cleaning systems. The transaction strengthens IPG's global position in high-precision laser systems for cleaning applications, an attractive growth market. Subject to satisfaction of customary closing conditions, including regulatory approval, the transaction is expected to close in the fourth quarter of 2024.
|
PYPL | Hot Stocks08:07 EDT PayPal seeing 15%-20% increase in buy now pay later use, says CEO
|
SUUN | Hot Stocks08:05 EDT SolarBank to develop 7.2 MW solar project in New York - SolarBank plans to develop a 7.2 MW DC ground-mount solar power project known as the North Main project on a site located in Wyoming County, New York. The clean energy generated by community solar projects feeds directly into the local electricity grid. Depending on the size and number of panels a community solar project has, renters and homeowners can earn credits on their electric bill and save money from the electricity that is generated by a project. The Project is expected to be eligible for incentives under the New York State Energy Research and Development Authority NY-Sun Program. The development of any project is subject to receipt of interconnection approval, required permits, the continued availability of third-party financing arrangements for the company and the risks associated with the construction of a solar power project.
|
PYPL | Hot Stocks08:03 EDT PayPal CEO says will host investor day February 25 in NYC
|
PYPL | Hot Stocks08:03 EDT PayPal CEO says actively discussing more collaborations across industry
|
WH | Hot Stocks08:03 EDT Wyndham Hotels nears 600 direct franchise hotels in China over five years - Wyndham Hotels surpassed a milestone in China signing nearly 600 direct franchise agreements across the country in five years. Wyndham is the largest U.S. based hotel company in China by number of properties, with a footprint spanning more than 1,600 hotels and more than 180,000 rooms across 13 of its 25 brands. In the first half of 2024, Wyndham signed direct franchise agreements for more than 70 hotels in key markets including Beijing, Jiangsu and Guangdong.
|
BGM | Hot Stocks08:02 EDT Qilian International to change name to 'BGM Group Ltd.,' effective October 30 - Qilian International is pleased to announce that effective on October 30, the company will change its name to "BGM Group Ltd." In connection with the name change, the trading symbol of the company's Class A ordinary shares has been changed to "BGM" on the Nasdaq Stock Market, effective on August 11, and the CUSIP number remains unchanged.
|
PYPL | Hot Stocks08:02 EDT PayPal CEO says Q3 was 'highly productive' - Says "early" in transformation journey. Comments taken from Q3 earnings conference call.
|
RAMPF SAN | Hot Stocks07:56 EDT Polaris Renewable Energy enters Equity Capital Contribution Agreement - Polaris Renewable Energy (RAMPF) has entered into an Equity Capital Contribution Agreement with respect to Punta Lima Wind Farm, a wholly owned subsidiary of Santander Bank (SAN). The project is an operating onshore wind farm called Punta Lima Wind Farm with a nameplate capacity of 26.0 MW's located in the Municipality of Naguabo, Puerto Rico. The Project was re-constructed and recommissioned by Santander and has a 20-year power purchase agreement in place with Puerto Rico Electric Power Authority terminating in March 2044. The transaction is being completed using a tax-equity structure which will result in Polaris becoming the manager and operator of the Project with a controlling equity interest and Santander retaining a tax equity interest in the Project. the transaction is subject to customary closing conditions, which principally consist of approval of the acquisition by local regulatory bodies as well as the execution of a corresponding LLC Agreement. It is expected that these conditions will take approximately 90 days to finalize. The total equity contribution of $20 million from Polaris will be subject to customary closing adjustments including working capital changes. Polaris intends to use cash on hand to fund the equity contribution. Santander Corporate & Investment Banking acted as sole financial advisor to Santander Bank
|
ELDN | Hot Stocks07:52 EDT Eledon announces data for islet transplant recipients treated with tegoprubart - Eledon Pharmaceuticals announced data for the first three islet transplant recipients treated with an immunosuppression regimen that includes tegoprubart, the Company's investigational anti-CD40L antibody, for prevention of islet transplant rejection in subjects with type 1 diabetes. The investigator-initiated trial, conducted by the research team at the University of Chicago Medicine's Transplantation Institute, demonstrated potentially the first human cases of insulin independence achieved using an anti-CD40L monoclonal antibody therapy without the use of tacrolimus, the current standard of care for prevention of transplant rejection. The first two subjects achieved insulin independence and normal hemoglobin A1C levels, a measure of average blood glucose, post-transplant. The third subject, who recently received an islet transplant, decreased insulin use by more than 60% three days following the procedure and continues on an insulin independence trajectory. Subjects on study received islet transplants combined with induction therapy, mycophenolate mofetil, and tegoprubart, given every third week by intravenous infusion. The first two subjects achieved insulin independence and presented stable islet graft function at approximately three months and six months post-transplant, respectively. Islet engraftment, measured by graft function standardized to the number of islets infused, was three to five times higher than three comparable subjects outside this study who received tacrolimus-based immunosuppression, suggesting treatment with tegoprubart is less toxic to transplanted islets resulting in improved graft survival and function. Treatment was generally well tolerated in all subjects with no unexpected adverse events or hypoglycemic episodes. After initial islet transplant, the first participant reduced insulin requirements by over 60% and normalized blood glucose control. The first patient then achieved insulin independence approximately two weeks after the second islet transplantation procedure. The data are being featured in an oral presentation at the International Pancreas and Islet Transplantation Association, Harvard Stem Cell Institute, and Breakthrough T1D 5th Annual Summit on Stem Cell Derived Islets on Tuesday, October 29, 2024.The first participant was a 42-year-old female with a baseline weight of 88 kg/194 lbs. At 90 days post-transplant, the participant's HbA1c level improved to 6.0% and daily insulin dose decreased to 16 units per day. After 16 weeks, the participant received a second islet transplant, and approximately two weeks later achieved insulin independence, maintaining improved HbA1c levels of 5.4% afterwards. The second participant was a 30-year-old female with a baseline weight of 50 kg/110 lbs. This patient stopped insulin support four weeks after the islet transplant. Her HbA1c levels improved to 5.8% and below starting at seven weeks after the transplant. The third participant was a 37-year-old male with a baseline weight of 92 kg/203 lbs with a baseline HbA1C of 9.3%. This patient was discharged home on day three post-transplant, requiring 29 units of insulin. The treatment was generally well tolerated in all subjects with no unexpected adverse events, severe hypoglycemic episodes, or graft rejection.
|
QNTM | Hot Stocks07:48 EDT Quantum retains services of Agoracom, ITG, Buyins and Stockjock - Quantum Biopharma has retained the services of Agoracom, Independent Trading Group, Buyins and Stockjock.com who which will each play a key role in assisting the Company to enhance its market awareness and foster productive, continuing dialogues with shareholders and other market participants. Management has made this decision following a thorough review of capital on hand and allocated these resources to the following companies it has engaged to conduct Investor Relations Activities on its behalf. Agoracom, based at 505 Consumers Rd, North York, Canada has been engaged for a period of 3 months with either party having the right to terminate the engagement upon providing 30-days notice. The cost of the engagement is $25,000 CAD. ITG will trade shares of the Company on the Canadian Securities Exchange to maintain an orderly market, improve the liquidity of the Company's shares and provide the company with market intelligence. Under the terms of the agreement, ITG will receive a fee of $7,500 CDN dollars per month for a minimum period of 3 months. After the initial 3 month period, the agreement may be terminated by the Company at any time upon 30 days written notice. The Company and ITG are unrelated entities. ITG has no present, direct or indirect interest in the Company or its securities. There are no performance factors in the agreement, and ITG will not receive shares or options as compensation. ITG is a member of the Investment Industry Regulatory Organization of Canada. Accordingly, ITG can access all Canadian Stock Exchanges and Alternative Trading Systems. Buyins based at 417 Orchid Avenue, Corona del Mar, CA has been engaged for a period of 1 month with either party having the right to terminate the engagement upon providing 10-days notice. The cost of the engagement is $15,000. Stockjock based at 22287 Mullholland Hwy., Calabasas, CA has been engaged for 3 events with either party having the right to terminate the engagement upon providing 10-days notice. The cost of the engagement is $15,000.
|
QNTM | Hot Stocks07:47 EDT Quantum Group announces start of sentinel dosing in Lucid-21-302 MAD trial - Quantum BioPharma announces through its subsidiary, HUGE Biopharma Australia, that sentinel dosing has started for its trial entitled "A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of Lucid-21-302 in Healthy Adult Participants."
|
ZENA | Hot Stocks07:44 EDT ZenaTech to establish new company in Taiwan - ZenaTech announced it will establish a new company in Taiwan to manufacture drone sensors and components for use in the drone products produced by its subsidiary ZenaDrone. The new company, named Spider Vision Sensors Ltd., will ensure ZenaDrone's products are compliant with the US National Defense Authorization Act, NDAA, an important requirement for the company to win more business with the US Military. Spider Vision Sensors Ltd. will manufacture drone sensors, electronics, and components such LiDAR, thermal, infrared, multi-spectral and hyper sensors, cameras, and PBCs
|
MGA | Hot Stocks07:44 EDT Magna debuts Dual Clutch Transmission Eco solution for European OEM - Magna announced the debut of its Dual Clutch Transmission Eco solution for a European OEM. This contract marks the first high-volume award for the new transmission family and supports various models in global markets with ICE transmissions. Magna has already started production for this program. The DCT Eco was launched in vehicle models earlier this year in South America, with various European models set to follow in 2025.
|
GLYC | Hot Stocks07:43 EDT GlycoMimetics enters acquisition agreement with Crescent Biopharma - GlycoMimetics announced it has entered into an acquisition agreement with Crescent Biopharma, a privately held biotechnology company. Upon completion of the transaction, the company plans to operate under the name Crescent Biopharma. In support of the acquisition, a syndicate of investors led by Fairmount, Venrock Healthcare Capital Partners, BVF Partners, and a large investment management firm, with participation from Paradigm BioCapital, RTW Investments, Blackstone Multi-Asset Investing, Frazier Life Sciences, Commodore Capital, Perceptive Advisers, Deep Track Capital, Boxer Capital Management, Soleus, Logos Capital, Driehaus Capital Management, Braidwell LP, and Wellington Management, has committed $200M to purchase GlycoMimetics common stock and GlycoMimetics pre-funded warrants to purchase its common stock. The transaction is expected to close in the second quarter of 2025. The financing is expected to close immediately following the completion of the transaction. The company's cash balance at closing is anticipated to fund operations through 2027, including advancement of the company's lead program CR-001, a tetravalent PD-1 x VEGF bispecific antibody, through preliminary proof of concept clinical data in solid tumor patients expected in the second half of 2026. Crescent is the fifth company to launch with assets discovered and developed by Paragon Therapeutics. CR-001, a tetravalent PD-1 x VEGF bispecific antibody, matches the format and pharmacology of ivonescimab, which delivered efficacy compared to the current market leader pembrolizumab in a large third party Phase 3 trial. In addition to CR-001, Crescent is developing CR-002 and CR-003, antibody-drug conjugates (ADCs) against undisclosed targets using topoisomerase inhibitor payloads; ADCs with topoisomerase inhibitor payloads have shown improved efficacy and safety compared to ADCs with alternative payloads. The Company anticipates that the IND for CR-001 will be filed in 4Q25 or 1Q26, and interim Phase 1 data from patients is expected in 2H26. CR-002, Crescent's first ADC program is expected to initiate Phase 1 in 2026; the company plans to disclose the target for CR-002 as the program approaches the clinic. The company intends to determine potential paths forward for its late-stage clinical candidate, Uproleselan, including by supporting continued data analyses of Uproleselan from NCI, its corporate partner for China, Apollomics, and investigator-initiated studies. Under the terms of the acquisition agreement, the pre-acquisition GlycoMimetics stockholders are expected to own approximately 3.1% of the combined company and the pre-acquisition Crescent stockholders are expected to own approximately 96.9% of the company. The percentage of the company that GlycoMimetics's stockholders will own as of the closing of the acquisition is subject to adjustment based on the amount of GlycoMimetics's net cash at the closing date. The transaction has received approval by the board of directors of both companies and is expected to close in the second quarter of 2025, subject to certain closing conditions, including, among other things, approval by the stockholders of each company and the satisfaction of customary closing conditions. The company will be named Crescent Biopharma and be led by Jonathan Violin, Crescent's interim CEO who will be joined on Crescent's board of directors by Peter Harwin, Managing Member of Fairmount.
|
ABEO | Hot Stocks07:43 EDT Abeona Therapeutics completes Pz-cel BLA resubmission to U.S. FDA - Abeona Therapeutics announced that the Company has resubmitted its Biologics License Application, BLA, to the U.S. Food and Drug Administration, FDA, for prademagene zamikeracel, its investigational autologous cell-based gene therapy, as a potential new treatment for patients with recessive dystrophic epidermolysis bullosa, RDEB. "We have worked closely with the FDA in preparing for the pz-cel BLA resubmission and thank the Agency for their ongoing guidance," said Vish Seshadri, Chief Executive Officer of Abeona. "We have incorporated the Agency's feedback and are confident that our resubmission package addresses all the Chemistry Manufacturing and Controls items identified in the Complete Response Letter, including observations from the completed Pre-License Inspection of our manufacturing facility. Upon acceptance of the BLA, we look forward to assisting the FDA in the completion of its review."
|
STRM | Hot Stocks07:42 EDT Streamline Health adds Quality Module to third eValuator client - Streamline Health Solutions announced that it has expanded its relationship with a leading academic medical center in Florida to include the recently released eValuator Quality Module. Streamline expects that this module will increase the SaaS revenues from its eValuator relationship with this client by 20%. "We are thrilled to see our new eValuator Quality Module being adopted by leading healthcare organizations, and expect these expansions to continue," stated Ben Stilwill, President and Chief Executive Officer, Streamline. "By providing real-time insights into risk scoring and quality metrics, , we are empowering our clients to enhance patient care while ensuring accurate reimbursement."
|
ERLFF | Hot Stocks07:42 EDT Entree Resources provides update on arbitration - As previously disclosed, on May 26, 2022, the Company commenced binding arbitration proceedings to seek declarations and orders for specific performance relating to certain provisions of the 2004 Equity Participation and Earn-in Agreement and the JV Agreement. The arbitration was commenced in Vancouver, British Columbia under the International Commercial Arbitration Act. A three-member Tribunal was appointed and the evidentiary hearing took place in Vancouver on April 8 and 9, 2024. Closing submissions were heard in Toronto on July 10, 2024. To date, no decision has been released and the Company does not know when a decision will be forthcoming. Further, the Company does not know if the Tribunal will release a partial or final decision. If a partial decision is released further submissions and hearings may be necessary. There can be no assurance that a decision will be favourable to the Company. If an arbitration decision is received prior to the execution of a definitive alternative agreement, there can be no assurances as to whether both parties would continue to try to progress a commercial resolution as currently contemplated or at all. Stephen Scott commented, "In 2022, Lift 1 Panel 0 underground development work was progressing. We were doubtful the Company could successfully negotiate a reasonable outcome before the work reached the JV license boundary, which at the time was expected at some point in 2023. We were facing the prospect of significant delays to JV development work if contractual certainty and transfer of the licenses could not be achieved. Nor could we advance discussions with the Government of Mongolia in a meaningful way without first confirming our underlying contractual rights and obligations vis-a-vis OTLLC. In that context, our Board made the difficult decision to commence binding arbitration. The Company's interest in the Entree/Oyu Tolgoi JV property has always been its most important asset, and our future cannot be left to chance. It appears we may yet need a positive decision from the Tribunal to avoid further delays to development. That said, the parties' preference has always been to align through negotiation, and we remain hopeful that can be achieved."
|
ME | Hot Stocks07:41 EDT 23andMe appoints three new independent directors to board - 23andMe announced the appointments of Andre Fernandez, Jim Frankola, and Mark Jensen, three accomplished and experienced executives, as independent members of the Company's Board of Directors, effective on October 28, 2024. Each of Fernandez, Frankola, and Jensen have been appointed to serve as members of the Board's Audit Committee and Compensation Committee, with Fernandez serving as the Chair of the Audit Committee and Jensen serving as the Chair of the Compensation Committee. In addition, Jensen has been appointed to serve as the Board's Lead Independent Director. The Board will now consist of the three new independent directors and Anne Wojcicki, the Company's Chief Executive Officer, Co-Founder, and Chair of the Board.
|
ERLFF | Hot Stocks07:41 EDT Entree Resources says committed to fulfilling obligation under Mongolian law - The Company is committed to fulfilling any obligation it has under applicable Mongolian law to share with the State of Mongolia up to 34% of the economic benefit derived by the Company from its interest in the Entree/Oyu Tolgoi JV property. CEO Stephn Scott commented, "Following the June 2024 election, we have met with Government officials to reaffirm that commitment. Entree is deeply invested in Mongolia. We have had operations and employees in-country since 2002. We have a scholarship program to provide financial support to students enrolled in undergraduate programs in geology, mining engineering, and environmental science in Mongolian universities, which we are continually expanding. While these things are important, we believe the most beneficial thing we can do for the people of Mongolia is resolve the longstanding issues surrounding the Entree/Oyu Tolgoi JV. Through consolidation of Oyu Tolgoi project license ownership in OTLLC, payment of associated license transfer taxes to the Government, and clearly defined life-of-mine rights and obligations, we can reduce the risk of future delays to lateral development work and establish a clear contractual foundation upon which Entree can share 34% of its economic benefit with the State. Achieving commercial production from Lift 1 Panel 1 as quickly as possible is in the best interests of all stakeholders."
|
OLLI | Hot Stocks07:40 EDT Ollie's Bargain Outlet acquires additional former Big Lots stores - Ollie's Bargain Outlet announced that it was the winning bidder in the latest bankruptcy sale process to acquire eight additional former Big Lots store leases. The eight stores were part of a bankruptcy auction for the second wave of Big Lots store closures, which included 170 stores. The acquisition of the eight additional store leases are subject to final bankruptcy court approval and customary closing conditions. Including these eight additional Big Lots locations, the Company has acquired a total of 15 former Big Lots store leases to date.
|
ZLAB | Hot Stocks07:40 EDT Zai Lab presents data from Phase 3 of KarXT for schizophrenia in China - Zai Lab announced positive topline results from the company's Phase 3 multi-center trial evaluating the safety and efficacy of KarXT or xanomeline and trospium chloride, in China. Consistent with previous global studies, the registrational bridging trial met its primary endpoint, with KarXT demonstrating a statistically significant 9.2-point reduction in the Positive and Negative Syndrome Scale or PANSS, total score compared to placebo at Week 5 . The study also met all key secondary efficacy endpoints, demonstrating a significant improvement in PANSS positive symptom subscale score, PANSS negative symptom subscale score, PANSS negative Marder factor score, the Clinical Global Impression-Severity CGI-S scale at week five and percentage of PANSS responders at week five compared to placebo. Key secondary endpoints were formally tested sequentially in a predefined order. "The positive findings we observed in this bridging trial will contribute to a large global dataset for KarXT and demonstrate that this novel compound has the potential to be an important new treatment option for adults with schizophrenia in China," said Rafael G. Amado, M.D., President, Head of Global Research and Development, Zai Lab. "More than 8 million people in China live with schizophrenia, and fewer than half receive treatment, while many more do not get adequate symptom relief and suffer debilitating side effects from available antipsychotic therapies. This clinical trial is an example of Zai Lab's capabilities as a partner that helps to expand access to innovative treatments in collaboration with our global partners." Based on these results, Zai is moving swiftly to submit New Drug Application NDA to China's National Medical Products Administration NMPA in early 2025
|
ERLFF RIO | Hot Stocks07:39 EDT Entree Resources provides update on Rio Tinto, OTLLC discussions - The Company has been engaged in discussions with Rio Tinto and OTLLC to finalize either the execution and delivery of the existing JV Agreement or conversion to an alternative agreement of equivalent economic value to govern their relationship during the development and mining stages. CEO Stephen Scott commented, "The commercial relationship between Entree and its JV partner is becoming more complicated as the Entree/Oyu Tolgoi JV property moves beyond the exploration stage. It is very important that we have certainty around the terms and conditions the parties will adhere to going forward. While Entree's preference has always been to achieve this contractual certainty through negotiation with OTLLC and Rio Tinto, we have had to look at other ways to ensure shareholder interests are protected, including arbitration". Key points in the discussions have been the transfer of the Shivee Tolgoi and Javhlant mining licenses to OTLLC, the treatment of taxes payable in Mongolia in connection with such license transfers, and ensuring there is an effective mechanism for Entree to fulfil any obligation under Mongolian law to share with the State up to 34% of Entree's economic benefit. Entree believes transfer of the licenses to OTLLC, as Manager and owner of an 80% participating interest in the Entree/Oyu Tolgoi JV, is necessary to maximize operational efficiencies and provide certainty with respect to taxes and royalties. Scott added, "Over the last couple of years, all parties have worked extremely diligently to achieve a commercial resolution that will benefit the Oyu Tolgoi project, the State of Mongolia and its people, and the JV partners and other stakeholders. The parties have identified a potential pathway forward, however, any definitive alternative agreement reached between the Company and OTLLC require the approval of the OTLLC board". Of the nine members of the OTLLC board, six are appointed by Rio Tinto and three are appointed by Erdenes Oyu Tolgoi. Given the importance of the Oyu Tolgoi project to the people of Mongolia, the Company understands OTLLC wants to ensure all board members are supportive before proceeding any further."
|
TBNK HOPE | Hot Stocks07:38 EDT Territorial Bancorp reaffirms recommendation shareholders vote 'FOR' merger - Territorial Bancorp (TBNK) announced that the Company's Board of Directors has reaffirmed its recommendation that Territorial shareholders vote "FOR" the merger with Hope Bancorp, (HOPE) at the November 6, 2024, Special Meeting of Stockholders. On October 25, 2024, Territorial received additional information from Blue Hill Advisors with respect to its preliminary indication of interest to acquire the Company. Territorial's Board of Directors, with the assistance of its legal and financial advisors, over the course of several meetings, carefully reviewed this information in accordance with its fiduciary duties, its commitment to serving the best interests of all Territorial shareholders and its obligations under Territorial's merger agreement with Hope Bancorp.
|
ERLFF | Hot Stocks07:38 EDT Entree Resources commences underground development on Entree/Oyu Tolgoi - Entree Resources announcde first Oyu Tolgoi Lift 1 Panel 1 underground development work on the Entree/Oyu Tolgoi joint venture property has commenced. The work is included in the 2024 Oyu Tolgoi Mine Plan previously submitted to and approved by the Mineral Resources and Petroleum Authority of Mongolia. The work is limited as to scope, and the timing of any future development work in the Hugo North Extension deposit footprint is contingent upon the resolution of certain outstanding issues, including the transfer of the Shivee Tolgoi license to the Company's joint venture partner Oyu Tolgoi. The joint venture Management Committee approved a maximum of 212 metres of lateral development work in the southwest corner of HNE in line with the 2024 Oyu Tolgoi Mine Plan. The 2024 Development Work will be performed in accordance with the terms and conditions of the joint venture agreement appended to the amended 2004 Equity Participation and Earn-in Agreement. The 2024 Development Work is part of the initial Panel 1 western ore handling truck chute design which, when completed, will include extraction level tipple development, which connects the truck chute chamber on the haulage level, and the supporting ventilation loop with the return air level. As the 2024 Development Work is in rock classified as waste, no saleable minerals, concentrates, metals or other saleable mineral end product is expected to be produced. The joint venture Management Committee approved a US$4.4 million direct capital budget for the 2024 Development Work and confirmed OTLLC will charge Entree a sum equal to 2% of actual costs allocated to Entree in lieu of general and administrative expenses. OTLLC will contribute Entree's 20% share of actual costs and charges when they are incurred, with such contribution to be treated as a loan in accordance with Article 10 of the JV Agreement.
|
DTM | Hot Stocks07:36 EDT DT Midstream raises 2024 adjusted EBITDA guidance to $950M-$980M - "Our year-to-date results are ahead of plan," said Jeff Jewell, Executive Vice President and CFO. "Our strong performance is leading us to increase our Adjusted EBITDA guidance for 2024 to $950 - $980 million."
|
UHAL | Hot Stocks07:35 EDT U-Haul acquires 2 self-storage facilities in Baldwin County, Alabama - U-Hau is now serving customers at two new self-storage locations in southern Alabama. he former Wolf Bay Storage facilities in Robertsdale and Elberta were acquired on Oct. 22. The properties had served as U-Haul dealer locations for more than 20 years. "Baldwin County is one of the fastest growing counties in the U.S. and a favorite spot for vacationers," stated Chad Rome, U-Haul Company of South Alabama president. "This is a great opportunity for U-Haul to expand into new markets and serve more customers with our trusted moving and storage products."
|
KNSA | Hot Stocks07:35 EDT Kiniksa sees FY24 ARCALYST revenue between $410M-$420M - Kiniksa expects 2024 ARCALYST net product revenue of between $410 million and $420 million, compared to prior guidance of between $405 million and $415 million. Kiniksa expects to remain cash flow positive on an annual basis.
|
BEBE | Hot Stocks07:31 EDT Hilco Global and TPG Angelo Gordon launch JV with Bluestar for consumer brands - Hilco Global or Hilco and TPG Angelo Gordon announced the formation of a new joint venture that will identify, acquire, and finance consumer brands and IP in partnership with Bluestar Alliance...In connection with the launch, the JV has completed a series of inaugural transactions, including: An approximately $190M investment in a securitization transaction established by BR Brand Management a subsidiary of B. Riley Financia financing certain brands managed, licensed, and co-owned by Bluestar, including Hurley, Justice, and Scotch & Soda, among others. A co-investment with Bluestar to acquire the international luxury streetwear brand, Off-White, from LVMH. Bluestar announced its initial acquisition of Off-White in September 2024. The acquisition of the assets and IP of the bebe and Brookstone brands from bebe stores, Since 2018, bebe stores, inc. has owned the intellectual property assets and Bluestar has managed the bebe and Brookstone brands. The JV will seek to continue to acquire or finance additional consumer brands and IP, alongside Bluestar. Ralph Gindi, Co-Founder and Chief Operating Officer of Bluestar, and Joseph Gabbay, Co-Founder and Chief Executive Officer of Bluestar said, "We're thrilled that Hilco Global and TPG Angelo Gordon will be new partners in many of our brands. TPG Angelo Gordon brings significant resources and expertise investing within the consumer sector, and Hilco has an impressive track record of successfully operating and investing in brands and other consumer assets globally. We are excited to partner with these blue-chip firms and leverage our combined expertise to identify and invest in future brand deal opportunities all over the world."
|
PFE | Hot Stocks07:28 EDT Pfizer: FY24 guidance includes ~$10.5B in revenue from Comirnaty, Paxlovid - The company's updated guidance for revenue includes approximately $10.5B in anticipated revenues for Comirnaty and Paxlovid, approximately $5B and $5.5B, respectively. Including the contribution from Seagen and excluding revenues from Comirnaty and Paxlovid, Pfizer continues to expect full-year 2024 operational revenue growth of 9% to 11% compared to 2023 revenues; and this growth guidance takes into consideration the reduction of sales associated with the previously announced global withdrawal of Oxbryta.
|
NB... | Hot Stocks07:28 EDT NioCorp announces consortium awarded UK Government funding - NioCorp Developments (NB) announced that an industry consortium in which it is working with automakers, manufacturers, and supply chain leaders has been awarded funding by the UK Government to support an $8 million program to design lightweight aluminum alloys and cast automotive components made of recycled aluminum strengthened by scandium, which NioCorp intends to produce at its Elk Creek Critical Minerals Project in Nebraska. The collaborative, known as Project PIVOT, includes such companies as Aston Martin (ARGGY), Sarginsons, Altair (ALTR), GESCRAP, and Brunel University London. The Project's Steering Committee includes Jaguar Land Rover, Boeing UK (BA), Alcon Industries, Linamar (LIMAF), Shell Re-Charge, and others. The UK government funding, which totals approximately $3.8 million and will be supplemented by funds from project participants, was awarded by the Advanced Propulsion Centre UK following a competitive process. Project PIVOT is led by Coventry, UK-based aluminum foundry and engineering company Sarginsons and seeks to revolutionize the global casting industry through overhauling the design, weight, carbon intensity and production of cast aluminum, with a target of 100% recycled content.
|
WLFFF | Hot Stocks07:23 EDT Wolfden Resources executes option agreement for Rockland Property - Wolfden Resources has executed an option agreement to earn up to a 75% interest in the Rockland Property in the Walker Lane Trend of Nevada USA. Located just south of south of Yerington, the 1,054 hectare property is underlain by a large, robust, low-sulphidation, quartz-adularia epithermal gold-silver system with similar characteristics to the neighbouring high-grade Aurora and Bodie vein deposits. With drill permits in place, and obvious potential below previously drilled well mineralized targets, Wolfden is targeting a larger hydrothermal system similar to the Silicon discovery by AngloGold, that is located further to the southeast along the same trend. As per the terms of the agreement with Evergold Corp, Wolfden must complete $1.175 million in exploration expenditures, including a minimum of 5,000 feet of drilling, and make cash payments of up to $600,000 over a period of three years to earn a 51% interest in the property by March 2028. Wolfden can elect to earn a 75% interest by completing a Pre-feasibility Study within 5 to 8 years and holds first rights of refusal on the remaining interest and royalties that can be purchased down to a 1.5% net smelter return. The terms of the transaction are subject to regulatory authorities and the TSX Venture exchange. Wolfden is running a process to sell some of its large land holdings in the USA, with an estimated value that could finance the Rockland option drill program and cash payments. The drill program bond will be paid before year end followed by a cash payment to the mineral rights holder in Q1 that totals approximately $200,000.
|
BOOT | Hot Stocks07:19 EDT Correct: Boot Barn was not initiated at BTIG
|
RILY | Hot Stocks07:17 EDT B. Riley Financial secures $236M in cash proceeds from brands assets - B. Riley Financial announced it and its subsidiary, bebe stores, have completed a transaction for their brand assets yielding approximately $236M in cash proceeds to B. Riley. At the closing of the transaction, B. Riley transferred and contributed its interests in the assets and intellectual property related to the licenses of several brands, including Hurley, Justice, Scotch & Soda, Catherine Malandrino, English Laundry, Joan Vass, Kensie, Limited Too and Nanette Lepore to a securitization vehicle, receiving approximately $189M in net proceeds in connection with the financing transaction. bebe sold its interests in the assets and intellectual property related to the licenses of the bebe and Brookstone brands for approximately $47M in net cash proceeds also at the closing. B. Riley acquired the portfolio of brands (excluding bebe and Brookstone) for approximately $222M and received $179M in distributions during its ownership. The company plans on utilizing the proceeds from this transaction to pay down outstanding senior secured debt and deleverage its balance sheet.
|
GLYC | Hot Stocks07:15 EDT GlycoMimetics: NCI Phase 2/3 study of uproleselan did not meet primary endpoint - GlycoMimetics announced the Phase 2 analysis of the adaptive Phase 2/3 study of uproleselan being conducted by the National Cancer Institute and the Alliance for Clinical Trials in Oncology in adults with newly diagnosed acute myeloid leukemia who are 60 years or older and fit for intensive chemotherapy. This study did not show a statistically significant improvement in event free survival for patients receiving uproleselan in combination with 7+3 chemotherapy versus chemotherapy alone. GlycoMimetics is coordinating with the Alliance for transfer of full trial data for additional analysis, including subgroup analysis to evaluate if there are efficacy signals in any patient population that may merit further study in future clinical trials. Top-line results from NCI/Alliance trial are expected to be presented by the NCI at a future medical conference.
|
TLRY | Hot Stocks07:15 EDT Tilray subsidiary releases new creation, Dad's Stash Whiskey - Breckenridge Distillery, a subsidiary of Tilray Brands, has teamed up with Flaviar to launch its newest creation, Dad's Stash Whiskey. This limited-edition whiskey is available to purchase now to support No-Shave November and raise funds for the awareness and treatment of colon and rectal cancers amongst men worldwide.
|
CAPT H | Hot Stocks07:14 EDT Captivision announces venture at Dream Hollywood hotel - Captivision (CAPT) announced its first collaboration with the Dream Hollywood hotel in Los Angeles. Crescent Hotels & Resorts, a leading hotel management company, manages Dream Hollywood. The property is part of Hyatt's (H) global portfolio of hotels, under the Dream Hotels brand. "Joining forces with Dream Hollywood is a pivotal venture for our company in multiple respects," said Gary Garrabrant, Chairman and CEO of Captivision. "Captivision is quickly becoming a solution provider across the LED product spectrum generating entirely new revenue streams with valued partners and clients. We believe this collaboration will kickstart an exciting new chapter of growth for Captivision in the United States and globally."
|
CLVT | Hot Stocks07:14 EDT Silverchair announces agreement with Clarivate to acquire ScholarOne - Silverchair, a portfolio company of Thompson Street Capital Partners, announced that is has entered into a definitive agreement with Clarivate to acquire ScholarOne, a provider of software and services to scholarly publishers and societies. Terms of the transaction were not disclosed. Founded in 1993 and based in Charlottesville, VA, Silverchair provides a suite of software and services to leading global publishers of scientific, technical, and medical content. The company has leveraged its feature-rich and extensible content management system, the Silverchair Platform, to build new products that help more than 400 publishers manage, distribute and monetize STM content.
|
SASKF | Hot Stocks07:13 EDT Atha Energy engages ICP Securities for automated market making services - ATHA has engaged the services of ICP Securities to provide automated market making services, including use of its proprietary algorithm, ICP Premium, in compliance with the policies and guidelines of the TSX Venture Exchange and other applicable legislation. ICP will be paid a monthly fee of C$7,500, plus applicable taxes, which will be payable within five business days of the receipt of an invoice from ICP by the Company, which will be provided on the first day of every month. The market making services agreement between the Company and ICP was dated effective October 15, 2024, and is for an initial term of three months. The Agreement will automatically renew for subsequent one month terms unless either party provides at least thirty days written notice prior to the end of the Initial Term or Additional Term, as applicable. There are no performance factors contained in the agreement and no stock options or other compensation in connection with the engagement of ICP by the Company. ICP and its clients may acquire an interest in the securities of the Company in the future. ICP is an arm's length party to the Company. ICP's market making activity will be primarily to correct temporary imbalances in the supply and demand of the Company's shares. ICP will be responsible for the costs it incurs in buying and selling the Company's shares, and no third party will be providing funds or securities for the market making activities.
|
SKYE | Hot Stocks07:12 EDT Skye Bioscience names Grayson as Chairman of the Board - Skye Bioscience announced the Board has appointed independent director Paul Grayson as Skye's new Chairman of the Board, effective October 25, 2024. Grayson currently serves as a member of Skye's Audit, Compensation and Nominating and Corporate Governance Committees. Punit Dhillon, Skye's Chief Executive Officer, will continue to serve as a member of the Board.
|
MTDR EPD | Hot Stocks07:12 EDT Matador receives ~$113M from sale of Pinon Midstream - Enterprise Products Partners L.P. (EPD) announced that it had completed its acquisition of Pinon Midstream. Matador Resources (MTDR) announced it had received its share of the sales proceeds, or approximately $113M, for Matador's approximate 19% ownership interest in the parent company of Pinon. Joseph Wm. Foran, Matador's Founder, Chairman and CEO, commented, "Congratulations to the Enterprise team on a smooth and successful transaction. We were pleased to have acquired an approximate 19% ownership interest in the parent company of Pinon in connection with our recent Ameredev acquisition that closed in September 2024. We look forward to working with Enterprise going forward as we develop our assets in southern Lea County, New Mexico. We plan to use the approximate $113 million in sales proceeds to pay down our $980 million in current outstanding borrowings under our $2.25 billion credit facility."
|
CLMB | Hot Stocks07:11 EDT Climb Channel launches North American partnership with Fortra - Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, announced a North American partnership with Fortra. Fortra provides trusted cybersecurity solutions that span every part of the cyber-attack chain, from detection to response. Through this partnership, Climb North American VARs and MSPs have access to Fortra's entire portfolio, which includes solutions covering digital risk and email protection, managed file transfer, data protection, infrastructure protection, managed security services, security awareness training, and automation.
|
SASKF | Hot Stocks07:11 EDT Atha Energy CFO Akash Patel resigns, Rheal Assie to succeed - ATHA Energy announced the appointment a new Non-Executive Director and a new CFO. Erinn Broshko has been appointed to its Board of Directors, effective immediately; and, Rheal Assie has been appointed as CDI, effective November 6, 2024. Broshko is currently the Managing Director of a Vancouver-based private equity firm. Assie worked for Deloitte for a number of years conducting audits on junior and major mining companies and providing advisory services to both the public, private and government sectors. He also worked for large mining companies including Agrium, Cameco, and as CFO & Corporate Secretary of NexGen Energy. ATHA also announces the resignations of Jeffrey Barber from the board of Directors of the Company as well as the resignation of Akash Patel as CFO, to be effective November 6, 2024. Each of Mr. Barber and Mr. Patel have agreed to provide consulting services to the Company for a period of time that provides for an orderly transition.
|
IVVD | Hot Stocks07:10 EDT Invivyd reports preliminary Q3 PEMGARDA product revenue $9.3M - The company estimates that Invivyd ended Q3 2024 with approximately $107 million in cash and equivalents, and, with anticipated growth of net product revenue and various operational efficiencies underway, believes existing cash and cash equivalents will be sufficient to fund operations through profitability. These estimates are preliminary and are subject to change upon completion of the company's financial closing procedures for Q3 2024, and finalization of the unaudited interim condensed consolidated financial statements. "We continue to feel confident about the demand for PEMGARDA and our ability to return to strong product growth despite the unnecessary headwinds inflicted by the Agency," said Marc Elia, Chairman of the Invivyd Board of Directors. "While we are engaged in discussions with key leaders at the FDA, it is clear that we must also focus on what matters most: the vulnerable populations who deserve more protection against this devastating virus, especially as we enter the winter season where many individuals hope to gather with friends and family. Our confidence in the ultimate commercial potential of PEMGARDA is unchanged."
|
PYPL | Hot Stocks07:10 EDT PayPal down 2% at $81.61 following Q3 results and updated guidance
|
SXI | Hot Stocks07:09 EDT Standex acquires Amran Instrument Transformers, Narayan Powertech - Standex International announced that it has acquired, in separate transactions, privately-held US-based Amran Instrument Transformers and India-based Narayan Powertech Pvt. in cash and stock transactions. These transactions represent a combined enterprise value of approximately $462M comprised of 85% cash and 15% in Standex common stock for Amran Instrument Transformers and 90% cash and 10% in Standex common stock for Narayan Powertech Pvt. Ltd. The 10% share exchange related to Narayan Powertech Pvt. Ltd. is subject to India regulatory approval, which is expected to take up to six months. The cash consideration of the transactions was financed using cash-on-hand, existing credit facilities, and a $250M 364-day term loan with existing lenders. The Company intends over the next several weeks to convert the 364-day term loan into exercise of the accordion feature under its existing credit facilities. Standex will remain committed to paying down debt and expects to reduce leverage below 1.0x net debt to EBITDA ratio within the first 24 months post-transaction. In calendar year 2024, Amran/Narayan Group estimates revenues of approximately $100M with an adjusted EBITDA margin above 40%. The transactions are expected to be immediately accretive to Standex's revenue growth, EBITDA margin, operating margin, earnings per share and free cash flow in the first full year post closing of the transactions, excluding any acquisition and integration related costs. Longer term, the combination is expected to create cross-selling opportunities given the companies' complementary offerings. Moving forward, Amran/Narayan Group's founders and leadership team will remain with the combined company. Their entrepreneurial know-how, technical skills, and extensive experience across the transformer industry will benefit the combined company with its integration efforts, innovation roadmap, and future growth. Amran/Narayan Group will be reported as part of Standex's Electronics business segment.
|
IVVD | Hot Stocks07:07 EDT Invivyd announces 12-month exploratory data from CANOPY Phase 3 trial - Invivyd announced positive 12-month exploratory clinical efficacy data from the company's ongoing CANOPY Phase 3 clinical trial of pemivibart, a half-life extended investigational monoclonal antibody, for the pre-exposure prophylaxis, PrEP, of COVID-19. The exploratory clinical efficacy data from follow-up months 7-12 in CANOPY Cohort B showed a relative risk reduction of 64% in the pemivibart arm compared to placebo in the likelihood of trial participants contracting confirmed symptomatic COVID-19. Continued protection over this follow-up period, absent continued dosing, was a prespecified exploratory endpoint and, added to initial 180-day clinical efficacy observations, generated an overall 12-month protection rate of 76% following two doses of pemivibart. The safety profile of pemivibart over the 12-month study period was reassuring with no new trends or safety signals observed for treatment-emergent adverse events or infusion-related reactions or hypersensitivity reactions since the disclosure of the 6-month CANOPY data.
|
CECO PFIE | Hot Stocks07:07 EDT Ceco Environmental to acquire Profire Energy for $125M - CECO Environmental (CECO) and Profire Energy (PFIE) announced a definitive agreement where CECO will acquire Profire, in an all-cash transaction. Profire is a leader in burner management technology and combustion control systems that provide mission-critical combustion automation and control solutions and services to improve environmental efficiency, safety and reliability for industrial thermal applications globally. Profire estimates its 2024 sales to be greater than $60 million with adjusted EBITDA margins of approximately 20 percent. Under the terms of the agreement, a subsidiary of CECO will commence a tender offer to acquire all issued and outstanding shares of Profire common stock at a price of $2.55 per share, in cash, without interest and subject to applicable withholding tax. The tender offer will initially remain open for 20 business days from the date of commencement of the tender offer, subject to extension under certain circumstances. The transaction, which has been unanimously approved by Profire's Board of Directors, implies an equity value of approximately $125 million and a total enterprise value for Profire of approximately $108 million. The tender offer is subject to customary closing conditions, including that at least a majority of the outstanding shares of Profire's common stock are tendered and not withdrawn in the tender offer and the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The price represents a 46.5% premium over Profire's closing share price of $1.74 on October 25, 2024 and a premium of 60.3% to Profire's 30-day volume weighted average share price on October 25, 2024. Following a successful completion of the tender offer, including the satisfaction of certain customary conditions, CECO will acquire all remaining untendered shares of Profire common stock at the same price of $2.55 per share in cash through a merger of Merger Sub with Profire, with Profire continuing as the surviving corporation. Upon completion of the transaction, Profire will become a wholly-owned subsidiary of CECO and shares of Profire's common stock will no longer be listed on any public market. The parties anticipate that the combination will be completed in the first quarter of 2025.
|
PYPL | Hot Stocks07:06 EDT PayPal reports total payment volume up 9% - Reports Q3: Transaction margin dollars increased 8% to $3.7 billion; Total payment volume increased 9% to $422.6 billion; 9% FXN; Payment transactions increased 6% to 6.6 billion; Payment transactions per active account on a trailing 12-month basis increased 9% to 61.4; Active accounts increased 0.9% to 432 million. On a sequential basis, active accounts increased 0.6%, or by 2.6 million.
|
MAC | Hot Stocks07:06 EDT Macerich refinances Queens Center with new $525M loan - Macerich has refinanced fortress property Queens Center at highly favorable terms with a new $525M loan bearing fixed interest of 5.37% and interest-only payments during the entire term. "We are pleased to share details on our just-completed refinance of Queens Center, consistently one of the best-performing properties in our entire portfolio," said Jack Hsieh, CEO "5.37% is the lowest rate on a refinance that Macerich has achieved since 2019, and this loan represents Macerich's largest outstanding loan. This completed transaction demonstrates confidence from the capital markets in Macerich's assets and in progress on our Path Forward Plan, launched earlier this year, which is sharply focused on three key areas: simplifying our business, improving operational performance and reducing leverage. Through advantageous refinancings like this, among other strategic initiatives, we are continuing to advance Macerich's mission to add long-term value for our shareholders, partners and customers."
|
SGMT | Hot Stocks07:04 EDT Sagimet Biosciences completes End-of-Phase 2 meeting with FDA on denifanstat - Sagimet Biosciences announced the completion of end-of-Phase 2 interactions with the U.S. Food and Drug Administration, supporting the advancement of denifanstat into Phase 3 in metabolic-dysfunction associated steatohepatitis. The planned program will include two Phase 3 trials: FASCINATE-3, evaluating patients with F2/F3 MASH, and FASCINIT, evaluating patients with suspected or confirmed diagnosis of metabolic dysfunction-associated steatotic liver disease/MASH. The Phase 3 program is expected to initiate by the end of 2024. Based on ongoing discussions with the FDA, the planned Phase 3 program will consist of two double-blind, placebo-controlled multicenter registrational trials: FASCINATE-3 in patients with F2/F3 MASH: The trial will evaluate the efficacy and safety of denifanstat in this population, with primary endpoints being liver biopsy and 4.5-year clinical outcomes. FASCINIT in patients with suspected or confirmed diagnosis of MASLD/MASH: The trial will evaluate the efficacy and safety of denifanstat in this population, with primary endpoints being safety and tolerability. Non-invasive biomarkers will be assessed as part of the secondary endpoints, and there will be no end-of-treatment liver biopsy. The Phase 3 program is designed to comprise a minimum of 1,800 patients exposed to denifanstat.
|
BITF | Hot Stocks07:04 EDT Bitfarms appoints Chang to its board of directors - Bitfarms announced that it has nominated Andrew Chang for election to its Board of Directors at the Special Meeting of shareholders to be held on November 20, 2024. Chang was a founding partner of Liberty City Ventures, a leading venture capital fund. Mr. Chang also served as Chief Operating Officer of Paxos
|
GPK | Hot Stocks07:03 EDT Graphic Packaging comments on Vision 2030 model, capital allocation priorities - The company said its Vision 2030 base financial model includes annual sales growth in the low single digits, annual adjusted EBITDA growth in mid-single digits, annual adjusted EPS growth in the high single digits. The base model includes sales of $8.8B, adjusted EBITDA of $1.7B, and $2.52B. Capital priorities include growing the dividend, repurchasing shares, and tuck-under M&A. Comments taken from Q3 earnings conference call presentation slides.
|
CXT | Hot Stocks07:02 EDT Crane NXT acquires smart packaging asssets of TruTag Technologies - Crane NXT announced that it has completed the acquisition of the Smart Packaging assets of TruTag Technologies. TruTag provides secure digitization of physical products through proprietary secure marking and smartphone authentication. "The addition of this technology to Crane NXT's product portfolio is an exciting expansion of our capabilities and further enhances our ability to provide differentiated and innovative technology solutions to our customers," Aaron W. Saak, Crane NXT's President and Chief Executive Officer, said. "TruTag's Smart Packaging technology will also expand our capability for direct-to-product marking in both consumer and industrial applications which will further drive profitable growth."
|
MCD | Hot Stocks07:02 EDT McDonald's reports Q3 global comparable sales decreased 1.5% - Q3 U.S. SSS increased 0.3%; International Operated Markets segment decreased 2.1%; International Developmental Licensed Markets segment decreased 3.5%.
|
COYA | Hot Stocks06:56 EDT Coya Therapeutics says Phase 2 LD-1L-2 study met primary, secondary endpoints - Coya Therapeutics announced that results from the placebo-controlled Phase 2 clinical trial of LD IL-2 in patients with mild to moderate Alzheimer's Disease were announced at the 17th Clinical Trials on Alzheimer's Disease Conference in Madrid, Spain. The study was led by Dr. Alireza Faridar and Dr. Stanley Appel from the Houston Methodist Research Institute. Dr. Appel is a member of Coya's Scientific Advisory Board. The study received funding from the Alzheimer's Association, the Gates Foundation, and the National Institute on Aging, with additional support from Coya. The investigator-initiated, randomized, double-blind, placebo-controlled Phase 2 trial evaluated two dosing regimens of subcutaneous low-dose interleukin-2 in 38 participants with Alzheimer's disease that were between the ages of 50 to 86 and had Mini-Mental State Examination scores ranging from 12 to 26. Of the 38 total participants, 22 were randomized in a 1:1 ratio to receive either 5 days of LD IL-2 or placebo every 4 weeks for 21 weeks. An additional 16 participants were randomized in a 2:1 ratio to receive 5-day cycles of LD IL-2 every 2 weeks or placebo for the same 21-week duration. All participants were monitored for 9 weeks post-treatment, resulting in a total study period of 30 weeks. Demographics and baseline disease characteristics were comparable among the treatment groups. The primary endpoint was the incidence and severity of adverse events, with the secondary endpoint evaluating changes in Tregs. Exploratory endpoints assessed changes in cerebrospinal fluid, AD-related biomarkers, and cognitive status. The study successfully met its primary and secondary endpoints, demonstrating that treatment with low-dose interleukin-2 is safe and well-tolerated in patients with Alzheimer's disease. Notably, LD IL-2 showed targeted biological activity, evidenced by a significant expansion of regulatory T cell populations in the LD IL-2 q4wks group without any off-target effects on other peripheral lymphocytes. Additionally, the q4wks regimen led to significant improvements in cerebrospinal fluid-soluble Abeta42 levels, an indicator of amyloid pathology, and showed a promising trend in stabilizing cognitive function, with a clinically meaningful 4.93-point improvement1 in the ADAS-Cog14 score compared to placebo. In contrast, the q2wks group, representing the higher total dose cohort, did not exhibit benefits in exploratory endpoints, underscoring the importance of appropriate IL-2 dosing for maintaining Treg functionality and its associated effects on CSF biomarkers and cognitive outcomes. LD IL-2 q2wks dosing also resulted in a reduction of Foxp3 expression, a critical marker of Treg functionality. While these unstable Tregs continue to show suppressive immune response in vitro, they may lose their immunomodulatory functions in vivo, potentially explaining the dose impact on Treg populations and associated exploratory endpoints. As a result of these data, the company will likely advance LD IL-2 q4wks. Shares of Coya Therapeutics are up 1% in pre-market trading.
|
MSCI | Hot Stocks06:48 EDT MSCI raises 2024 CapEx view to $105M-$115M from $95M-$105M
|
PFE | Hot Stocks06:48 EDT Pfizer sees 'at least' $4B by 2024-end from cost realignment program - Approximately $1.5B expected by end of 2027 from first phase of manufacturing optimization program.
|
DHI | Hot Stocks06:35 EDT D.R. Horton raises quarterly dividend to 40c per share - Subsequent to year-end, the company declared a quarterly cash dividend of 40c per common share, an increase of 33% compared to its most recent dividend paid. The dividend is payable on November 19, 2024 to stockholders of record on November 12, 2024.
|
BKYI | Hot Stocks06:28 EDT BIO-key secures $910,000 order from financial services customer - BIO-key announced that it has received a $910,000 order from a long-term financial services customer to upgrade to BIO-key's "fingerprint only" Biometric Customer Identification Technology. The technology enhancement builds on the customer's expanding deployment of BIO-key technology to verify the identity of customers, now totaling over 25M enrolled individuals. Previously customers were verified at a branch location by matching their fingerprint scan and their ID number, account number or card. By upgrading to BIO-key's "fingerprint only" identification, the customer will be able to identify each of its clients by a simple fingerprint scan - without the need for a card, account or ID number, saving an estimated thirty seconds per client encounter. The financial services customer plans to upgrade all its users to BIO-key's fingerprint-only identity solution in order to further streamline what is already a best-in-class client experience of its existing BIO-key-based verification solution. The new client identification solution will be entirely hosted on Amazon Web Services infrastructure in order to support the technical demands of real-time, one-to-many biometric identification as compared to one-to-one matching of a fingerprint scan with a biometric associated with an account number, ID number or card. Following full deployment of the enhanced biometric customer identification solution during 2025, BIO-key expects annual recurring revenue from this financial services customer to increase to approximately $1.4M per year.
|
NOK HPQ | Hot Stocks06:16 EDT Nokia signs patent license agreement with HP - Nokia (NOK) announced it has signed a multi-year patent license agreement with HP (HPQ) covering the use of Nokia's video technologies in HP's devices. Under the agreement HP will make royalty payments to Nokia. The agreement resolves all patent litigation between the parties, in all jurisdictions. The terms of the agreement remain confidential as agreed between the parties.
|
BEEM | Hot Stocks06:09 EDT Beam Global receives first order for BeamSpot curbside EV chargers - Beam Global has received the first order for its BeamSpot curbside chargers from a Fortune 500 company in the utility and energy solutions sector. Multiple corporate offices will each install three BeamSpot systems for EV charging and street lighting. This announcement comes shortly after last month's launch of the product, which is part of Beam Global's line up of renewably energized, grid independent, electric vehicle charging solutions. The patented BeamSpot sustainable curbside charging system is a streetlight replacement that combines solar, wind and utility-generated electricity stored in Beam Global's proprietary integrated batteries, to provide resiliency, lighting and curbside EV charging. The BeamSpot solution combines three sources of electricity in its on-board batteries allowing for a higher capacity EV charge which is largely provided by renewable energy.
|
EPD | Hot Stocks06:09 EDT Enterprise Products completes Phase 2 of TW Products system - Enterprise Products Partners announced that its refined products truck terminal serving the Grand Junction, Colorado and Moab, Utah areas is now in service, marking the completion of the second phase of the company's Texas Western Products system. Located in Grand County, Utah, the facility features storage capacity of 400,000 barrels for gasoline and diesel and can load trucks at a rate of up to 20,000 barrels per day. In addition, the terminal is strategically located with direct access to Interstate 70, allowing it to serve markets in both eastern Utah and western Colorado. The new terminal joins three other facilities that began service earlier in 2024, which are located in Gaines County, Texas and the Jal and Albuquerque areas in New Mexico. Combined, the four terminals offer 1.5M barrels of refined products storage capacity and can load up to 63,000 BPD.
|
TPC | Hot Stocks06:08 EDT Tutor Perini unit awarded contract valued at more than $1B for project in CA - Tutor Perini announced that its subsidiary, Rudolph and Sletten, has been awarded a contract valued at more than $1B for a healthcare campus project in California. The project scope of work includes the construction of a new hospital, an energy center and a parking garage. Work is expected to begin in late 2024 with substantial completion anticipated in 2029. The contract value was added to the company's backlog in the third quarter of 2024.
|
CECO PFIE | Hot Stocks06:06 EDT Ceco Environmental to acquire Profire Energy for $125M in cash - Ceco Environmental (CECO) and Profire Energy (PFIE) announced a definitive agreement where CECO will acquire Profire in an all-cash transaction. Profire is a leader in burner management technology and combustion control systems that provide mission-critical combustion automation and control solutions and services to improve environmental efficiency, safety and reliability for industrial thermal applications globally. Profire estimates its 2024 sales to be greater than $60M with adjusted EBITDA margins of approximately 20%. Under the terms of the agreement, a subsidiary of CECO will commence a tender offer to acquire all issued and outstanding shares of Profire common stock at a price of $2.55 per share, in cash, without interest and subject to applicable withholding tax. The tender offer will initially remain open for 20 business days from the date of commencement of the tender offer, subject to extension under certain circumstances. The transaction, which has been unanimously approved by Profire's Board of Directors, implies an equity value of approximately $125M and a total enterprise value for Profire of approximately $108M. Upon completion of the transaction, Profire will become a wholly-owned subsidiary of CECO and shares of Profire's common stock will no longer be listed on any public market. The parties anticipate that the combination will be completed in the first quarter of 2025.
|
CHKP | Hot Stocks06:02 EDT Check Point reports Q3 adjusted EPS $2.25, consensus $2.25 - Reports Q3 revenue $635M, consensus $634.86M. "Check Point delivered great third quarter financial results that were bolstered by double-digit Infinity Platform growth. This success is underscored by double-digit revenue growth in Harmony Email and Infinity Global Services," said Gil Shwed, Check Point founder and CEO. "We expanded our offerings into the Security Operation Center market with the Cyberint acquisition that delivers proactive, AI powered threat intelligence and exposure management. We're looking forward to continued success with our Infinity Platform and the broader adoption of our technologies as we close out the year."
|
MSFT... | Hot Stocks05:57 EDT Microsoft says Google running 'shadow campaigns' in Europe to discredit it - Microsoft (MSFT) has accused Google (GOOGL) of running "shadow campaigns" to discredit it with regulators in Europe, including organizing an "astroturf group" with European cloud providers. Microsoft lawyer Rima Alaily wrote in a blog post that Google hired a firm to recruit European cloud companies to represent the search company's case. "This week an astroturf group organized by Google is launching," Alaily wrote. "It is designed to discredit Microsoft with competition authorities, and policymakers and mislead the public. Google has gone through great lengths to obfuscate its involvement, funding, and control, most notably by recruiting a handful of European cloud providers, to serve as the public face of the new organization." Alaily said Google's tactics "go beyond creating astroturf lobbying organizations. They're also speaking out in their own name in disingenuous ways and putting forward paid commentators to discredit us. Why? I suspect much has to do with the fact that Google is facing a reckoning. Never in the past two decades have Google's search, digital advertising, and mobile app store monopolies faced such a concerted and determined threat as they do today. By our count, there are at least 24 antitrust investigations against Google in the leading digital markets around the world. At a time when Google should be focused on addressing legitimate questions about its business, it is instead turning its vast resources towards tearing down others. It is disappointing that, with the foundation of their business facing jeopardy, they have sought to bolster their cloud computing service - Google Cloud Platform - by attacking ours. It seems Google has two ultimate goals in its astroturfing efforts: distract from the intense regulatory scrutiny Google is facing around the world by discrediting Microsoft and tilt the regulatory landscape in favor of its cloud services rather than competing on the merits... We will continue to listen and evolve when we hear credible, legitimate, and addressable concerns, but as Google continues to demonstrate with its actions, the arguments it wants you to believe are none of these." Reference Link
|
FDS | Hot Stocks05:36 EDT FactSet to acquire Irwin from K1 Investment, terms undisclosed - K1 Investment Management announced that its portfolio company Irwin, a provider of investor relations and capital markets software, has entered into a definitive agreement to be acquired by FactSet. The transaction is expected to close in the coming weeks and marks K1's second exit to a publicly traded strategic buyer since the summer. Since K1's initial investment in 2021, Irwin grew revenue by 4x by introducing new products such as Irwin IQ, expanding into the European market, and securing partnerships with groups such as FactSet and New York Stock Exchange. K1 has realized over $2.9B in enterprise value year-to-date through notable exits including GoCanvas and Axcient.
|
BP | Hot Stocks05:31 EDT BP sees FY24 upstream production slightly higher than FY23 - The company said, "bp continues to expect both reported and underlying upstream production* to be slightly higher compared with 2023. Within this, bp continues to expect underlying production from oil production & operations to be higher and production from gas & low carbon energy to be lower. In its customers business, bp continues to expect growth from convenience, including a full year contribution from TravelCenters of America; a stronger contribution from Castrol underpinned by volume growth in focus markets; and continued margin growth from bp pulse driven by higher energy sold. In addition, bp continues to expect fuels margins to remain sensitive to the cost of supply. In products, bp continues to expect a lower level of industry refining margins relative to 2023, with realized margins impacted by narrower North American heavy crude oil differentials. bp continues to expect refinery turnaround activity to have a lower financial impact compared to 2023, reflecting the lower margin environment. Phasing of turnaround activity in 2024 is heavily weighted towards the second half, with the highest impact in the fourth quarter. bp now expects other businesses & corporate underlying annual charge to be $0.3-0.4 billion for 2024. bp continues to expect the depreciation, depletion and amortization to be slightly higher than 2023. bp continues to expect the underlying ETR* for 2024 to be around 40% but it is sensitive to a range of factors, including the volatility of the price environment and its impact on the geographical mix of the group's profits and losses. bp continues to expect capital expenditure* for 2024 to be around $16 billion. bp now expects divestment and other proceeds to be greater than $3 billion in 2024. Having realized $19.2 billion of divestment and other proceeds since the second quarter of 2020, bp continues to expect to reach $25 billion of divestment and other proceeds between the second half of 2020 and 2025. During the fourth quarter, bp completed the transactions to acquire a further 50% of the issued ordinary shares of bp Bunge Bioenergia and 50.03% of the issued ordinary shares of Lightsource bp and now owns 100% of the ordinary shares of both companies. Full earnings from both companies will be included in bp's results from the date the transactions complete and finance debt acquired is expected to be approximately $3.7 billion. bp continues to expect Gulf of Mexico settlement payments for the year to be around $1.2 billion pre-tax including $1.1 billion pre-tax paid during the second quarter."
|
BP | Hot Stocks05:28 EDT BP sees Q4 reported upstream production lower than Q3 - The company said, "Looking ahead, bp expects fourth quarter 2024 reported upstream production to be lower compared with the third-quarter 2024. In its customers business, bp expects seasonally lower volumes compared to the third quarter and fuels margins to remain sensitive to movements in the cost of supply. In products, bp expects realized refining margins to remain low in the fourth quarter, albeit to continue to remain sensitive to relative movements in product cracks."
|
DD | Hot Stocks05:21 EDT DuPont, Zhen Ding Technology enter strategic cooperation agreement - DuPont and Zhen Ding Technology announced they have entered into a strategic cooperation agreement in advanced printed circuit board, or PCBs, technology. The signing ceremony, held yesterday at the Shenzhen Avary Time Center, was attended by Charles Shen, chairman, Zhen Ding; Yi Zhang, president of the Asia Pacific Region, DuPont; and Thean Ming Tan, global business director for laminates, DuPont. Through this strategic partnership, DuPont and Zhen Ding will work to enhance end-user applications, advance research and development, improve material performance, and promote the sustainable development of the electronics sector. Furthermore, they intend to deepen their cooperation in advancing smart manufacturing, corporate governance, and sustainability initiatives.
|
HSBC | Hot Stocks05:20 EDT HSBC says guidance remains unchanged - HSBC said its guidance remains unchanged from that set out at its Interim results on July 31. The bank continues to target a mid-teens return on average tangible equity in 2024 and 2025, excluding the impact of notable items, while acknowledging the outlook for interest rates has changed, and been volatile, since its first half results announcement in July. HSBC's banking net interest income guidance of around $43B for 2024 remains unchanged and it continues to target cost growth of approximately 5% for 2024 compared with 2023, on a target basis.
|
HSBC | Hot Stocks05:18 EDT HSBC announces new $3B share buyback program - HSBC said it completed the $3B share buyback announced at its interim results and intends to initiate a share buyback of up to $3B, which it expects to complete within the four-month period before its 2024 full-year results announcement.
|
QGEN | Hot Stocks05:18 EDT Qiagen announces FDA clearance of QIAstat-Dx Respiratory Panel Mini test - Qiagen announced that the FDA has cleared the QIAstat-Dx Respiratory Panel Mini test for clinical use. It is the third test to receive FDA clearance for use with QIAstat-Dx systems in 2024. The QIAstat-Dx Respiratory Panel Mini is designed to support clinical decision making in diagnosing upper respiratory infections in outpatient settings and covers five common viral causes of illness: influenza A, influenza B, human rhinovirus, respiratory syncytial virus and SARS-CoV-2.
|
IDCC | Hot Stocks05:12 EDT InterDigital enters license agreement with Oppo Group, ends pending litigations - InterDigital announced that it has signed a new license agreement with Oppo Group. The agreement covers Oppo, realme and OnePlus branded mobile devices worldwide. As part of the agreement, both parties have agreed to dismiss all pending litigations between them.
|
FINV | Hot Stocks05:10 EDT AdaKami enters $32M strategic funding agreement with PT Super Bank Indonesia - FinVolution announced that its Indonesian financial application, AdaKami, has entered into a strategic funding agreement with PT Super Bank Indonesia, a digital-focused bank in Indonesia. Under the terms of the agreement, Superbank will provide AdaKami with a funding facility of $32M. With this agreement, Superbank will become AdaKami's funding partner in Indonesia. Currently, AdaKami has established cooperation with multiple lenders including Superbank, Seabank, Bank Jago, Bank Permata, OCBC NISP among others.
|
ERIC | Hot Stocks05:07 EDT Ericsson, MasOrange announce five-year Open RAN-ready future-network partnership - Ericsson and MasOrange are embarking on a five-year Open RAN-ready future-network partnership that will put the Spanish operator at the forefront of Europe's open and programmable networks. Under the deal, Ericsson will integrate Orange Spain's and Masmovil's existing networks. This will include supporting the consolidated MasOrange network through high-performing and sustainable network solutions designed for an increasingly open architecture. This approach enables greater flexibility, scalability, and innovation in network operations and service delivery. Starting in October, the project will run in parallel with the deployment of Ericsson-powered 5G Standalone in rural areas of Spain. When complete, the project will equip MasOrange with one of the most 5G Standalone mobile networks in Europe, enabling it to provide 5G services to subscribers throughout the country.
|
J | Hot Stocks05:03 EDT Jacobs appointed to plan, design water assets in Northern Ireland - Jacobs was appointed by Northern Ireland Water to a new professional services framework supporting water and wastewater capital improvements across the region. Northern Ireland Water provides water and sewerage services to approximately 840,000 households and businesses in Northern Ireland. The framework will support Northern Ireland Water with the remainder of its business plan - a six-year investment program that includes significant upgrades to Northern Ireland Water's infrastructure for water and wastewater. Jacobs' scope of work covers feasibility, design and climate change management services, including design services for major projects, water and wastewater network modelling and climate adaptation and net zero planning. The framework runs for an initial four-year period, with the option to extend for up to four additional years.
|